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Inflammatory bowel disease (IBD) is a chronic autoimmune disease 
characterised by inflammation of the gastrointestinal tract. The pathogenesis of 
IBD is not fully understood and curative therapies are lacking. Consequently, 
development of robust intestine models, representative of the pathogenesis of 
IBD remains an unmet need. Thus, the overall aims of the studies presented in 
this thesis were to develop a number of models of small intestine including: 
genetically engineered murine model, epithelial cell culture models, and an 
intestinal stem cell organoid model which could reflect or be used to study the 
pathogenesis of IBD. 
Interleukin 1 (IL-1) is an important mediator of inflammation and tissue damage 
in IBD. The balance between IL-1 and IL-1Ra as a natural inhibitor plays a vital 
role in a variety of diseases. Here, this thesis investigated whether changes 
seen during IBD could be induced spontaneously by the removal of IL-1Ra in 
mice that lack a functional IL-1rn gene. Data presented from this thesis 
highlighted the importance of IL-1 in the pathogenesis of inflammatory bowel 
disease.  
In addition, the potential of L-pNIPAM hydrogel scaffolds, which were developed 
by the research team at Sheffield Hallam University, was utilised to develop 
long-term 3D co-cultures of layered Caco-2 and HT29-MTX cells under 
conditions representative of inflammation by treatment with IL-1β, TNFα, and 
hypoxia (1% O2) for 1 week was investigated. In vitro cell culture studies in this 
thesis have demonstrated that L-pNIPAM hydrogel supported long-term 3D co-
culture model and stimulation with factors seen during inflammation 
recapitulated features of IBD.  
Finally, the potential of L-pNIPAM hydrogel scaffolds to develop 3D intestinal 
stem cell organoid model was investigated. The in vitro study demonstrated the 
ability of L-pNIPAM hydrogel as scaffold to support organoid formation and cell 





Dissemination: Scientific publications 
 Dosh R. H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. (2018). 
Tissue engineering laboratory models of the small intestine. Tissue 
Engineering Part B, 24(2), 98-111. A schematic diagram illustrating the 
morphology of the small intestinal layers was chosen as the art cover 
for the journal. 
 
 Dosh R. H., Essa A., Jordan-Mahy N., Sammon C., and Le Maitre C. L. 
(2017). Use of hydrogel scaffolds to develop an in vitro 3D culture model of 
human intestinal epithelium. Acta Biomaterilia, 62, 128-143. 
 
 Dosh R. H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. (2018). Long-
term in vitro 3D hydrogel co-culture model of inflammatory bowel disease.  
Scientific Reports. Manuscript submitted July 2018. 
 
 Dosh R. H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. (2018). 
Interleukin-1 is a key driver of inflammatory bowel disease - demonstration 
in a murine IL-1Ra knockout model. Inflammatory bowel disease. Manuscript 
submitted July 2018. 
 
 Dosh R. H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. (2018). 
Isolation and in vitro expansion of murine small intestinal stem cells using 





 Dosh R. H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. (2017) 
 The use of pNIPAM-laponite® hydrogel in 3D-cell culture of the intestine.                               
 European Cells and Materials. Abstract, 33 Suppl. 2 (P517). 
  
Dissemination: Oral and poster presentations 
Oral presentations 
 January 2017 - Royal Society of Chemistry Biomaterials, Belfast, UK: Novel 
in vitro three-dimensional culture of human intestinal epithelium. Dosh R. H., 
Jordan-Mahy N., Sammon C., and Le Maitre C. L. 
 
 October 2016 - 6th Clinical Gastroenterology and Hepatology, Toronto, 
Canada: Novel in vitro three-dimensional culture of human intestinal 
epithelium. Dosh R. H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. 
 
 October 2016 - 9th Euro - Global Gastroenterology Conference, Valencia, 
Spain: Novel in vitro three-dimensional culture of human intestinal epithelium. 
Dosh R.H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. 
 
 Poster presentations 
 September 2017 - 1st Iraqi Society Conference, Sheffield. UK: The use of 
pNIPAM-laponite hydrogel in 3D cell culture of the intestine. Dosh R.H., 
Jordan-Mahy N., Sammon C., and Le Maitre C. L. (3rd Place Poster Prize).  
 
 July 2017 - TCES, Manchester, UK: Development of a 3D in vitro co-culture 
cells model for studying inflammatory bowel disease. Dosh R.H., Jordan-
vi 
 
Mahy N., Sammon C., and Le Maitre C. L.  
 
 June 2017 - TERMIS, Davos, Switzerland: The use of pNIPAM-laponite 
hydrogel in 3D cell culture of the intestine. Dosh R.H., Jordan-Mahy N., 
Sammon C., and Le Maitre C. L. 
 
 December 2016 - BMRC Winter Poster Session, Sheffield, UK: Interleukin-1 
receptor antagonist knockout mice as a model of the inflammatory bowel 
disease. Dosh R.H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. 
 
 October 2016 - 6th Clinical Gastroenterology and Hepatology, Toronto, 
Canada: Interleukin-1 receptor antagonist knockout mice as a model of the 
inflammatory bowel disease. Dosh R.H., Jordan-Mahy N., Sammon 
C., and Le Maitre C. L. 
 
 October 2016 - 9th Euro-Global Gastroenterology Conference, Valencia, 
Spain: Interleukin-1 receptor antagonist knockout mice as a model of the 
inflammatory bowel disease. Dosh R.H., Jordan-Mahy N., Sammon 
C., and Le Maitre C. L. 
 
 July 2016 - Health and Wellbeing Faculty Research Day, Sheffield, UK: 
Novel in vitro three-dimensional culture of human intestinal epithelium. Dosh 
R.H., Jordan-Mahy N., Sammon C., and Le Maitre C. L. 
 
 January 2016 - Royal Society of Chemistry Biomaterials, Birmingham, UK: 
In vitro three-dimensional hydrogel culture of human intestinal cell lines to 
develop a 3D model. Dosh R.H., Jordan-Mahy N., Sammon C., and Le 
Maitre C. L. 
vii 
 
 December 2015 - BMRC Winter Poster Session, Sheffield, UK: In vitro 
three-dimensional hydrogel culture of human intestinal cell lines to develop a 





















I hereby declare that the work presented in the thesis entitled "Developing 
Models of the Small Intestine" in fulfilment of the requirements for the award 
of the Degree of Philosophy, Biomolecular Sciences Research Centre, 
Sheffield Hallam University, is an authentic record of my own work carried 
out under the supervision of Professor Christine Le Maitre, Dr. Nicola 
Jordan-Mahy, and Professor Christopher Sammon. The matter embodied in 
this thesis has not been submitted in part or full to any other university or 
institute for the award of any degree in the UK or abroad. 
 








Table of contents 
Dedication ............................................................................................................ i 
Acknowledgements ............................................................................................. ii 
Abstract…………………………………………………………………………………iii 
Dissemination: Scientific publications ................................................................ iv 
Dissemination: Oral and poster presentations .................................................... v 
Declaration ....................................................................................................... viii 
List of figures.................................................................................................... xvi 
List of tables ................................................................................................... xxiv 
List of abbreviations ........................................................................................ xxv 
Chapter 1: General introduction .......................................................................... 1 
1.1 The gastrointestinal tract (GIT) ................................................................... 2 
 The human small intestine ...................................................................... 2 1.1.1
1.1.1.1 Anatomy of the human small intestine .................................................. 2 
1.1.1.2 Histology of the small intestine ............................................................. 5 
1.1.1.3 Intestinal epithelial cell types ................................................................ 6 
1.1.1.3.1 Intestinal stem cells ............................................................................ 7 
1.1.1.3.1.1 Stem cell niche .............................................................................. 11 
1.1.1.4 Digestion and absorption in the small intestine ................................... 12 
1.2 Inflammatory bowel disease ..................................................................... 13 
1.3 Models of the small intestine .................................................................... 17 
 Knockout mice models of inflammatory bowel disease ......................... 17 1.3.1
1.3.1.1 Cytokine knockout mice models ......................................................... 17 
1.3.1.2 Matrix degrading enzyme knockout mice models ............................... 19 
1.3.1.3 Mucosal expression knockout mice models........................................ 19 
 Cell culture models ................................................................................ 20 1.3.2
x 
 
1.3.2.1 The use of cell lines in intestinal engineering ..................................... 21 
1.3.2.1.1 Caco-2 cells ..................................................................................... 21 
1.3.2.1.2 HT29-MTX cells ............................................................................... 22 
1.3.2.1.3 2D co-culture models of the small intestine ...................................... 25 
1.3.2.2 3D cell culture models of the small intestine ....................................... 29 
1.3.2.2.1 Biomaterials for tissue engineering of the small intestine ................. 29 
1.3.2.2.1.1 Natural biomaterials ....................................................................... 32 
1.3.2.2.1.2 Synthetic biomaterials ................................................................... 33 
1.3.2.3 Recapitulating the dynamic mechanical microenvironment of the small 
intestine .............................................................................................. 36 
1.3.2.4 Tissue engineering the small intestine ................................................ 37 
 Stem cells models ................................................................................. 37 1.3.3
1.3.3.1 Isolation of small intestinal stem cells ................................................. 37 
1.3.3.2 In vivo implantation of organoid seeded scaffolds .............................. 41 
1.3.3.3 3D cell culture of pluripotent stem cells .............................................. 43 
1.4 Aims and objectives .................................................................................. 45 
Chapter 2: Interleukin-1 is a key driver of inflammatory bowel disease- 
demonstration in a murine IL-1Ra knockout model. ......................... 47 
2.1 Introduction ............................................................................................... 48 
2.2 Materials and methods ............................................................................. 50 
 IL-1rn-/- BALB/c mice ............................................................................. 50 2.2.1
 Tissue preparation and histological assessment ................................... 50 2.2.2
2.2.2.1 Crypt-villus axes height and villus width ............................................. 51 
2.2.2.2 Goblet cells per crypt-villus axis ......................................................... 51 
 Immunohistochemical assessment ....................................................... 51 2.2.3
2.2.3.1 Pro-inflammatory cytokine expression and immune cell infiltration ..... 51 
xi 
 
2.2.3.2 Matrix-degrading enzyme expression ................................................. 52 
2.2.3.3 Polarity of enterocytes and digestive enzyme expression .................. 52 
 Statistical analysis ................................................................................. 54 2.2.4
 Ethical consideration ............................................................................. 55 2.2.5
2.3 Results ..................................................................................................... 56 
 Histological analysis .............................................................................. 56 2.3.1
2.3.1.1 Crypt-villus axis height and villus width .............................................. 56 
2.3.1.2 Number of goblet cells per crypt-villus axis......................................... 59 
 Immunohistochemistry staining ............................................................. 61 2.3.2
2.3.2.1 Assessment of pro-inflammatory cytokine expression and 
localization ..........................................................................................61 
2.3.2.2 Assessment of degrading enzyme expression and localization .......... 69 
2.3.2.3 Assessment of enterocyte polarity and digestive enzyme expression 
and localization. .................................................................................. 69 
2.4 Discussion ................................................................................................ 77 
Chapter 3: Use of hydrogel scaffolds to develop an in vitro 3D culture model of 
human intestinal epithelium .............................................................. 83 
3.1 Introduction ............................................................................................... 84 
3.2 Materials and methods ............................................................................. 88 
 Hydrogel scaffolds synthesis ................................................................. 88 3.2.1
3.2.1.1 Alginate hydrogel scaffolds ................................................................. 88 
3.2.1.2 L-pNIPAM hydrogel scaffolds ............................................................. 88 
3.2.1.3 L-pNIPAM-co-DMAc hydrogel scaffolds ............................................. 89 
 Material Characterisation ...................................................................... 89 3.2.2
3.2.2.1 Scanning electron microscopy (SEM) ................................................. 89 
3.2.2.2 Dynamic mechanical analysis (DMA) ................................................. 90 
xii 
 
 Cell lines ............................................................................................... 90 3.2.3
3.2.3.1 Culture conditions ............................................................................... 91 
3.2.3.2 Cytospins of monolayer control cells .................................................. 92 
3.2.3.3 Metabolic activity of cells .................................................................... 93 
 Histological assessment ........................................................................ 93 3.2.4
 Immunohistochemical assessment ....................................................... 94 3.2.5
 Scanning electron microscopy following cell culture ............................. 95 3.2.6
 Statistical analysis ................................................................................. 96 3.2.7
3.3 Results ..................................................................................................... 97 
 Material properties of alginate, L-pNIPAM and L-pNIPAM-co-DMAc 3.3.1
scaffolds. ............................................................................................... 97 
 Metabolic activity of Caco-2 cells in three hydrogel scaffolds ............... 98 3.3.2
3.3.2.1 Alginate hydrogel scaffold................................................................... 98 
3.3.2.2 L-pNIPAM hydrogel scaffold ............................................................... 99 
3.3.2.3 L-pNIPAM-co-DMAc hydrogel scaffold ............................................... 99 
3.3.2.4 Comparison of metabolic activity between three hydrogel systems. . 100 
 Morphological and phenotypic assessment of Caco-2 cells cultured in 3.3.3
hydrogel systems ................................................................................ 102 
 Scanning electron microscopy of Caco-2 cells .................................... 109 3.3.4
 Metabolic activity of HT29-MTX cells in three hydrogel scaffolds ....... 112 3.3.5
3.3.5.1 Alginate hydrogel scaffold................................................................. 112 
3.3.5.2 L-pNIPAM hydrogel scaffold ............................................................. 112 
3.3.5.3 L-pNIPAM-co-DMAc hydrogel scaffold ............................................. 113 
 Comparison of cell metabolic activity in three hydrogel systems. ....... 113 3.3.6
 Morphological and phenotypic assessment of HT29-MTX cells cultured 3.3.7
in hydrogel systems ............................................................................ 116 
xiii 
 
 Scanning electron microscopy of HT29-MTX cells .............................. 123 3.3.8
3.4 Discussion .............................................................................................. 125 
Chapter 4: Long-term in vitro 3D hydrogel co-culture model of inflammatory 
bowel disease. ............................................................................... 134 
4.1 Introduction ............................................................................................. 135 
4.2 Materials and Methods ........................................................................... 140 
 L-pNIPAM hydrogel scaffolds synthesis .............................................. 140 4.2.1
 Monocultures and co-cultures of Caco-2 and HT29-MTX layered on L-4.2.2
pNIPAM hydrogel scaffolds ................................................................. 140 
 Long-term co-cultures ......................................................................... 141 4.2.3
 Alamar blue assessment of metabolic activity ..................................... 141 4.2.4
 Histological assessment ...................................................................... 142 4.2.5
 Immunohistochemical assessment ..................................................... 142 4.2.6
 Scanning electron microscopy for monocultures and co-cultures ....... 143 4.2.7
 Statistical analysis ............................................................................... 143 4.2.8
4.3 Results ................................................................................................... 144 
 Metabolic activity of monocultures and co-cultures of Caco-2 and HT29-4.3.1
MTX cells layered on L-pNIPAM hydrogel scaffolds under dynamic 
culture conditions ................................................................................ 144 
 Morphological and phenotypic assessment of monocultures and co-4.3.2
cultures of Caco-2 and HT29-MTX cells layered on L-pNIPAM hydrogel 
scaffolds under dynamic culture conditions ......................................... 146 
 Scanning electron microscopy of monocultures and co-cultures following 4.3.3
7 weeks ............................................................................................... 149 
 Treatment monocultures and co-cultures with pro-inflammatory 4.3.4
cytokines or cultured under hypoxic conditions ................................... 149 
xiv 
 
 Scanning electron microscopy of long-term co-cultures following 12 4.3.5
weeks .................................................................................................. 159 
4.4 Discussion .............................................................................................. 162 
Chapter 5: Isolation and in vitro expansion of small intestinal stem cells from 
mice using L-pNIPAM hydrogel ...................................................... 170 
5.1 Introduction ............................................................................................. 171 
5.2 Materials and methods ........................................................................... 175 
 Mice .................................................................................................... 175 5.2.1
 Culture media ...................................................................................... 175 5.2.2
 Small intestinal crypt extraction ........................................................... 175 5.2.3
 Suspension of small intestinal crypts within Matrigel ........................... 177 5.2.4
 Suspension of small intestinal crypts within L-pNIPAM hydrogel ........ 177 5.2.5
 Layering of small intestinal crypts on L-pNIPAM hydrogel .................. 178 5.2.6
 Suspension of small intestinal crypts within Matrigel followed by 5.2.7
suspension within or layered on L-pNIPAM hydrogel .......................... 178 
 Isolation of small intestinal stem cells ................................................. 179 5.2.8
 Magnetic Activated Cell Sorting (MACS) separation ........................... 179 5.2.9
 Cytospin of Lgr5+ sorted cells .............................................................. 180 5.2.10
 Suspension of Lgr5+ stem cells within Matrigel .................................. 181 5.2.11
 Suspension of Lgr5+ stem cells within L-pNIPAM hydrogel ................. 181 5.2.12
 Layering of Lgr5+ stem cells on L-pNIPAM hydrogel ........................... 182 5.2.13
 Suspension of Lgr5+ stem cells within Matrigel followed by resuspension 5.2.14
within or layered on L-pNIPAM hydrogel ............................................. 182 
 Characterisation of crypts and Lgr5+ stem cells ................................. 183 5.2.15
5.2.15.1 Abright field images of the crypts and Lgr5+ stem cells .................... 183 
5.2.15.2 Histological assessment ................................................................... 183 
xv 
 
5.2.15.3 Immunohistochemical Assessment .................................................. 183 
5.3 Results ................................................................................................... 185 
 Morphological assessment of crypts isolated from the small intestine 5.3.1
suspended within Matrigel, L-pNIPAM hydrogel or layered on L-pNIPAM 
hydrogel .............................................................................................. 185 
 Morphological assessment of the organoids when released from 5.3.2
Matrigel, dissociated and suspended within or layered on L-pNIPAM 
hydrogel. ............................................................................................. 185 
 Phenotypical assessment of the organoids derived from crypts 5.3.3
suspended directly in L-pNIPAM hydrogel or in  Matrigel for 7 days then 
dissociated and  re-suspended in L-pNIPAM for 10 days ................... 190 
 Morphological assessment of the isolated Lgr5+ small intestinal stem 5.3.4
cells suspended within Matrigel, L-pNIPAM hydrogel, or layered on L-
pNIPAM hydrogel ................................................................................ 192 
5.4 Discussion .............................................................................................. 202 
Chapter 6: General discussion ........................................................................ 208 
6.1 Future directions ..................................................................................... 214 
 Genetically engineered animal model ................................................. 214 6.1.1
 Epithelial cell culture model ................................................................. 214 6.1.2





List of figures  
Figure  1.1: Blood supply to the small intestine: (A) Schematic representation of 
arterial supply to the small intestine. (B) Schematic representation of veins 
supply to the small intestine.. .............................................................................. 4 
 
Figure  1.2: (A) Schematic diagram illustrating morphology of the small intestinal 
layers containing crypt–villus units together with the main intestinal cells of the 
epithelial layer, crypt intestinal stem cells, and their niche. (B) Histology of the 
crypt–villus axis represents intestinal cells (C) Enterocytes, (D) Goblet cells, (E) 
Paneth cells, and (F) Enteroendocrine cells. ...................................................... 9 
 
Figure  1.3: Schematic diagram illustrating the morphology of the microvilli which 
cover the apical surface of the enterocytes.. ..................................................... 10 
 
Figure  1.4: Schematic diagram illustrating the Lgr5+ stem cells generating 
transit amplifying cells which then rapidly proliferated to one of several 
differentiated lineages: enterocytes, goblet, enteroendocrine and Paneth cells.
 .......................................................................................................................... 10 
 
Figure  1.5: Bright field image of human colon adenocarcinoma cell lines in 
monolayer (A) Caco-2 cells and (B) HT29-MTX cells. ...................................... 23 
 
Figure  1.6: Summary of two dimensional monoculture, co-culture, and triple co-
culture of Caco-2 and HT29-MTX cells.. ........................................................... 28 
 
Figure  1.7: Summary of three-dimensional monoculture and co-culture of Caco-
2 and HT29-MTXcells using collagen gel, collagen scaffolds, and PLGA 
scaffolds.. .......................................................................................................... 35 
 
Figure  1.8: Schematic diagram illustrating growth of intestinal organoids from 
isolated crypts and single Lgr5+ stem cells cultured in Matrigel. ....................... 39 
 
Figure  2.1: Histological analysis and morphology of the intact well-oriented 
crypt-villus axis heights and villus widths of the  Jejunum ................................. 58 
 
Figure 2.2: Histological analysis and morphology of the intact well-oriented 
xvii 
 
crypt-villus axis heights and villus widths of the 
ileum…………………………………………………………………………………...58  
Figure  2.3: Histological analysis and morphology of goblet cells per intact well-
oriented crypt-villus axis of the A: Jejunum and B: Ileum. ................................. 60 
 
Figure  2.4: Immunohistochemistry staining of the expression and localization of 
pro-inflammatory cytokine A: IL-1α; B: IL-1β; C: IL-1RI ..................................... 62 
 
Figure  2.5: Immunohistochemistry staining of the expression and localization of 
pro-inflammatory cytokines: IL-1α (A and B); IL-1β (C and D); IL-1RI (E and F) 
in the ileum........................................................................................................ 63 
 
Figure  2.6: Immunohistochemistry staining of the expression and localization of 
pro-inflammatory cytokines IL-15 (A); TNFα (B) in the jejunum. ....................... 65 
 
Figure  2.7: Immunohistochemistry staining of the expression and localization of 
pro-inflammatory cytokines: IL-15 (A and B); TNFα (C and D) in the ileum ...... 66 
 
Figure 2.8: Immunohistochemistry staining of the infiltrated cells: 
Polymorphonuclear cells (PMNs) (A) and Macrophage cells (B) into the lamina 
propria in the jejunum. ...................................................................................... 67 
 
Figure  2.9: Immunohistochemistry staining of the infiltrated cells: 
Polymorphonuclear cells (PMNs) (A) and Macrophage cells (B) into the lamina 
propria of the intact well oriented crypt-villus axis in the ileum .......................... 68 
 
Figure  2.10: Immunohistochemistry staining of the expression and localization 
of degrading enzymes: MMP2 (A); MMP9 (B); ADAMTS1 (C) in the jejunum ... 70 
 
Figure  2.11: Immunohistochemistry staining of the expression and localization 
of degrading enzymes: MMP2 (A); MMP9 (B); ADAMTS1 (C) in the ileum ....... 71 
 
Figure  2.12: Immunohistochemistry staining of the expression and localization 
of junctional proteins: ZO-1 (A); E-cadherin (B) in the jejunum ......................... 72 
 
Figure  2.13: Immunohistochemistry staining of the expression and localization 




Figure  2.14: Immunohistochemistry staining of the expression and localization 
of digestive  enzymes: ALP (A); SI (B); and DPP IV (C) in the jejunum. ........... 75 
 
Figure  2.15: Immunohistochemistry staining of the expression and localization 
of the digestive enzymes: ALP (A and B); SI (C and D); and DPP IV (E and F) in 
the ileum. .......................................................................................................... 76 
 
Figure  3.1: Pore size (µm) for acellular alginate, L-pNIPAM, and L-pNIPAM-co-
DMAc hydrogels determined using SEM analysis. B: Storage Modulus (G') 
values for acellular alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels 
determined using DMA.. ................................................................................... 97 
 
Figure  3.2: Viability of Caco-2 cells at a cell density of 2×10
6
 cells/ml layered on 
or suspended within Alginate; L-pNIPAM; L-pNIPAM-co-DMAc. .................... 101 
 
Figure  3.3: Histological analysis of Caco-2  cells layered on or suspended within 
alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or 
dynamic culture conditions 2 days .................................................................. 103 
 
Figure  3.4 Histological analysis of Caco-2  cells layered on or suspended within 
alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or 
dynamic culture conditions following 7 days ................................................... 103 
 
Figure 3.5: Histological analysis of Caco-2 cells layered on or suspended within 
alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or 
dynamic culture conditions following 14 days…………………………………...105 
Figure  3.6: Histological analysis of Caco-2  cells layered on or suspended within 
alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or 
dynamic culture conditions following 21 days ................................................. 105 
 
Figure  3.7: Immunohistochemistry staining of MUC2 and MUC5AC. A: Caco-2 
cells monolayer and layered on or suspended within alginate; B and C: Caco-2 
cells layered on L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels, under static or 




Figure  3.8: Immunohistochemistry staining (yellow arrows) for CD10, Zonulin-1 
(ZO-1), Alkaline phosphatase (ALP), Dipeptidyl peptidase IV (DPP IV), and 
Sucrase-isomaltase (SI) of Caco-2 cells in 0 h monolayer and Caco-2 cells 
layered on L-pNIPAM hydrogel under static or dynamic culture conditions..... 107 
 
Figure  3.9: Scanning electron micrographs of Caco-2 cells layered on A:  L-
pNIPAM; and B:L-pNIPAM-co-DMAc hydrogels under static or dynamic culture 
conditions ........................................................................................................ 108 
 
Figure  3.10: Scanning electron micrographs of Caco-2 and HT29-MTX cells 
layered on or suspended within L-pNIPAM hydrogel under static or dynamic 
culture conditions ............................................................................................ 110 
 
Figure  3.11: Viability of HT29-MTX cells at a cell density of 2×106 cells/ml 
layered on or suspended within Alginate; L-pNIPAM; L-pNIPAM-co-DMAc 
following 21 days under static or dynamic culture conditions .......................... 111 
 
Figure  3.12: Histological analysis of HT29-MTX cells layered on or suspended 
within alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or 
dynamic culture conditions following 2 days ................................................... 115 
 
Figure  3.13: Histological analysis of HT29-MTX cells layered on or suspended 
within alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or 
dynamic culture conditions following 7 days ................................................... 117 
 
Figure  3.14: Histological analysis of HT29-MTX cells layered on or suspended 
within alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or 
dynamic culture conditions following 14 days ................................................. 118 
 
Figure  3.15: Histological analysis of HT29-MTX cells layered on or suspended 
within alginate,   L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or 
dynamic culture conditions following 21 days ................................................. 119 
 
Figure  3.16: Immunohistochemistry staining (yellow arrows) of MUC2 and 
MUC5AC. A: monolayer and IgG negative control. HT29-MTX cells layered on 
or suspended within B: Alginate, C: L-pNIPAM, and D: L-pNIPAM-co-DMAc 




Figure  3.17: Scanning electron micrographs for HT29-MTX cells layered on or 
suspended within A: L-pNIPAM and B: L-pNIPAM-co-DMAc hydrogels under 
static or dynamic culture conditions ................................................................ 122  
 
Figure  4.1: Metabolic activity of monocultures and co-cultures of Caco-2 and 
HT29-MTX cells. ............................................................................................. 145 
 
Figure  4.2: Morphology of monocultures and co-cultures of Caco-2 and HT29-
MTX cells at a total cell density of 2×106 cells/ml with different percentages 
layered on L-pNIPAM hydrogel scaffolds under dynamic culture conditions ... 147 
 
Figure  4.3: Mucin expression by monocultures and co-cultures of Caco-2 and 
HT29-MTX cells at different percentages layered on L-pNIPAM hydrogel 
scaffolds under dynamic culture conditions .................................................... 148 
 
Figure  4.4: Scanning electron micrographs of monocultures and co-cultures of 
Caco-2 and HT29-MTX cells at different percentages layered on L-pNIPAM 
hydrogel scaffolds under dynamic culture conditions ...................................... 150 
 
Figure  4.5: Morphology of monocultures and co-cultures of Caco-2 and HT29-
MTX cells at different percentages layered on L-pNIPAM hydrogel scaffolds 
under dynamic culture conditions for 6 weeks and then treated with 10ng/ml IL-
1β for 1 week under dynamic culture conditions or hypoxic at 1% O2  for 1 week 
under static culture conditions......................................................................... 151 
 
Figure  4.6: Immunopositivity (brown) of co-culture Caco-2 and HT29-MTX cells 
at percentages 90% Caco-2 / 10% HT29-MTX layered on L-pNIPAM hydrogel 
scaffolds under dynamic culture conditions following 7 weeks as a control or for 
6 weeks and then treated with 10 ng/ml IL-1β for 1 week under dynamic culture 
conditions or hypoxic at 1% O2 for 1 week under static culture conditions. .... 153 
 
Figure  4.7: Immunopositivity (brown) of co-culture Caco-2 and HT29-MTX cells 
at percentages of 75% Caco-2 / 25% HT29-MTX layered on L-pNIPAM 
hydrogel scaffolds following 7 weeks  as a control or for 6 weeks and then 
treated with 10ng/ml IL-1β for 1 week under dynamic culture conditions or 




Figure  4.8: Morphology of long term co-culture of Caco-2 and HT29-MTX cells 
at percentages A: 90% Caco-2 / 10% HT29-MTX; B: 75% Caco-2 / 25% HT29-
MTX layered on L-pNIPAM hydrogel scaffolds under dynamic culture conditions 
following 12 weeks as a control or for 11 weeks and then treated with 10 ng/ml 
IL-1β or 10 ng/ml TNFα for 1 week under dynamic culture conditions or hypoxic 
at 1% O2 for 1 week under static culture conditions.. ...................................... 157 
 
Figure  4.9: Immunopositivity (brown) of co-culture Caco-2 and HT29-MTX cells 
at percentages 90 %Caco-2 / 10% HT29-MTX layered on L-pNIPAM hydrogel 
scaffolds under dynamic culture conditions following 12 weeks as a control or 
for 11 weeks and then treated with 10 ng/ml IL-1β or 10 ng/ml TNFα for 1 week 
under dynamic culture conditions or hypoxic at 1% O2 for 1 week under static 
culture conditions. ........................................................................................... 158 
 
Figure  4.10: Scanning electron micrographs of long-term co-culture Caco-2 and 
HT29-MTX cells at percentages 90% Caco-2 / 10%HT29-MTX cells layered on 
L-pNIPAM hydrogel scaffolds under dynamic culture conditions following 12 
weeks as a control or for 11 weeks and then treated with 10 ng/ml IL-1β or 10 
ng/ml TNFα for 1 week under dynamic culture conditions or hypoxic at 1% O2 
for 1 week under static culture conditions. ...................................................... 160 
 
Figure  4.11: Scanning electron micrographs of long term co-culture Caco-2 and 
HT29-MTX cells at percentages 75% Caco-2 / 25% HT29-MTX cells layered on 
L-pNIPAM hydrogel scaffolds under dynamic culture conditions following 12 
weeks as a control or for 11 weeks and then treated with 10ng/ml IL-1β or 
10ng/ml TNFα for 1 week under dynamic culture conditions or hypoxic at 1% O2 
for 1 week under static culture conditions. ...................................................... 161 
 
Figure  5.1: Bright-field morphology of the isolated small intestinal crypts 
suspended within Matrigel for 0-14 days. ........................................................ 187 
 
Figure  5.2: Morphology of the isolated small intestinal crypts when suspended 
directly within or layered on L-pNIPAM hydrogel under dynamic culture 




Figure  5.3: Morphology of the isolated small intestinal crypts when suspended 
within Matrigel for 7 days then the derived organoids were released from 
Matrigel and dissociated into small fragments and then (A) re-suspended within 
or (B) layered on L-pNIPAM hydrogel under dynamic culture conditions for 10 
days. ............................................................................................................... 189 
 
Figure  5.4: Immunohistochemistry staining (black arrows) for Lgr5, E-cadherin, 
MUC2, Chromogranin-A, and Lysozyme of the isolated small intestinal crypts
 ........................................................................................................................ 191 
 
Figure  5.5: Bright-field morphology of the isolated Lgr5
+ 
intestinal stem cells 
suspended within Matrigel from day 0 to 14. ................................................... 192 
 
Figure  5.6: Morphology of the isolated Lgr5
+ 
intestinal stem cells: (A) suspended 
within L-pNIPAM hydrogel and (B) Layered on L-pNIPAM hydrogel under 
dynamic culture conditions for 10 to 14 days. ................................................. 193 
 
Figure  5.7: Morphology of the isolated Lgr5
+ 
intestinal stem cells suspended 
within Matrigel for 7 days then the organoids were released from Matrigel and 
dissociated into single cells and (A) were suspended in L-pNIPAM hydrogel or 
(B) were layered on L-pNIPAM hydrogel under dynamic culture conditions for 7 
to 28 days. ...................................................................................................... 194 
 
Figure  5.8: Immunohistochemistry staining (black arrows) for Lgr5 in: (A) the 
intact mouse small intestine, (B) cytospin of Lgr5
+ 
intestinal stem cells, (C) 
Caco-2 cells and (D) HT29-MTX cell lines.. .................................................... 195 
 
Figure  5.9: Immunohistochemistry staining for (A) E-cadherin; (B) MUC2; (C) 
Chromogranin-A and  (D) Lysozymes in cytospin of the isolated Lgr5
+ 
intestinal 
stem cells.   ..................................................................................................... 196 
 
Figure  5.10: Immunohistochemistry staining (black arrows) for Lgr5 in isolated 
Lgr5
+ 
intestinal stem cells when suspended within Matrigel for 7 days then the 
organoids were released from Matrigel and dissociated into single cells then (A) 
suspended within L-pNIPAM hydrogel or (B) layered on L-pNIPAM hydrogel 




Figure  5.11: Immunohistochemistry staining (black arrows) for E-cadherin of the 
isolated Lgr5+ intestinal stem cells suspended within Matrigel for 7 days then 
the organoids were released from Matrigel and dissociated into single cells and 
(A) suspended within L-pNIPAM hydrogel; (B) layered on L-pNIPAM hydrogel 
under dynamic culture conditions for 7 to 28 days. ......................................... 198 
 
Figure  5.12: Immunohistochemistry staining (black arrows) for MUC2 of the 
isolated Lgr5
+ 
intestinal stem cells suspended within Matrigel for 7 days then the 
organoids were released from Matrigel and dissociated into single cells and (A) 
suspended within L-pNIPAM hydrogel; (B) layered on L-pNIPAM hydrogel under 
dynamic culture conditions for 7 to 28 days. ................................................... 199 
 
Figure  5.13: Immunohistochemistry staining (black arrows) Chromogranin-A of 
the isolated Lgr5
+ 
intestinal stem cells suspended within Matrigel for 7 days then 
the organoids were released from Matrigel and dissociated into single cells and 
(A) suspended within L-pNIPAM hydrogel; (B) layered on L-pNIPAM hydrogel 
under dynamic culture conditions for 7 to 28 days. ......................................... 200 
 
Figure  5.14: Immunohistochemistry staining (black arrows) for lysozyme 
production of the isolated Lgr5+ intestinal stem cells suspended within Matrigel 
for 7 days then the organoids were released from Matrigel and dissociated into 
single cells and (A) suspended within L-pNIPAM hydrogel; (B) layered on L-
pNIPAM hydrogel under dynamic culture conditions for 7 to 28 days. ............ 200 
xxiv 
 
List of tables 
Table  1.1: Summary of the major two dimensional cell culture systems of 
intestinal cell lines.. ........................................................................................... 24 
 
Table  1.2: Summary of three dimensional cell culture systems of intestinal cell 
lines.. ................................................................................................................ 31 
 






List of abbreviations 
2D  Two Dimensional 
3D  Three Dimensional 
ADAMTS A Disintegrin and Metalloproteinase with Thrombospondin  
  Motifs 
ALP  Alkaline Phosphatase 
ATCC  American Type Culture Collection 
BMP  Bone Morphogenetic Protein 
BSA  Bovine Serum Albumin 
CCK  Cholecystokinin 
CD  Crohn’s Disease 
Coll  Collagen 
DAB  3-3' Diaminobenzidine Tetrahydrochloride 
DMAc  N,N'-dimethyl acrylamide 
DMEM Dulbecco's Modified Eagles Media 
DPP IV Dipeptidyl Peptidase 4 
ECM  Extracellular Matrix 
EDTA  Ethylen Diamine Tetra-acetic Acid 
EGF  Epidermal Growth Factor 
FBS  Foetal Bovine Serum 
GIP  Glucose-dependent Insulin-tropic Peptide 
GSK3β Glycogen Synthase Kinase 3 beta 
HATH 1 BHLH transcription factor 
H&E   Haematoxylin and Eosin 
xxvi 
 
HEPES  (4-(2-Hydroxyethyl)-1-Piperazineethanesulfonic Acid 
HIF  Hypoxia Induced Factor 
HInEpC Human Intestinal epithelial Cells 
HMECs Human Microvascular Endothelial Cells 
HRP  Horseradish Peroxidase 
IBD  Inflammatory Bowel Disease 
IHC  Immunohistochemistry 
IL-1  Interleukin-1 
IL-1β  IL-1 beta 
IL-1α   IL-1 alpha 
IL-1Ra Interleukin-1 Receptor Antagonist 
IL-1RAcP IL-1 Receptor Accessory Protein 
IL-1RI  Interleukin-1 Receptor I 
IL-1RII Interleukin-1 Receptor II 
IMS  Industrial Methylated Sprit 
iPSC   induced Pluripotent Stem Cells 
ISCs   Intestinal Stem Cells 
ISEMF Intestinal Sub-Epithelial Myofibroblasts 
JNK   JUN N Terminal kinase 
KLF4  Kruppel Like Factor 4 
LCST  Lower Critical Solution Temperature 
Lgr5  Leucine rich repeat containing G protein-coupled receptor 5 
L- pNIPAM Laponite Crosslinked pNIPAM 
MACS Magnetic Activated Cell Sorting 
MAPK Mitogen-Activated Protein kinase 
MLCK  Myosin L Chain Kinase 
MMP  Matrix Metalloproteinases 
NF-KB           Nuclear Factor Kappa B 
xxvii 
 
NK  Natural Killer  
NOD/SCID Non-Obese Diabetic/Severe Combined Immune Deficiency 
PAS  Periodic Acid Schiff's 
PBS   Phosphate Buffer Saline 
PDMS  Polydimethylsiloxane 
PEG  Poly Ethylene Glycol 
PGA  Poly Glycolic Acid 
PLA  Poly Lactic Acid 
PLGA  Poly-Lactic-Glycolic Acid 
PMNs  Polymorphonuclear Cells 
pNIPAM  Poly N-isopropylacrylamide 
SEM   Scanning Electron Microscope  
SI  Sucrase-Isomaltase 
TA  Transit-Amplifying Cells 
TEER  Trans Epithelial Electrical Resistance 
TGF-B Transforming Growth Factor Beta 
Th1  T-helper 1 
TNFα  Tumour Necrosis Factor Alpha 
UC  Ulcerative Colitis 
WT  Wild Type 




Chapter 1: General introduction 
Some of this chapter has been published as a literature review:   
Tissue engineering laboratory models of the small intestine. 
Rasha H. Dosh, Nicola Jordan-Mahy, Chris Sammon, Christine L. Le Maitre. 
Tissue Engineering Part B, Vol. 24, 98-111, 2018. 
  
Author Contributions:  
R.H.D. drafted the manuscript. N.J.M., C.S., and C.L.LM., critically revised the 









1.1 The gastrointestinal tract (GIT) 
The gastrointestinal tract (GIT) is a tube which extends from the mouth to the 
anus and consists of the oral cavity, oesophagus, stomach, small intestine, 
large intestine, rectum and the anus (McCance & Huether 1998; Tortora & 
Derrickson 2016).  
 The human small intestine 1.1.1
The main place for absorption of nutrients from ingested materials is the small 
intestine. The small intestine is a long, coiled tube that digests and absorbs 
about 90% of the nutrients and water in the gastrointestinal tract. It is only 2.5 
cm in diameter and about 5-6 meters in length. The small intestine starts at the 
pyloric sphincter of the stomach, winds throughout the abdominal cavity and at 
the end opens into the large intestine, where the ileum joins the caecum 
(McCance & Huether 1998; Tortora & Derrickson 2016). 
1.1.1.1 Anatomy of the human small intestine 
Anatomically, the small intestine includes three regions; the duodenum, jejunum, 
and ileum. The duodenum is the first, shortest (25 cm) and widest part of the 
small intestine which is attached to the pyloric sphincter of the stomach at the 
right side, and ends at the duodenojejunal junction on the left side. The 
duodenum makes a C-shaped tube around the head of the pancreas and is 
fixed to the retroperitoneum by suspensory ligament of Treitz (Tortora & 
Derrickson 2016). The arterial supply of the duodenum is derived from the 
gastroduodenal artery and inferior pancreaticoduodenal artery which is a branch 
of the superior mesenteric artery (Figure 1.1 A), the veins drain into the hepatic 
portal vein (Figure 1.1 B). Lymphatic drainage is to the pancreaticoduodenal 
and superior mesenteric nodes (McCance & Huether 1998; Tortora & 
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Derrickson 2016). The Jejunum represents the main site of the nutrient 
absorption. It is approximately 2.5 metres in length, with a larger diameter, and 
thicker wall than the most distal end of the small intestine, the ileum. The 
jejunum has tall and closely packed plica circulars, which are the circular folds 
that play a crucial role in increasing the surface area for absorption (Tortora & 
Derrickson 2016). The jejunum is attached to the posterior abdominal wall by 
mesentery which is a double fold of peritoneum. The final and longest region 
(approximately 3.5 meters) of the small intestine is the ileum which connects to 
the large intestine via the ileocecal sphincter. Here there is the completion 
absorption of nutrients which were neglected in the jejunum (McCance & 
Huether 1998; Tortora & Derrickson 2016).  
The arterial supply to the jejunum and ileum are from branches of the superior 
mesenteric artery (Tortora & Derrickson 2016) (Figure 1.1 A). The venous 
drainage passes through the superior mesenteric vein which joins with the 
splenic vein to form the hepatic portal vein at the neck of the pancreas (Figure 
1.1 B). Lymphatic drainage is into the superior mesenteric nodes (McCance & 





Figure  1.1: Blood supply to the small intestine: (A) Schematic representation of arterial supply to the small intestine. (B) Schematic 
representation of veins supply to the small intestine. Adapted from (Morton et al. 2011). 
 







1.1.1.2 Histology of the small intestine  
The small intestinal wall is made up of the same four distinct layers of tissue 
that comprise the rest of the GIT: mucosa, submucosa, muscularis externa, and 
adventitia or serosa (McCance & Huether 1998) (Figure ‎1.2). The mucosa layer 
lines the lumen of the GIT. It is made up of a simple columnar epithelium. The 
mucosa surface is folded into projections known as circular folds, which 
increase their surface area. The surface area is further increased by the 
formation of finger-like projections called villi. Each the columnar epithelial cell 
or enterocytes have tiny cylindrical projections called microvilli (1µm long) which 
further increase the surface area of the small intestine for absorption. Under the 
light microscope they form fuzzy lines known as the brush border (Figure  1.3). 
The number and shape of the intestinal villi varies, depending on the position 
along its length (McCance & Huether 1998), with the highest number of villi 
seen in the proximal jejunum, decreasing towards the end of the ileum. The 
morphology of the villi differs through the small intestine, decreasing in size 
from the proximal to the distal end of the small intestine. In the duodenum, the 
villi are leaf-like, whilst those of the jejunum and ileum having a tongue-like, and 
then finger-like appearance, respectively (Tortora & Derrickson 2016). At the 
base of the villi are crypts of Lieberkuhn (Barker et al. 2013), these crypts are 
tubular glands which descend into the underlying muscularis mucosa (Barker et 
al. 2008) and form the intestinal stem cell niche (Figure  1.2). The mucosa of the 
ileum has lymphoid follicles called Peyer's patches. The lamina propria is made 
up of extracellular matrix (including proteoglycan and fibrous proteins such as 
collagen, elastin, fibronectin, and laminin), containing fibroblasts and leukocytes 
including: lymphocytes, monocytes/ macrophages, eosinophils, and mast cells  
(Tortora & Derrickson 2016). The submucosa is rich supply of blood and 
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lymphatic vessels and is innervated by the ganglionated plexuses of Meissner's 
nervous plexus; ganglia are composed of enteroglial cells and neurons. 
Beneath the submucosa is the muscularis externa, composed of an inner 
circular and outer longitudinal smooth muscle layers separated by a thin layer of 
connective tissue and innervated by the Auerbach's plexus, which enables the 
peristaltic movement of food along the intestine (Bitar & Zakhem 2013). This 
layer is finally supported by a single layer of mesothelium called the serosa 
(McCance & Huether 1998) (Figure  1.2). 
1.1.1.3 Intestinal epithelial cell types  
The intestinal mucosa contains six main cell types, each with a specialized 
function. The most abundant are the absorptive columnar epithelial cells or 
enterocytes, which are highly polarized cells with their microvilli on their apical 
surface (Figure  1.2). These enterocytes are responsible for producing digestive 
enzymes and the absorption of nutrients (McCance & Huether 1998; Barker et 
al. 2010; 2012). The second most abundant cell types are unicellular glandular 
mucus-secreting goblet cells. Mucins are secreted into the lumen of the 
intestine, giving rise to an adherent mucus layer which surrounds and coats the 
intestinal villi. This mucus layer acts as a lubricant and creates a milieu which 
facilities digestion and absorption of nutrients (Barker et al. 2013). Located at 
the base of intestinal crypts are Paneth cells, which secrete antimicrobial 
lysozymes that protect the crypt from pathological microorganisms (Rubin 1971; 
Barker et al. 2010). There are also three types of hormone-secreting 
enteroendocrine cells: S cells, which secrete secretin; CCK cells, which secrete 
cholecystokinin (CCK) and K cells, which secrete glucose-dependent insulin-
tropic peptide (GIP). These hormones regulate digestion and absorption in the 
small intestine (Figure  1.2). A limited number of tuft cells are also located within 
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the small intestine; their role is to defend against parasites. Finally, microfold or 
M-cells are located within lymphoid peyer's patches and are responsible for 
transporting antigens from the lumen to the underlying lymphoid tissues (Barker 
et al. 2010, 2012).   
1.1.1.3.1 Intestinal stem cells 
Importantly, a small population of stem cells are located at the villus base, 
within crypts and are responsible for maintaining intestinal epithelial 
homeostasis (Figure  1.2). These stem cells differentiate as they migrate along 
the length of the villi, replacing cells which are lost at the villus tip (Clevers 
2009; Van Der Flier, & Clevers 2009; Simons & Clevers 2011; Clevers 2013). 
This process of cell renewal ensures that the functions of the intestinal 
epithelium are maintained throughout life.  
These stem cells generate transit-amplifying cells (TA), which rapidly proliferate 
to one of several lineages (Cheng & Leblond 1974; Vanuytsel et al. 2013; 
Leushacke & Barker 2014) which terminally differentiate to all intestinal cell 
types: enterocytes, goblet, enteroendocrine, Paneth cells, tuft, and M cells  
(Potten 1998; Clatworthy & Subramanian 2001; Montgomery & Breault 2008; 
Belchior et al. 2014) (Figure  1.4). The proliferative capacity of these stem cells 
ensures there are sufficient cells to regenerate any damaged tissue (Lutolf et al. 
2009) and continually maintain digestion and absorption processes. Therefore, 
these cells are ideal candidates for use in tissue engineering and regenerative 
medicine (Barker et al. 2007; Snippert et al. 2010; Barker 2014; Leushacke & 
Barker 2014). The use of stem cell markers is essential for isolation of pure 
stem cell populations for using in tissue engineering. In the small intestine, there 
are two stem cell populations within the crypt, classified by location and cycling 
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dynamics (Barker et al. 2008, 2012; Clevers 2013). The first of these stem cells 
are mitotically active slender cells found at the bottom of the crypt between 
paneth cells, these are known as crypt base columnar cells. These cells 
express several stem cell markers including: Lgr5; CD133 (Prom1); Ascl2; 
Olfm4; Smoc2 and Sox9low (Becker et al. 2008; Tian et al. 2011; Barker et al. 
2013; Zhang & Huang 2013; Clevers 2016). The second stem cell populations 
are quiescent stem cells, which are located in the crypt directly above the 
terminally differentiated paneth cells (Potten et al. 1978). These quiescent stem 
cells express Bmi-1, Hopx, mTert, and Lrig1, and Soxhigh (Potten et al. 1974; 









Figure  1.2: (A) Schematic diagram illustrating morphology of the small intestinal 
layers containing crypt–villus units together with the main intestinal cells of the 
epithelial layer, crypt intestinal stem cells, and their niche. (B) Histology of the crypt–
villus axis represents intestinal cells (C) Enterocytes, (D) Goblet cells, (E) Paneth 














Figure  1.4: Schematic diagram illustrating the Lgr5
+
 stem cells generating transit amplifying 
cells which then rapidly proliferated to one of several differentiated lineages. 
 
Figure  1.3: Schematic diagram illustrating the morphology of the microvilli which cover the 
apical surface of the enterocytes (Tortora & Derrickson 2016).  







1.1.1.3.1.1 Stem cell niche 
The specific environment where adult stem cells are located in the small 
intestine is known as the stem cell niche. This provides signals to maintain the 
undifferentiated state and self-renewal capacity (stemness) (Walker et al. 2009). 
The stem cells niche is composed of cells which together with the basement 
membrane derived extracellular matrix regulate stem cell differentiation and fate 
(Walker et al. 2009; Henning & Furstenberg 2016; Sailaja et al. 2016; Sasaki et 
al. 2017). Due to the location of stem cells in direct contact with Paneth cells at 
the base of crypts, it seems likely that Paneth cells have important role on the 
crypt base columnar stem cells niche (Simons & Clevers 2011; Sato et al. 
2011a; Sasaki et al. 2017). Several regulatory pathways have been found to 
play a role in the maintenance, proliferation and differentiation of stem cells 
(Barker et al. 2008); these include: Wnt; Notch; epidermal growth factor (EGF) 
and bone morphogenetic protein (BMP) pathways (Yeung et al. 2011; Date & 
Sato 2015; Van Rijn et al. 2016). Canonical Wnt signaling is well recognized as 
the main regulator of epithelial renewal in the small intestine (Clevers 2016). 
EGF signaling maintains stemness and prompts proliferation (Wong et al. 2012; 
Sato & Clevers 2013; Leushacke & Barker 2014). Whilst Notch signaling 
controls differentiation to enterocytes, inhibition of Notch signaling leading to the 
differentiation of stem cell towards secretory lineages, including: goblet, Paneth, 
enteroendocrine, and tuft cells (VanDussen et al. 2012). Bone morphogenetic 
protein (BMP) signaling negatively regulates stem-cell characteristics and 
promotes differentiation of progenitor cells in the villus compartment, but has no 
effect on stem cells located in the crypts (He et al. 2004). Thus, the 
manipulation of these signaling pathways in in vitro culture can be used to 
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maintain stem cell characteristics or drive differentiation of stem cells to 
appropriate lineages. 
1.1.1.4 Digestion and absorption in the small intestine 
The main function of the small intestine is digestion of food and absorption of 
nutrients and water (Clevers 2013). The absorption of the majority of essential 
nutrients occurs in the proximal jejunum and distal ileum. The pancreas 
secretes large amounts of digestive enzymes directly to the small intestine via 
the pancreatic duct. These enzymes include: pancreatic amylase which break 
down large carbohydrates to simple sugars, and trypsinogen which is converted 
to trypsin in the presence of the intestinal enzyme enterokinase 
(enteropeptidase). Trypsin then digests proteins to produce amino acids. 
Similarly, chymotrypsinogen, elastase, peptidase and carboxypeptidase digest 
large peptides to smaller peptides and amino acids. Pancreatic lipase acts on 
fats (triglycerides) that have been emulsified by bile salts and convert them to 
fatty acids and monoglycerides. Finally nucleases break down RNA and DNA to 
pentose and nitrogenous bases. 
In addition, the intestinal enterocytes synthesize and produce several brush 
border enzymes: aminopeptidase, peptidase and dipeptidase that digest 
peptides to give rise to small peptides and amino acids, alongside lactase, 
sucrase and maltase that digest lactose, sucrose and maltose, respectively to 
produce simple monosaccharides (Tortora & Derrickson 2016). Absorption of 
digested nutrients occurs through diffusion, facilitated diffusion, active transport, 
and osmosis. The mucosal epithelial cells transport nutrients (amino acids 
derived from proteins, monosaccharides derived from carbohydrate, some 
vitamins and salts) from the lumen of the small intestine into the network of 
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capillaries. Whilst fatty acids and monoglycerides derived from lipids 
(triglycerides) under the action of pancreatic lipases are transported into tiny 
lymphatic vessels or micelles, and are absorbed into the enterocytes where 
they are reassembled into triglycerides and coated in a protein to form a 
chylomicron which is absorbed into lymphatic vessels in the lamina propria of 
the villi. Lymph drains back into the bloodstream at the subclavian vein by the 
thoracic duct  (Tortora & Derrickson 2016). All the products of digestion and 
absorption are passed via the blood vessels to different organs of the body 
while undigested food or unabsorbed materials are moved onwards to the large 
intestine (Tortora & Derrickson 2016). 
1.2 Inflammatory bowel disease        
Inflammatory bowel disease (IBD) is a chronic autoimmune disease of the 
gastrointestinal tract. Clinically, IBD includes Crohn’s disease (CD) and 
ulcerative colitis (UC), which mainly impact on the colon (UC and CD), rectum 
(UC) or any part of the gastrointestinal tract from the mouth to the anus (CD) 
(Blumberg et al. 1999; Garrett et al. 2010; Biasi et al. 2013). Inflamed intestinal 
mucosa is identified by abdominal pain, weight loss, diarrhoea, bloody stools, 
and infiltration of immune cells such as macrophages and neutrophils. These 
macrophages and neutrophils secrete cytokines, free radicals, and proteolytic 
enzymes which cause inflammation (Wong et al. 2006). The diagnosis of IBD is 
depend on clinical, radiologic, endoscopic, and histologic criteria (Seldenrijk et 
al. 1991; Mazzucchelli et al. 1994).  
The aetiology of IBD is still unknown and the present notion is that a 
combination of genetic susceptibility, microbiome, environmental factors, and 
the immune system, (Elson et al. 1995; Baumgart & Carding 2007; Landy et al. 
14 
 
2016) leading to secretion of pro-inflammatory mediators resulting in loss of 
homeostasis and epithelial damage (Sartor 2006; Bosca-Watts et al. 2015). 
Several components of the mucosal immune system are involved in the 
pathogenesis of IBD and consist of intestinal epithelial cells, innate lymphoid 
cells (natural killer cells (NK)), cells of the innate (macrophages/monocytes, 
neutrophils, and dendritic cells) and adaptive (T-cells and B-cells) immune 
system, and their secreted mediators (cytokines and chemokines) (Shih & 
Targan 2008; Wallace et al. 2014). The role of cytokines in mucosal immune 
system has been investigated intensely. It has been found that increased levels 
of the pro-inflammatory cytokines interleukin-1 (IL-1), IL-6, IL-8, and tumour 
necrosis factor α (TNFα) are present in patients with IBD (Isaacs et al. 1992; 
Rogler & Andus 1998). These pro-inflammatory cytokines are expressed by 
lymphocytes, macrophages, and polymorphonuclear cells (PMNs). Production 
of these pro-inflammatory cytokines is prompted by the activation of nuclear 
factor kB (NF-KB), mitogen-activated protein kinase (MAPK), and JUN N 
terminal kinase (JNK) pathways (Elson et al. 1995; Beck & Wallace 1997; 
Rogler & Andus 1998; Williams 2001; Wong et al. 2006; Shih & Targan 2008).  
It is hypothesised that IBD could be caused by an imbalance between pro- and 
anti-inflammatory cytokines in local tissues and lead to inflammation and 
malfunction of the barrier in the intestinal tissue. Interleukin 1 (IL-1) is a key 
mediator of innate immunity and inflammation which results in tissue damage in 
IBD. The IL-1 family consists of a number of agonists, antagonists, receptors 
and accessory proteins. Of which two key agonists: IL-1α and IL-1β are key 
proinflammatory cytokines (Dinarello 2011). These agonists bind to and activate 
the IL-1 receptor type1 (IL-1RI) in conjugation with the accessory protein (IL-1R 
AcP), whilst IL-1RII acts as decoy receptor and does not initiate signalling 
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cascades (Dinarello 2011). In addition, a natural antagonist for IL-1RI exist 
known as: IL-1 receptor antagonist (IL-1Ra), this binds to IL-1RI but fails to 
recruit IL-1RAcP and thus does not initiate a signalling cascade (Rider et al. 
2011).  
IL-1α is synthesized as a precursor protein, which is fully active in pro- and 
cleaved forms; it is produced by numerous cell types within the body including 
the epithelia of the gastrointestinal tract, liver, kidney, lung, endothelial cell and 
astrocytes (Casini-Raggi et al. 1995; Ludwiczek et al. 2004). Further IL-1α is 
released from necrotic cells after cell death by necrosis initiating neutrophil 
inflammation (Chen et al. 2007; Garlanda et al. 2013). IL-1β is also synthesized 
as a precursor protein but in contrast to IL-1α precursor, the IL-1β precursor is 
not active and requires cleavage by cysteine protease called caspase-1 (also 
known as IL-1 converting enzyme (ICE)), releasing the active IL-1β precursor 
into the extracellular space to be able to bind to IL-1 receptor (Dinarello 2011). 
IL-1β is also expressed by a wide number of cells within the body although 
classically is considered as an inflammatory cytokine synthesised by 
inflammatory cells (Beck & Wallace 1997; Rogler & Andus 1998; Dinarello 
2009).  
There is a wide range of negative regulators which tightly regulate the action of 
pro-inflammatory cytokines IL-1α and IL-1β, including IL-1Ra, decoy receptors 
(IL-1RII), and accessory proteins (IL-1RAcP) by trapping the ligands. IL-1Ra is 
a member of IL-1 family which is secreted by epithelial cells, immune cells and 
adipocytes. IL-1Ra act as a natural inhibitor of IL-1α and IL-1β and regulates IL-
1 pro-inflammatory activity by competing with IL-1 for binding sites of the cell 
surface IL-1RI preventing IL-1 from sending signal to target cells. IL-1Ra binds 
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IL-1RI with high affinity, but unable to recruit the IL-1RAcP (Re et al. 1996). IL-
1RII is found in the cytoplasm and secreted by limited cell types such as 
monocytes, neutrophils, macrophages, B cells, and T regulatory cells, IL-1RII 
binds IL-1 both preventing the binding between IL-1 and IL-1RI (Martin et al. 
2013; Garlanda et al. 2013).  
The importance of the balance between IL-1 and IL-1Ra in IBD has been 
demonstrated in experimental animal models and in human tissues. Findings in 
immune complex induced colitis in rabbits revealed that IL-1 synthesis 
happened early in the colitis disease and IL-1 levels associated with the state of 
tissue inflammation (Cominelli et al. 1992). High levels of colonic IL-1Ra (10 
fold) above those of IL-1 were detected, addressing resolution of the 
inflammation in rabbit immune complex induced colitis (Ferretti et al. 1994). The 
administration of neutralizing anti-serum against rabbit IL-1Ra resulted in 
sustained intestinal inflammation and significantly increased mortality, indicating 
the importance of endogenous IL-1Ra. In contrast, exogenous administration of 
IL-1Ra blockade in colonic inflammation in this animal model and in acetic acid 
induced colitis in rats (Thomas et al. 1991). Hence, studies of animal models of 
IBD have demonstrated an important role for IL-1 in inducing inflammation and 
tissue disruption, with both endogenous and exogenous IL-1Ra reducing 
severity of disease. In humans suffering with IBD the importance of IL-1 and IL-
1Ra has also been demonstrated. Specifically mucosal biopsies from patients 
with active and inactive Crohn’s disease (CD) and active ulcerative colitis (UC) 
contained mRNA for IL-1 while mRNA for IL-1Ra was decreased in active 
ulcerative colitis and Crohn’s disease (Malyak et al. 1998). The intestine IL-1Ra 
and IL-1 ratio was significantly decreased in CD and UC patients compared to 
controls. This ratio was negatively related to the degree of the inflammation. IL-
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1Ra were produced by normal human intestinal epithelial cells (IEC) while high 
amounts of IL-1 were produced in inflamed mucosa by lamina propria 
mononuclear cells in Crohn’s disease patients (Daig et al. 2000).  
1.3 Models of the small intestine 
Maintenance of intestinal homeostasis requires interaction between intestinal 
mucosa, microbiota, and immune components (Garrett et al. 2010; Manresa & 
Taylor 2017). Thus, it is very important to develop experimental models that can 
reproducibly generate the intestinal microenvironment with three dimensional 
(3D) architecture. 
 Knockout mice models of inflammatory bowel disease 1.3.1
Knockout mice are genetically modified mice in which specific genes are 
deleted, these can either be systemic deletion or targeted promoter controlled 
deletions (Wirtz & Neurath 2007; Eltzschig et al. 2014; Kiesler et al. 2015). 
Knockout mice models are very useful to determine the functions of genes by 
investigating how the loss of genes can cause or contribute to diseases, from 
which, the findings are often translated to roles in human diseases 
(Longenecker & Kulkarni 2009). Although mouse models can not completely 
mimic human IBD, some of knockout systems have been used to model IBD 
which have provided substantial insights into the mechanism of diseases and in 
development of novel therapies for IBD (Mizoguchi et al. 2016). A number of 
different genetically engineered mice models have been utilized for studying 
IBD. 
1.3.1.1 Cytokine knockout mice models 
Wolf et al (2000) studied the effect of IL-1 on the cellular homeostasis of small 
intestinal mucosa, using C57BL6 IL-1R1 knockout mice, demonstrating that 
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both apoptosis and proliferation increased in intestinal epithelial cells. The 
importance of IL-1Ra, encoded by the IL-1rn gene, as an endogenous IL-1 
inhibitor has been investigated in immune deficient mice (RAG2) (lacking T and 
B cells) where IL-1Ra knockout mice spontaneously developed colitis (Akitsu et 
al. 2014). Knockout of particular genes including IL-2, IL-10, and transforming 
growth factor β (TGF-β) also resulted in the development of murine models of 
spontaneous colitis (Sadlack et al. 1993; Kühn et al. 1993; Kulkarni et al. 1993). 
IL-2 is a cytokine predominantly secreted by activated T-helper 1 (Th1) cells 
and promotes proliferation of T cells. Thus, IL-2 levels were increased in 
inflamed mucosa of patients with Crohn's disease due to the increased activity 
of Th1 (Sadlack et al. 1993). IL-10 is also a regulatory cytokine secreted mainly 
by T cells and macrophages. IL-10 is an effective inhibitor of macrophages and 
Th1 cells. IL-10 knockout mice develop spontaneous colitis and show increased 
levels of IL-1, IL-6, and TNFα. Thus, these observations suggest that IL-10 has 
the ability to protect the intestinal barrier (Kühn et al. 1993). TGF-β is produced 
by macrophages and induces collagen production by fibroblasts or intestinal 
smooth muscle cells which lead to rapid healing of injured intestine. TGF-β 
knockout mouse develops colitis possibly mediated by a defective inhibition of 
lymphocytes (Kulkarni et al. 1993). IL-15 is highly expressed in IBD and 
regulates the production of pro-inflammatory cytokines from T cells (Liu et al. 
2000). IL-15 is produced by several cells involving macrophages, dendritic cells 
and intestinal epithelial cells. IL-15 has a role in intestinal inflammation by 
recruitment and activation of T cells, activation of neutrophils, natural killer (NK) 
cell proliferation, and inhibition of apoptosis (Van Heel 2006). In acute colitis, IL-
15 knockout mice displayed a reduction in T cells and NK cells and decreased 
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the level of TNFα. These observations suggest that IL-15 is a potential new 
therapeutic target in IBD (Yoshihara et al. 2006).  
1.3.1.2 Matrix degrading enzyme knockout mice models 
The gelatinases matrix metalloproteinase MMP2 and MMP9 play a crucial role 
in inflammatory bowel disease where MMP9 mediated tissue injury in colitis, 
while MMP2 knockout prevented tissue damage and preserves intestinal barrier 
function (Garg et al. 2009). Induction of colitis in MMP2 and MMP9 knockout 
mice models by treating with dextran sodium sulfate, Salmonella typhimurium, 
and trinitrobenzene sulfonic acid demonstrated that these knocked out mice 
were resistant to development of colitis as compared to the induction of colitis to 
wild type mice which revealed tissue damage due to the upregulated activity of 
MMP2 and MMP9 (Garg et al. 2009).  
1.3.1.3 Mucosal expression knockout mice models 
The role of the mucus layer in maintaining intestinal epithelial barrier has been 
displayed in MUC2 knockout mice, which developed spontaneous colon 
adenocarcinoma at 6 months of age (Velcich et al. 2002). Furthermore, colitis 
with inflammatory cell infiltration was determined mainly in the distal colon of 
MUC2 knockout mice at 5 weeks of age (Van der Sluis et al. 2006). In addition, 
the role of intestinal alkaline phosphatase (ALP) as a mucosal defence factor 
essential for maintaining of normal intestinal microbial homeostasis was 
investigated. ALP knockout mice (C57BL/6) demonstrated increased severity of 
intestinal inflammation and bacterial growth and translocation into bloodstream 
as compared to wild type mice (Bilski et al. 2017).  
Whilst animal models are useful for studying human diseases, there are a 
number of limitations to their use. In addition to the major ethical concerns, 
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animal experiments require skilled people, time consuming procedures, and 
have high cost. Thus, cell culture models were proposed to overcome the 
drawbacks related to animal experiments and support the 3Rs principle 
(replacement, reduction, and refinement).  
 Cell culture models 1.3.2
Until recently, in vitro intestinal models have been restricted to simple two-
dimensional (2D) cell culture on standard cell-culture plates or transwell culture 
inserts (Haycock 2011). However, three-dimensional (3D) cell culture models 
are currently under investigation by groups worldwide to determine if these 3D 
cell cultures can more closely mimic the in vivo environment and support cell 
differentiation and 3D tissue organization which is not possible in conventional 
2D cell culture systems (Cukierman et al. 2002; Huh et al. 2011; Rimann & 
Graf-Hausner 2012; Ader & Tanaka 2014; Costello et al. 2014a; Pastuła et al. 
2016). 
These 3D cell culture models have been evaluated for use in tissue engineering 
and drug discovery (Balimane & Chong 2005; Tibbitt & Anseth 2009) and used 
as an alternative to in vivo animal models in drug toxicity studies (Pampaloni et 
al. 2007; Ravi et al. 2015). Tissue engineering studies have promised an 
improved understanding of small intestinal physiology, as well as the response 
of the small intestine to infection, toxicity and new therapies (Basu & Bertram 
2014). Furthermore, using these systems it may be possible to develop 
personalized intestinal tissue grafts which can be used to repair the intestine, 
whilst avoiding the risks of immune system rejection (Day 2006).   
These 3D scaffolds are often designed to biodegrade after the deposition of 
extracellular matrix, when the cells become mechanically independent (Day 
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2006; Bitar & Zakhem 2013) and could potentially be used therapeutically (Sato 
et al. 2009), however matching the degradation rates to synthesis and 
deposition of new matrix remains a key challenge in tissue engineering (Sung et 
al. 2004; Wu & Ding 2004; Lee & Mooney 2012). The most important element 
for successful tissue engineering of the small intestine is the use of specialized 
biomaterial scaffolds providing cells a substrate for the deposition of 
extracellular matrix and subsequent cell adhesion (Drury & Mooney 2003; 
Tibbitt & Anseth 2009; Ehrbar et al. 2011). 
1.3.2.1 The use of cell lines in intestinal engineering 
Due to failed attempts to establish long-term primary cell culture of normal small 
intestine, researchers have successfully utilized cell lines which are derived 
from gastrointestinal tumours (Pusch et al. 2011). The human colonic 
adenocarcinoma cell lines: Caco-2 and HT29-MTX cells are probably the most 
frequently used cell lines due to their ability to differentiate into enterocyte-like 
cells and mucus-producing goblet cells, respectively (Figure  1.5) (Howell et al. 
1992; Ferraretto et al. 2007; Rao & Sankar 2009) whilst these would not be 
suitable for the tissue engineering applications due to their cancerous nature 
they are alternativet models for in vitro cultures.  
1.3.2.1.1 Caco-2 cells 
Caco-2 cells can spontaneously differentiate into cells with the ability to form 
tight junctions and produce large amounts of digestive brush border enzymes, 
similar to small bowel enterocytes (Meunier et al. 1995; Yamashita et al. 2002; 
Quante & Wang 2009). Caco-2 cells express a number of digestive enzymes 
including sucrase-isomaltase, lactase, peptidase, and alkaline phosphatase. 
The expression of these enzymes are used as markers of intestinal 
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differentiation and digestive function (Van Beers et al. 1995; Basson et al. 1996; 
Olejnik et al. 2003; Ferruzza et al. 2012; Natoli et al. 2012; Lea 2015). However, 
Caco-2 cells in 2D culture have tight junctions similar to those of the colon, 
rather than the small intestine. This has led to criticism of their use as a model 
for the epithelium of the small intestine (Shah et al. 2006; Araujo & Sarmento 
2013). Furthermore, Caco-2 cell behaviour can be affected by culture condition 
(serum supplemented and serum free media), passage number, cell density 
and incubation times (Ranaldi et al. 2003; Sambuy et al. 2005) all of which 
make it difficult to compare research findings between different studies 
(Nollevaux et al. 2006; Natoli et al. 2011). 
Caco-2 cells are often used to mimic small intestinal enterocytes and have been 
used extensively in absorption and transport studies of nutrients and drugs 
(Gamsiz et al. 2011; Kauffman et al. 2013) (Table  1.1), for example, insulin 
transport studies (Foss & Peppas 2004; Carr & Peppas 2010). Moreover, Caco-
2 cells have been used to investigate the cytotoxicity, for example, that of 
acrylic-based copolymer protein as an oral insulin delivery system (Foss & 
Peppas 2004). Caco-2 cells can also be utilized to verify toxicology when 
exposed to nanoparticles such as polystyrene, which resulted in increased level 
of iron absorption (Mahler et al. 2009).  
1.3.2.1.2  HT29-MTX cells 
HT29-MTX cells are also a commonly used cell line in intestinal modeling. 
These cells are derived from human colonic adenocarcinoma cells and are 
resistant to 10-5 mol/L methotrexate (MTX). HT29-MTX cells are composed 
entirely of differentiated mucus-secreting goblet cells. They maintain this 
differentiated phenotype in monolayer culture and are used to mimic intestinal 
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goblet cells, and are commonly co-cultured with Caco-2 cells in 2D culture 
(Orian-Rousseau et al. 1998; Pontier et al. 2001; Navabi et al. 2013; Martínez-
Maqueda et al. 2015). HT29-MTX cells have been utilized in studies 
investigating the diffusion of drugs across the mucus layer (Walter et al. 1996; 
Behrens et al. 2001; Chen et al. 2010), these have been used to test the 
mucoadhesive and toxicity of nanoparticles as drug delivery systems 
(Adamczak et al. 2016), and to test adhesion and invasion of Salmonella strains 
(Gagnon et al. 2013) (Table  1.1).    
 
 
Figure  1.5: Bright field image of human colon adenocarcinoma cell lines in monolayer 




Cell type         Method                          Key findings            Ref 
Caco-2     Short- term culture (3 days) 
for absorption.       
 Barrier formed with high activity transporters. (Yamashita et al. 
2002)      
Caco-2 A microchip-based system 
for intestinal absorption 
studies.                  
A high permeability coefficient for cyclophosphamide.  (Imura et al. 2009)      
Caco-2        In situ method to measure 
activities of enzymes.             
 Increase of alkaline phosphatase and sucrase activity.  
 An absence of aminopeptidase activity. 
(Ferruzza et al. 
2012)                                                                                                                     
Caco-2 + HT29-MTX      Permeability study.          Both passive permeability values and diffusion coefficients were  
same in both cell lines. 
(Pontier et al. 
2001)      
Serum free co-culture 
Caco-2 and  
HT29-MTX  
Permeability study. Permeability to macromolecules was decreased. Alkaline phosphatase activity was 
increased in co-culture compared to Caco-2 monoculture.  
(Nollevaux et al. 
2006)      
Co-culture Caco-2 
and HT29-MTX  
Iron bioavailability study.                       Increasing the ratio of HT29-MTX cells led to decrease the amount 
 of iron bioavailability.   
(Mahler et al. 
2009)      
Co-culture Caco-2 
and HT29-MTX  
Drug permeability study.  
 
TEER values were decreased and permeability coefficient of  
drugs were increased following 21day culture time.       
(Chen et al. 2010)      
Co-culture Caco-2 
and HT29-MTX  
Permeability study.          TEER value decreased as the proportion of HT29-MTX increased. 
Significant increase in permeability of intestinal fluoride after remove of mucus. 
(Rocha et al. 
2012)      
Caco-2 + HT29-MTX      Host-pathogen interaction. Adhesion and invasion of Salmonella strains to HT29-MTX cells 
were higher than to Caco-2 cells.  
(Gagnon et al. 
2013)      
Caco-2, HInEpC, 
iPSC 
Permeability and drug 
transport.  
HInEpC and iPSC expressed E-cadherin, CDX2, and Villin more 
than Caco-2.  
(Kauffman et al. 
2013)      
 
 
Table  1.1: Summary of the major two dimensional cell culture systems of intestinal cell lines. (Yamashita et al. 2002; Imura et al. 2009; Ferruzza et al. 
2012; Pontier et al. 2001; Nollevaux et al. 2006; Mahler et al. 2009; Chen et al. 2010; Rocha et al. 2012; Gagnon et al. 2013; Kauffman et al. 2013). 
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1.3.2.1.3  2D co-culture models of the small intestine 
In order to mimic the native small intestinal epithelium which is composed of 
diverse absorptive and secretory cells a number of studies have co-cultured 
Caco-2 cells alongside HT29-MTX cells (Walter et al. 1996; Nollevaux et al. 
2006; Mahler et al. 2009; Chen et al. 2010; Gagnon et al. 2013; Béduneau et al. 
2014) (Table  1.1). These studies have enabled the formation of a Caco-2 
derived enterocyte-like layer, which is interspersed with mucus secreting HT29-
MTX cells, and avoided the limitations and drawbacks previously seen in mono-
cultures (Walter et al. 1996). 
Walter et al. (1996) co-cultured Caco-2 and HT29-MTX cells in cell culture 
inserts in a transwell format, where they were shown to produce an adherent 
mucus layer which covered the cell monolayer. The cells were shown to have 
structures similar to microvilli, although they were of irregular shape and size. 
The mucus layer which formed by the HT29-MTX cells during co-culture with 
Caco-2 cells was proposed to play an important role in digestion and 
bioavailability (Mahler et al. 2009) (Figure  1.6). Many studies have exploited in 
vitro co-cultures of Caco-2 and HT29-MTX cells to provide a drug absorption 
model (Walter et al. 1996; Mahler et al. 2009), to study drug permeability (Chen 
et al. 2010; Carr & Peppas 2010; Béduneau et al. 2014), and to improve 
alternative in vitro systems for the evaluation of cytotoxicity of nanoparticles to 
replace animal testing (Walczak et al. 2015). Furthermore, different co-culture 
ratios of Caco-2 and HT29-MTX cells have been used to investigate the co-
culture ratio most physiologically relevant to in vivo situations (Nollevaux et al. 
2006; Rocha et al. 2012; Wan et al. 2014). 
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Another significant aspect of co-culture is the facility to introduce additional cell 
types to more closely mimic the native multicellular environment seen in vivo 
(Figure 1.6). Antunes et al. (2013), developed the triple co-culture model based 
on the use of Caco-2 and HT29-MTX cells, incorporating Raji B lymphocytes. 
The Raji B lymphocytes were selected to stimulate differentiation of Caco-2 
cells to M-cells (Antunes et al. 2013; Araujo & Sarmento 2013; Lozoya-Agullo et 
al. 2017) (Figure  1.6). This triple co-culture system was used to investigate 
absorption of insulin, demonstrating insulin permeability was greater in triple co-
cultures compared to co-culture of Caco-2 and Raji B cells alone (Antunes et al. 
2013). Moreover, in vitro triple co-culture model has been used for polystyrene 
nanoparticle permeability studies that demonstrated the strong influence of 
HT29-MTX cells and M-cells on the nanoparticle permeation. In this study, 
cellular uptake of polystyrene nanoparticles was affected by the presence of 
mucus layers. Where, nanoparticle transport was significantly increased in 
Caco-2/M cells due to a lack of mucus secretion from M cells (Schimpel et al. 
2014). Most recently, the Caco-2/HT29-MTX co-culture and Caco-2/HT29-
MTX/Raji B triple co-culture models have been successfully used to investigate 
the intestinal permeability of different biopharmaceutical characteristics of drugs. 
Where it was shown that higher permeability of drugs were observed in more 
complex models compared with Caco-2 monoculture (Lozoya-Agullo et al. 
2017). Taken together, these studies demonstrate the importance of cell-cell 
interactions which can impact on the physiological function in intestinal cells. 
These models can also be combined with bacterial cells to mimic the microbiota 
seen within the small intestine (Lievin-Le Moal & Servin 2013; Kang & Kim 
2016). Whilst these 2D static culture models of intestinal cells in Transwells 
display a number of advantages, these models fail to develop villi morphology 
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(Kim et al. 2012). Furthermore, these models fail to undergo cytodifferentiation 
due to lack of the 3D microenvironment, including luminal flow, and fluid shear 













Caco-2 cells formed monolayers and differentiated into enterocyte-like 
cells, produced tight junction protein (ZO1). 







HT29-MTX cells formed monolayer and differentiated into goblet cells 






21 days Co-cultured Caco-2 and HT29-MTX cells formed monolayer and 
differentiated into enterocyte and goblet-like cells as above. 




and HT29-MTX cells 
for 14 days then Raji B 
cells were added and 
maintained together for 
6-7 days. 
HT29-MTX cells maintained their phenotype and produced mucus. 





al. 2017)  
Figure  1.6: Summary of two dimensional monoculture, co-culture, and triple co-culture of Caco-2 and HT29-MTX cells. (Pinto 1983; Rousset 1986; Walter et al. 




1.3.2.2 3D cell culture models of the small intestine  
A major shortcoming of two dimensional studies is that they do not reproduce 
the villus-crypt architecture of the small intestine. To overcome this shortcoming, 
Wang et al. (2009a) investigated the effect of a biomimetic crypt-like microwell 
on Caco-2 phenotype. A significant positive correlation between the crypt like 
topography and Caco-2 metabolic activity and migration with low level of 
differentiation which mimics cells in crypts of native small intestine was 
observed. In addition, a number of studies have microfabricated villus-shaped 
collagen scaffolds into which Caco-2 cells were cultured (Sung et al. 2011; Yu 
et al. 2012; Kim et al. 2014; Costello et al. 2014a) (Figure  1.7). These studies 
demonstrated that the culture of Caco-2 cells on these prefabricated villi 
structures led to the formation of villi which were comparable to those of human 
jejunum after 3 weeks in culture (Sung et al. 2011). The transepithelial electrical 
resistance (TEER) was measured, which is a technique used to assess the 
barrier tissue integrity and permeability of cell monolayer, it has been observed 
that TEER of cells in these villus-like structures were lower than those in cells 
grown on 2D flat substrate.  
1.3.2.2.1 Biomaterials for tissue engineering of the small intestine 
A major shortcoming of the research utilizing intestinal cells in 2D culture is that 
it does not mimic the complex architecture of the small intestine and fails to 
mimic the in vivo phenotype. Thus, several biomaterial scaffolds have been 
investigated for 3D cell culture and tissue engineering of the small intestine 
(Basson et al. 1996; Drury & Mooney 2003; Leonard et al. 2010; Sung et al. 
2011; Costello et al. 2014a). 
30 
 
These scaffolds provide a physical structure in which cells migrate and utilize 
topography to stimulate cell development and formation of tissue networks. 
Scaffold porosity is a critical factor in directing cell fate within the 3D scaffold 
architecture. Pore size is essential for the diffusion of cells inside the 3D 
scaffolds, pores enable cells to penetrate into the matrix and provide a space 
for cells to reside and synthesize new extracellular matrix (Sung et al. 2004; Wu 
& Ding 2004; Bitar & Zakhem 2013; Costello et al. 2014a; Ravi et al. 2015). 
Accordingly, many attempts have been undertaken to develop porous 
biomaterials such as tubular constructs with mechanical and physical properties 
well suited to the small intestine (Choi & Vacanti 1997; Grikscheit et al. 2004; 
Huh et al. 2011; Totonelli et al. 2012; Tabriz et al. 2015; Dedhia et al. 2016). 
The rate of cell growth, however, varies depending on the scaffold used 
(Cukierman et al. 2001, 2002). In 3D cell culture models, the interaction 
between cells and the scaffold is regulated by the material characteristics of the 
scaffold. Some materials provide natural adhesion sites for cells whilst others 
provide a substratum for the deposition of extracellular matrix which 
subsequently provides adhesion sites for cells (Ehrbar et al. 2011). The 
mechanical characteristics and degradation dynamics of the scaffold are 
important for specific tissue engineering applications (Kropp & Cheng 2000; 
Terada et al. 2000). The mechanical properties of scaffolds control the shape of 
cells during tissue reconstruction and provide mechanical cues to cells to tailor 
differentiation (Bitar & Zakhem 2013; Costello et al. 2014a), whilst also 
providing support for load (Baker et al. 2009). Scaffolds investigated to date 
include natural hydrogels (e.g. collagen gels and Matrigel) and synthetic 
scaffolds (e.g poly-lactic-glycolic acid) (PLGA) which have a number of key 




Cell Types      Scaffolds                           Key Findings        Ref 
Caco-2 Collagen type I, 
 IV and  laminin 
             
Alkaline phosphatase, dipeptidyle peptidase and 
sucrase-isomaltase activities were higher in Laminin 
 and coll IV compared to coll I  
(Basson et al. 
1996)      
Caco-2 Microfabricated of PDMS 
coated with fibronectin 
Crypt-like topography resulted in higher metabolic activity and lower cell 
differentiation. 
(Wang et al. 




Collagen  IL-8 and mucus was released after IL-1 β treatment.  (Leonard et al. 
2010)      
Caco-2  Collagen and PEG Caco-2 cells proliferated; formed finger-like structures mimicked the human jejunal 
villi. 
 (Sung et al. 





Caco-2 cells behaved in a similar fashion to enterocytes, but there was an increased 
the membranes permeability. p-glycoprotein transporter protein was increased. 
(Pusch et al. 
2011)      
Caco-2  Collagen + Matrigel Regeneration of basal proliferative crypts and formation of four types of intestinal 
cells: enterocytes, goblet, enteroendocrine and paneth cell. 
 (Kim et al. 
2012)      
Caco-2   PLGA Determined the location of the 4 strains of bacteria to the Caco-2 monolayers and 
evaluated the therapeutic ability of probiotic. 
 (Costello et al. 
2014a)      
Caco-2 + 
HT29-MTX  
  PLGA Alkaline phosphatase activity was increased. The TEER values were high. (Costello et al. 
2014b)      
Caco-2 Fabricated of collagen  
into 3D villi scaffold 
Caco-2 growth was increased. Alkaline phosphatase activity was increased. The 
TEER values were decreased. 
(Yi et al. 2017)      
Table  1.2: Summary of three dimensional cell culture systems of intestinal cell lines. (Basson et al. 1996; Wang et al. 2009; Leonard et al. 2010; Sung 




1.3.2.2.1.1  Natural biomaterials  
Type I collagen gels are commonly used for 3D culture, as they are easy to 
prepare, inexpensive, can support a range of cell types (Li et al. 2013; Lelièvre 
et al. 2017), and enable encapsulation of cells (Chougule et al., 2012) 
(Table  1.2). Furthermore, pore size, rigidity, and ligand density can be adjusted 
by changing the collagen concentration or utilizing chemical cross-links (Baker 
et al. 2009). Li et al. (2013) used collagen gels to seed fibroblasts, Caco-2 and 
HT29-MTX cells, which was used to evaluate drug permeability and was shown 
to have more physiologically relevant drug absorption rates. Pusch et al. (2011) 
performed 3D co-culture of Caco-2 cells and human microvascular endothelial 
cells (hMECs), created multilayers of enterocyte-like cells which expressed villin, 
E-cadherin, and the transporter p-glycoprotein at levels that were similar to that 
of a normal human jejunum. Whilst Viney et al. (2009) co-cultured intestinal 
epithelial cell lines (IEC6: a rat small intestinal epithelial cell line; IPI-21: a small 
boar ileum epithelial cell line, and CRL-2102: a human epithelial cell line derived 
from colorectal adenocarcinoma) with Rat-2 (fibroblast-like cells) in collagen 
gels alone or in combination with Matrigel. After 20 days, optimal epithelial cell 
growth was seen in collagen gels supplemented with Matrigel, where multi-
layered intestinal epithelium were seen, which included clusters of cells similar 
to the morphology of crypts. This highlighted the importance of the interaction 
between the cell lines, extracellular matrix and other cell types such as 
fibroblasts; and how they can impact on cellular proliferation and differentiation 
(Walker & Stappenbeck 2008). These interactions with localized cells were 
further demonstrated when rat intestinal sub-epithelial myofibroblasts (ISEMF) 
were co-cultured with IEC-6 cells on a collagen gel scaffold (Yoshikawa et al. 
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2011), where the myofibroblasts induced differentiation of intestinal epithelial 
cells into enteroendocrine cells (Table  1.2) (Figure  1.7). 
1.3.2.2.1.2 Synthetic biomaterials  
Synthetic scaffolds have also been studied for their ability to reconstruct the 
small intestine. Synthetic biodegradable copolymers: poly lactic acid (PLA) and 
poly glycolic acid (PGA) have been combined to form poly lactic glycolic acid 
(PLGA). This polymer has been investigated for scaffold fabrication in tissue 
engineering of the small intestine (Boomer et al. 2014; Ravi et al. 2015). The 
chemical properties of PLGA co-polymer permitted hydrolytic degradation of the 
ester bond into the acidic, non-toxic monomers (PLA and PGA) which are 
removed by natural metabolic pathways. Physical properties of PLGA have 
been found to be related to the molecular weight of the monomers, the 
hydrophobic PLA/hydrophilic PGA ratio, the storage temperature and the 
exposure time to water. These studies demonstrated the rate of degradation 
negatively affected cell proliferation, with the fastest degradation rates 
displaying the poorest viability (Sung et al. 2004; Wu & Ding 2004). 
In addition, Costello et al. (2014b) used fabricated PLGA as a porous 3D tissue 
scaffold which mimicked the shape and size of intestinal villi. They showed that 
co-culture of Caco-2 and HT29-MTX on PLGA resulted in proliferation and 
differentiation of co-cultured cells. However, these Caco-2 and HT29-MTX cells 
were differentiated under the stimulation of epidermal growth factor which was 
added to the basolateral side of scaffolds (Figure  1.7). 
 Although the latest procedures to engineer the small intestine in vitro have 
been shown to have some positive outcomes, the surface area created is not 
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adequate for human therapy and the majority of in vitro methods created only 





                  Experimental design   Culture duration                                            Key findings           Ref 
 
 
         21 days Co-cultured cells proliferated for 3 weeks and the cells formed 
monolayer and secreted mucus. Low level of ZO-1 expression.   
(Yoshikawa et al. 
2011)      
 
 
         21 days Decreased TEER value. ISEMF cells well maintained IEC-6 
cells.IEC-6 cells proliferated, formed multilayer structures and 
expressed enteroendocrine markers such as chromogranin A. 
(Yu et al. 2012)      
 
 
         21 days Caco-2 cells proliferated on the surface of fabricated collagen 
scaffolds and mimicked the intestinal villi. The height of the 
collagen scaffold condensed to approximately half of the original 
height and was incapable of withstanding long term culture without 
loss of villi integrity. 
(Sung et al. 2011)      
 
 
         28 days Co-cultured cells proliferated on the surface of fabricated porous 
PLGA scaffolds and mimicked the intestinal villi. Caco-2 cells 
differentiated into enterocyte like cells and HT29-MTX cells 
differentiated into goblet like cells, this differentiation was 
stimulated by adding epidermal growth factor to the basolateral 
side. 
(Costello et al. 
2014a)      
 
Figure  1.7: Summary of three-dimensional monoculture and co-culture of Caco-2 and HT29-MTXcells using collagen gel, collagen scaffolds, and PLGA 




1.3.2.3 Recapitulating the dynamic mechanical microenvironment of the 
small intestine 
Under an in vitro static culture microenvironment, cells can be supplied with 
nutrients by manual medium replacement. Thus, long term culture under static 
conditions possesses multiple limitations such as poor delivery of nutrients, 
accumulation of waste and risk of contamination. To overcome these limitations, 
and for long term maintenance of intestinal cells in a healthy state, many 
studies have developed dynamic culture microenvironments. An automated 
perfusion system (Minucells and Minutissue) has been used to study the 
differentiation and drug transport properties of Caco-2 cells (Masungi et al. 
2004; Masungi et al. 2009). The enzymatic activities and permeability coefficient 
of drugs in differentiated Caco-2 cells in perfusion systems were increased 
when compared to Caco-2 cells differentiated in traditional culture using 
snapwell inserts (Masungi et al. 2004; Masungi et al. 2009).   
Similarly, microfluidic culture methods play an important role in addressing this 
issue and assist in the development of enhanced barrier function of Caco-2 
cells (Imura et al. 2009). Several studies have developed gut-on-a-chip 
microdevices to mimic the dynamic motion seen in the human small intestine 
(Huh et al. 2011; Kim et al. 2012; Kim & Ingber 2013; Mochel et al. 2017; Bein 
et al. 2018). Microfluidic gut-on-a-chip microdevices are an alternative in vitro 
model, which have the ability to recapitulate the 3D structures of native human 
intestinal villi. In these models, Caco-2 cells exposed to dynamic fluid flow and 
peristalsis-like motions resulted in cytodifferentiation of Caco-2 cells into four 
main types of intestinal epithelial cells and formed proliferative crypts (Huh et al. 
2011; Kim et al. 2012; Kim & Ingber 2013; Bein et al. 2018). 
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1.3.2.4 Tissue engineering the small intestine 
The small intestine becomes dysfunctional in a number of diseases including 
inflammatory driven pathologies (such as ulcerative colitis; Crohn's disease; 
celiac disease), congenital diseases (such as lactose intolerance and short 
bowel syndrome) and cancer. These can become extremely debilitating 
disorders impacting on quality of life or can even become life-threatening 
(Abadie & Jabri 2014; Belchior et al. 2014; Valatas et al. 2015). 
Thus, the ability to replace damaged and malfunctioning tissues with a tissue-
engineered small intestine could be of use in these conditions (Nakamura & 
Sato 2018). Furthermore, engineered intestinal tissue could be created using 
patient-specific explants; small samples of healthy tissue could be collected 
from a patient and expanded within the laboratory. If these cells could then be 
utilized in the generation of a tissue-engineered small intestine, this could then 
be returned to the patient to enable intestinal repair or augmentation. Use of 
self-tissue would avoid the requirement of tissue donors, and the need for 
lifelong immunosuppression to prevent rejection of tissues (Grant et al. 2015). 
 Stem cell models 1.3.3
1.3.3.1 Isolation of small intestinal stem cells  
For the successful isolation of stem cells from intestinal crypts a clear stem cell 
marker is essential to enable purification of intestinal stem cells, and whilst 
there are a variety of stem cells markers, a leucine-rich repeat-containing G-
protein coupled receptor 5 (Lgr5), also known as GPR49, has been suggested 
as the most appropriate marker for purification of stem cells (Barker et al. 2007, 
2008, 2010; Sato et al. 2011a; Barker et al. 2012, 2013). Lgr5 is expressed in 
cycling columnar cells in the base of the crypts, but not in the villi (Barker et al. 
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2007; Snippert et al. 2010). Lgr5 is a target of Wnt signaling and these cells are 
capable of generating all epithelial lineages in in vitro culture (Barker et al. 
2007; Sato et al. 2009; Tan & Barker 2015). Furthermore, intestinal stem cells 
are capable of self-organizing into organoid units that recapitulate the intestinal 
villi and crypt domains and reflect main structural and functional properties of 
the small intestine (Sato et al. 2009, 2011a; Fuller et al. 2012; Sato & Clevers 
2012,  2013; Wang et al. 2013a; Date & Sato 2015; Sato & Clevers 2015; 
Sasaki et al. 2017).  
Studies over the past two decades have provided promising results in tissue 
engineering of small intestine due to the successful isolation of intestinal crypts 
which could form organoid units (Figure  1.8). It is possible to take complete 
crypts from intestinal tissues, which contain progenitor cells and expand these 
crypts in vitro to form organoid units and differentiate following transplantation 
(Mochel et al. 2017). Kim et al. (2007) harvested intestinal epithelial organoid 
units from neonatal rats and seeded them on biodegradable polyglycolic acid 
scaffolds, which were maintained in a perfusion bioreactor for 2 days. The cells 
were shown to distribute and adhere to the polymer scaffold. Similarly, Sato and 
colleagues (2009) developed a 3D culture system of mouse intestinal crypts 
known as ‘mini-gut’ culture or organoid culture. These 3D cultures in Matrigel 
supplemented with growth factors (R-spondin-1, epidermal growth factor, and 
the BMP inhibitor: Noggin). In this system, the crypt-villus organoids developed 
not only from whole crypts but also from single Lgr5+ stem cells. These single 
intestinal stem cells were shown to form crypt-like structures by day 1-4, and 




Figure  1.8: Schematic diagram illustrating growth of intestinal organoids from isolated crypts and 
single Lgr5
+
 stem cells cultured in Matrigel. 
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In similar studies conducted by Jabaji et al, (2013; 2014) type 1 collagen was 
compared with Matrigel as an alternative scaffold for growing isolated crypt 
units. They showed that the intestinal crypts enlarged and formed enteroids in 
vitro when cultured in both scaffolds as monoculture and when cultured with 
myofibroblasts for 1 week. Khalil et al. (2016) developed a long-term culture 
model of juvenile and adult porcine intestinal crypts to generate budding 
enteroids. Pastula et al. (2016) modified Sato's 3D culture methods using a 
combination of Matrigel and collagen and co-cultured the epithelial organoid 
with myofibroblast, and neuronal cells. Where myofibroblasts and neuronal cells 
supported the growth of epithelial organoids. However, the presence of collagen 
led to a reduction in the budding of epithelial organoids, potentially due to 
increased mechanical rigidity. 
They concluded that these systems enabled the organoids to align and fuse 
forming the macroscopic hollow structures. However, in this model although 
cellular differentiation was observed, villi structures were still missing (Sachs et 
al. 2017). Whilst Wang et al. (2017) successfully generated crypt-villus 
architecture from intestinal stem cells cultured on a fabricated collagen scaffold. 
Furthermore, application of chemical gradients applied to the scaffold promoted 
and supported cell migration along the crypt-villus axis. Demonstrating a 
combined approach of microengineered scaffolds together with biophysical 
cues and chemical gradients could hold the potential for tissue engineering a 
small intestinal model in vitro.  The creation of the 3D organoids provides an 
ideal culture system to examine how stem cells integrate the multiple signals to 
maintain stemness, the 3D nature of organoids, however, does not enable the 
visualisation of the stem cells destiny; which is a great challenge when 
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investigating the interaction between stem cells and other niche cells (Gjorevski 
et al. 2016).  
This work has been progressed by the use of human intesitnal stem cells. Scott 
et al. (2016) cultured human small intestinal crypts in 2D monolayers, on a thin 
layers of bovine type 1 collagen. These human intestinal crypts were expanded 
in  long-term culture, with the ultimate aim being that one day these cultures 
could be used in clinical cell transplantations. Similalry, Liu et al. (2018) 
successfully established a self-renewing 2D monolayer culture system for 
investigation of the dynamic of Lgr5+ intestinal stem cells. Isolated intestinal 
crypts from mice were seeded on Matrigel coated glass sheets. Lgr5+ intestinal 
stem cells in monolayer showed stem cell properties, as they efficiently formed 
3D organoids in Matrigel.  
The use of Matrigel and collagen as cell culture scaffolds suffer the drawbacks 
of batch to batch variability, high costs, and risk of pathogen contamination. In 
addition the Matrigel is derived from mouse sarcoma, thus, synthetic scaffolds 
which are defined physiochemical and mechanical properties were used to 
overcome these drawbacks (Holmberg et al. 2017).   
1.3.3.2 In vivo implantation of organoid seeded scaffolds 
A number of studies have directly seeded the organoid units onto biodegradable 
scaffolds to test their ability to regenerate the intestine post-implantation in 
rodents (Choi & Vacanti 1997; Choi et al. 1998; Finkbeiner et al. 2015) and 
large animals (Agopian et al. 2009). In (1988), Vacanti et al., isolated organoid 
units from neonatal rat intestine and seeded these onto a tubular scaffold of 
polyglycolic acid and poly-L-lactic acid prior to implantation into the omentum of 
the syngeneic adult rat. These organoid units survived, proliferated and had 
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characteristic villus-crypt structures. Choi & Vacanti (1997), demonstrated that 
the organoid units isolated from 6-day-old neonatal rat intestines, seeded on 
PGA and then implanted into adult rats survived, proliferated, and regenerated 
small intestine-like structures. Similarly, organoid units isolated from 7 week old 
Yorkshire swine and cultured on tubular biodegradable scaffolds and implanted 
intraperitoneally in the autologous host, intestinal cells innervated the 
muscularis mucosa and intestinal sub-epithelial myofibroblasts were identified 
(Sala et al. 2009).  
Levin et al (2013) seeded multicellular organoid units derived from postnatal 
human small intestine resections onto a biodegradable PGA / PLA polymer. 
Following transplantation into NOD/SCID gamma chain-deficient mice, the 
human tissue formed villus-crypt architecture similar to that of the mature 
human small intestine, which contained all differentiated epithelial cell types and 
mesenchymal cells which expressed muscular and neural markers. In vivo 
subcutaneous implantation using PGA scaffolds of one week old collagen 
based enteroids derived from 3D co-cultures of small intestinal crypts and 
myofibroblasts resulted in sustainable re-formed intestinal organoids with 
differentiated lineages after 5 weeks (Jabaji et al. 2013). Cromeens et al. (2016) 
produced neomucosa by seeding enteroids derived from LGR5-EGF transgenic 
mice on Matrigel for 10-14 day and then these enteroids were released from 
Matrigel and seeded onto PGA scaffolds and implanted into the peritoneal 
cavity of immunocompromised NOD/SCID mice. After 4 weeks, neomucosa 
was produced with clear crypt domains and blunted villi. The shortcoming of this 
study was that villi were blunted and did not extend to the length of native small 
intestinal villi. The main limitations of these attempts to generate small intestinal 
tissue are the high number of cells required for engineering functional tissue 
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and the absence of scaffolds which mimic the native intestine and those 
capable of generating an intestinal stem cell niche. 
1.3.3.3 3D cell culture of pluripotent stem cells  
Multipotent stem cells can generate numerous tissues in the body and have 
high proliferative capacity, making them attractive for use in regenerative 
medicine (Wang & Sander 2012). Mesenchymal stem cells have been 
investigated as a promising source of smooth muscle layer for small intestinal 
tissue engineering. Hori et al. (2002) investigated mesenchymal stem cells to 
study the feasibility of muscle regeneration, the limitations considered the lack 
of ability to regenerate smooth muscle layer.  
Over recent years, several studies have provided evidence that human induced 
pluripotent stem cells (iPSCs) can be used to generate intestinal tissue (Spence 
et al. 2011; Watson et al. 2014; Finkbeiner et al. 2015; Mahe et al. 2017). A 
study published in 2011 aimed to direct the differentiation of human pluripotent 
stem cells to generate fetal intestinal-like immature properties using 
manipulation of growth factors (Spence et al. 2011). Similarly, Yoshida et al. 
(2012) demonstrated that pluripotent stem cells from mice were successfully 
differentiated into smooth muscle in vitro. Watson et al. (2014) generated 
human intestinal organoids from human iPSCs and embedded these in collagen 
type I scaffolds prior to transplantation into immunocompromised mice for a 
period of 6 weeks. Following transplantation, iPSCs fully differentiated into all 
types of small intestinal cells and smooth muscle layers when compared with in 
vitro human intestinal organoids. A study conducted by Finkbeiner et al. (2015) 
also showed that human intestinal organoids derived from iPSCs generated a 
tissue that resemble the native human intestinal tissue when seeded onto 
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PGA/PLA scaffolds and implanted into immunocompromised mice for 12 weeks. 
While these are promising findings, tissue engineered intestines were 
supplemented with further neuronal cell types to generate physiologically 
functional tissue-engineered intestine. 
1.3.4 Conclusions 
Taken together, several effective models for the small intestine exist, whilst they 
have their advantages they also have a number of limitations. Namely none to 
date have been able to identify causative factors of inflammatory bowel disease. 
Furthermore in vitro culture models fail to recapitulate the natural villi structure 
of the small intestine spontaneously. The use of natural biomaterials is hindered 
by batch to batch variation, contamination and reproducibility, of particular note 
is the dependence of organoid cultures on Matrigel and collagen gels which 
hamper their development. Thus, the design of experimental models that can 
reproducibly generate the intestinal microenvironment which closely mimic the 
native healthy and diseased small intestine are essential to investigate the 










1.4 Aims and objectives 
Development of a robust intestine model which reflects the pathogenesis of IBD 
remains a considerable unmet need. Thus, this thesis aimed to develop several 
models of the small intestine including: genetically engineered murine model, 
epithelial cell culture models, and an intestinal stem cell organoid model which 
could be used to study the pathogenesis of IBD and define new therapeutics.  
Specific objectives 
1. The majority of current animal models of IBD focused on the large intestine 
where an imbalance between IL-1 and IL-1Ra has been thought to contribute to 
the pathogenesis of IBD. However, whether this is a causative factor in small 
intestine is unclear. Thus, this study utilised a murine IL-1Ra knockout mice 
model to investigate whether features of inflammatory bowel disease would 
develop spontaneously (Chapter 2). 
2. To date, no realistic 3D models which form intestinal villi without 
prefabrication of structures prior to culture have been achieved. Hence, this 
study to investigate the potential hydrogel systems which could be utilised to 
determine their use as scaffolds to support formation of the villi architecture 
(Chapter 3).  
3. The current cell culture studies did not consider the effect of inflammatory 
conditions in a 3D co-culture model to develop model of the IBD. Thus, the 
potential of L-pNIPAM hydrogel scaffolds to develop a long-term 3D co-culture 
model of Caco-2 and HT29-MTX cells under conditions representative of 




4. Current organoid culture systems are dependent on animal-derived hydrogels 
with many limitations which make them inappropriate for organoid expansion 
with clinical applications. Thus, the potential of L-pNIPAM hydrogel scaffold to 
support proliferation and differentiation of small intestinal crypts and stem cells 
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Inflammatory bowel disease (IBD) is a chronic autoimmune disease 
characterised by inflammation of the gastrointestinal tract and can be divided 
into two main types Crohn’s disease (CD) which affects any part of the 
gastrointestinal tract mainly in the terminal ileum and colon; and ulcerative 
colitis (UC) which affects the rectum and colon (Ludwiczek et al. 2004). 
Although the pathogenesis of IBD is not fully understood, IBD could be caused 
by an imbalance between pro and anti-inflammatory cytokines in local tissues 
and lead to inflammation and malfunction of the barrier in the intestinal tissue. 
Interleukin 1 (IL-1) is a key mediator of innate immunity and inflammation which 
results in tissue damage in IBD.  
An imbalance between IL-1 and IL-1Ra has been shown in the inflamed 
mucosa of patients with IBD where the levels of IL-1 and IL-Ra were increased, 
but importantly the ratio of IL-1Ra to IL-1 was significantly decreased compared 
with controls (Casini-Raggi et al. 1995; Ludwiczek et al. 2004). In patients with 
IBD, IL-1 is generally produced by intestinal macrophages, whilst IL-1Ra is 
secreted by intestinal epithelial cells (Daig et al. 2000). During Crohn's disease, 
IL-1β is significantly raised and there is a positive correlation between the 
severity of mucosal inflammation and the levels of IL-1β (Al-Sadi et al. 2008). 
IL-1 stimulates recruitment and activation of polymorphonuclear cells (Coccia et 
al. 2012). It can also result in apoptosis of epithelial cells causing tissue 
damage and barrier dysfunction. Subsequently, the role of IL-1Ra in disease 
progression has been studied in various experimental animal models of IBD 
(Cominelli et al. 1990; Ferretti et al. 1994; McCall et al. 1994).    
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In the SAMP/YiT experimental mice model, which has an increase in Th-1 
activity which mediates intestinal inflammation, there was a spontaneous 
appearance of chronic ileitis which was similar in appearance to Crohn's 
disease due to increased intestinal paracellular permeability (Olson et al. 2006; 
Kiesler et al. 2015). This chronic ileitis is characterised by intestinal 
inflammation, mononuclear and polymorphonuclear infiltrates of the lamina 
propria; plus hyperplasia of paneth and goblet cells (Kosiewicz et al. 2001). 
Although studies have reported that an imbalance between IL-1 and IL-1Ra 
contributes to inflammation in the large intestine in patients of IBD and in 
experimental animal models (Hirsch et al. 1996; Arend 2002; Ludwiczek et al. 
2004) whether this is a causative factor is unclear. Here, the histological 
changes in the small intestine of IL-1Ra knockout mice were investigated to 
assess the expression of pro-inflammatory cytokines, infiltration of immune 
cells, matrix-degrading enzymes, junctional proteins, and digestive enzymes in 
the small intestine of IL-1Ra knockout mice compared to wild-type mice in two 
age groups in order to determine whether features associated with IBD could be 
induced spontaneously in the small intestine by the removal of IL-1Ra in mice.
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2.2 Materials and methods  
 IL-1rn-/- BALB/c mice 2.2.1
IL-1rntm1Nick deficient mice (IL-1rn-/-) have been described previously (Nicklin et 
al. 2000). All mice were housed behind positive pressure barriers and were 
reared under UK Home Office licenses. All materials were supplied sterile and 
certified pathogen free. This work was approved by the University of Sheffield 
ethical review panel. Formalin-fixed mice were a kind gift from Dr. Martin 
Nicklin, University of Sheffield.    
 Tissue preparation and histological assessment 2.2.2
The entire jejunum and ileum portions of small intestine were dissected from 
BALB/c IL-1rn-/- knockout mice aged 50-55 days (n=4) and 155-185 day old 
(n=4), together with age-matched BALB/c wild-type (WT) controls (n=4 at each 
age). Following dissection, tissues were rinsed in PBS and fixed in 10% v/v 
formalin for 24 h and then transferred to 70% v/v ethanol. Tissues were 
processed and embedded in paraffin wax. Five-micron sections were cut and 
mounted onto positively charged slides (Leica Microsystem Milton Keynes, UK). 
Sections were deparaffinised in Sub-X and rehydrated in industrial methylated 
spirits (IMS) prior to rehydration in distilled water. Sections were then stained 
with either: Haematoxylin and Eosin; Mayer's Haematoxylin (Leica Microsystem, 
Milton Keynes, UK) for 2 min rinsed in water for 5 min and immersed in Eosin 
(Leica Microsystem, Milton Keynes, UK) for 1 min;  or Alcian Blue/Periodic acid 
Schiff's (PAS): 1% w/v Alcian Blue (PH 2.5) (Sigma-Aldrich, Poole, UK) in 3% 
(v/v) acetic acid (Sigma-Aldrich, Poole, UK) for 30 min and immersed in 0.5% 
(w/v) Periodic acid  for 10 min and rinsed three times in deionised water. Slides 
were then immersed in Schiff reagent (Merck KGaA, Germany) for 10 min, and 
then rinsed three times with deionised water. Following staining, sections were 
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dehydrated in IMS, cleared with Sub-X and mounted in Pertex (Leica 
Microsystem, Milton Keynes, UK). The slides were examined with an Olympus 
BX 51 microscope and images captured by the digital camera and Capture Pro 
OEM V8.0 software (Media Cybernetics, Buckinghamshire, UK).  
The tissue morphology was assessed using the Capture Pro OEM V8.0 
software measurement tools as follows:  
2.2.2.1 Crypt-villus axes height and villus width  
Twenty well oriented crypt-villus axes height and villus width at half-axis height 
in longitudinal tissue sections were measured in the jejunum and ileum of all 
mice, from each age range and genotype. 
2.2.2.2 Goblet cells per crypt-villus axis  
The numbers of goblet cells within twenty well oriented crypt-villus axes were 
counted in the jejunum and ileum of all mice from each age range and 
genotype.  
 Immunohistochemical assessment  2.2.3
2.2.3.1 Pro-inflammatory cytokine expression and immune cell 
infiltration 
The expression of pro-inflammatory cytokines IL-1α, IL-1β, and their receptor: 
IL-1RI; IL-15, and TNFα were investigated by immunohistochemistry. In 
addition, the number of immune cells which infiltrated into lamina propria of 
crypt-villus axis was determined using immunohistochemistry of 
polymorphonuclear cell marker: CD11b and macrophage marker CD68, in the 




2.2.3.2 Matrix-degrading enzyme expression 
The expression of matrix-degrading enzymes: MMP2, MMP9, and ADAMTS1 
were assessed in the jejunum and ileum of three randomly selected mice, from 
each age range and genotype using immunohistochemistry. 
2.2.3.3 Polarity of enterocytes and digestive enzyme expression 
The expression of tight junction proteins Zonulin 1 (ZO-1) and adherent junction 
protein E-cadherin, were assessed alongside digestive enzymes: alkaline 
phosphatase (ALP), sucrase-isomaltase (SI), and dipeptidyl peptidase IV (DPP 
IV) in the jejunum and ileum of three randomly selected mice, from each age 
range and genotype.  
Immunohistochemistry was performed as described previously (Le Maitre et al. 
2005). Briefly, 5 µm sections were de-waxed, rehydrated, and endogenous 
peroxidase blocked using hydrogen peroxide (Sigma-Aldrich, Poole UK). After 
washing in Tris-buffered saline (TBS) (20mM Tris, 150mM sodium chloride, pH 
7.5), tissue sections were subjected to antigen retrieval sections were subjected 
to an appropriate antigen retrieval method, specific to the antibodies 
investigated (Table 2.1). Following this sections were washed in TBS.  
Following TBS washing, nonspecific binding sites were blocked at room 
temperature for 90 min with 25% (w/v) serum (Abcam, Cambridge, UK) in 1% 
(w/v) bovine serum albumin in TBS. Sections were incubated overnight at 4°C 






Table 2.1: Target antibodies used in Immunohistochemistry. 
 





























Rabbit polyclonal  




































































For each immunohistochemistry method, a negative control was performed, 
replacing the primary antibody with either rabbit or mouse IgG (Abcam, 
Cambridge, UK) as appropriate, at a concentration equal to that of the primary 
antibody. Sections were washed in TBS and then incubated in 1:500 dilution of 
an appropriate biotinylated secondary antibody for 30 min at room temperature. 
Binding of the secondary antibody was visualised after exposure to horseradish 
peroxidase (HRP) streptavidin-biotin complex (Vector Laboratories, 
Peterborough, UK) for 30 min. Sections were washed in TBS, and treated with 
0.08% (v/v) hydrogen peroxide in 0.65mg/ml 3, 3′-diaminobenzidine 
tetrahydrochloride (Sigma-Aldrich, Poole, UK) in TBS for 20 min. Sections were 
counterstained with Mayer’s haematoxylin, dehydrated, cleared and mounted in 
Pertex. Immunohistochemical staining were examined with an Olympus BX51 
microscope and images captured by digital camera and Capture Pro OEM v8.0 
software (Media Cybernetics, Buckinghamshire, UK). Immunopositive intensity 
across the small intestine architecture was independently quantified by two 
assessors (CLM and NJM), blinded to animal genotype and age. A scale of 0 to 
6 was utilised where 0 was no immunopositivity and 6 signifies maximum 
immunopositivity. The number of immunopositive (CD11b and CD68) immune 
cells were counted within twenty well oriented crypt-villus axes of each of three 
randomly selected mice, from each age range and genotype.  
 Statistical analysis 2.2.4
Data was plotted using GraphPad Prism V6.0. Crypt-villus axes height and 
villus width were assessed for normality using Stats Direct program and found 
to be non-parametric and therefore statistical comparisons were performed by 
Kruskal-Wallis with a pairwise comparison (Conover-Inman) between ages and 
genotypes. Statistical significance was set at P ≤ 0.05, for statistical analysis the 
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mean villi height, width and goblet cells per villi per mouse were utilised for 
statistical analysis. All replicates are shown with the median values for each 
mouse to demonstrate clearly the spread of replicates.  
 Ethical consideration  2.2.5
To ensure that experimental procedures aligned with the 3Rs principle, initial 
work was completed on n=4 and statistical analysis performed, as statistically 
significant differences were seen in n=4 it was not deemed ethically appropriate 




 Histological analysis 2.3.1
2.3.1.1 Crypt-villus axis height and villus width  
In the jejunum, there was a significant decrease in height of crypt-villus axis of 
the 155-185 day old IL-1rn-/- mice compared with age-matched WT mice 
(P≤0.05) (Figure 2.1). However, the crypt-villus height of the jejunum was 
significantly greater in the 155-185 day compared to the 55-day in WT groups 
(P≤0.05). The width of the villus at half crypt-villus axis was unchanged in all 
groups (Figure 2.1). Morphology of jejunal villi of 155-185 day old IL-1rn-/- mice 
revealed moderate epithelial damage with separation of the columnar epithelia 
from the lamina propria within the villi and the formation of large spaces 
between the crypt base and the muscularis mucosa in the 55-day old IL-1rn-/- 
mice (Figure 2.1). 
 In the ileum, there was a significant decrease in the crypt-villus axis height of 
both the 55-day old and 155-185 day old IL-1rn-/- mice compared with WT mice 
(P≤0.05) and a significant decreased in 155-185 day old IL-1rn-/- mice compared 
with 55-day IL-1rn-/- mice (P≤0.05). In contrast, the crypt-villus axis height was 
significantly increased in 155-185 day old IL-1rn+/+ mice compared with 55-day 
IL-1rn+/+ mice. A significant decrease was seen in villus width in 155-185 day 
old IL-1rn-/- mice compared with 155-185 day old WT mice and 55-day IL-1rn-/- 
mice (P≤0.05). While villus width in the ileum was significantly increased in 155-
185 day WT mice compared with 55-day old WT mice (P≤0.05) (Figure 2.2). 
Once again there was a separation of the columnar epithelium from the lamina 
propria within the villi and the formation of large spaces between the crypt base 




Figure  2.1: Histological analysis and morphology of the intact well-oriented crypt-villus axis 
heights and villus widths of Jejunum in the 55 day old IL-1rn
-/-
 mice and 155-185 day old IL-1rn
-/-
 
mice compared to age-matched wild-type mice. Stained with H&E. Black arrows indicate 
moderate epithelial damage in 155-185 day old IL-1rn
-/-
 mice, enlarged space between the crypt 




Figure  2.2: Histological analysis and morphology of the intact well-oriented crypt-villus axis 
heights and villus widths of Ileum in the 55 day old IL-1rn
-/-
 mice and 155-185 day old IL-1rn
-/-
 
mice compared to age-matched wild-type mice. Stained with H&E. Black arrows indicate 





2.3.1.2 Number of goblet cells per crypt-villus axis 
In the jejunum and ileum, there was a significant increase in the number of 
goblet cells per crypt-villus axis in all IL-1rn-/- mice groups compared with WT 
mice (P≤0.05). Furthermore, in jejunum, there was a significant increase in the 
number of goblet cells per crypt-villus axis in 155-185 day old IL-1rn+/+ 
compared to 55 day old IL-1rn+/+ mice (P≤0.05) (Figure  2.3 A & B). Moderate 
and intense PAS (pink) staining was observed in 55 day old IL-1rn+/+ and        
IL-1rn -/- mice and intense alcian blue staining was observed in 155-185 day old 
IL-1rn+/+ and IL-1rn -/- mice (Figure  2.3 A & B). This indicated the presence of 
neutral mucins in younger mice, and acidic mucins in older mice in both the 





Figure  2.3: Histological analysis and morphology of goblet cells per intact well-oriented crypt-
villus axis of the A: Jejunum and B: Ileum of 55 day old and 155-185 days old IL-1rn
-/-
 mice 





 Immunohistochemistry staining 2.3.2
2.3.2.1 Assessment of pro-inflammatory cytokine expression and 
localization 
Across the small intestine (jejunum and ileum), the expression of pro-
inflammatory cytokine IL-1α was highly expressed in both the villi and crypts. 
There was a significant increase in IL-1α in 155-185 day old IL-1rn-/- mice, 
compared with WT mice and 55 day IL-1rn-/- mice (P≤0.05) (Figure  2.4 A and 
Figure  2.5 A & B). Whilst high levels of IL-1α were seen in all mice, only low 
levels of immunopositivity was seen in WT mice with a significant increase in IL-
1β in the 55 day old and 155-185 day old IL-1rn-/- mice, compared with WT mice 
(P≤0.05) (Figure  2.4 B, and Figure  2.5 C & D). The expression of IL-1R1 was 
primarily located in villi; however, there was a significant decrease in IL-1R1 
expression in both the 55 day old and 155-185 day old IL-1rn-/- mice compared 
with WT mice (P≤0.05). IL-1R1 expression in 155-185 day old IL-1rn+/+ and 155-
185 day old IL-1rn-/- mice were significantly lower than those seen in the 55 day 
old IL-1rn+/+ and 55 day old IL-1rn-/- mice, respectively (P≤0.05) (Figure  2.4 C 





Figure  2.4: Immunohistochemistry staining of the expression and localization of pro-
inflammatory cytokine A: IL-1α; B: IL-1β; C: IL-1RI in the jejunum of the 55-day old and 155-185 
days old IL-1rn
-/-
 mice compared with WT mice. Cell nuclei were stained with haematoxylin 









IL-15 expression was observed only at low levels in the 55 day old IL-1rn-/- 
mice, and localized in both the villi and crypts, but significantly increased in the 
155-185 day old IL-1rn-/- mice, compared with WT mice (P≤0.05) (Figure  2.6 A 
and Figure  2.7 A & B). TNFα expression was also observed at low levels in the 
55 day old IL-1rn-/- mice. TNFα was localized in the villi of the jejunum and in 
the submucosa of the ileum, and was expressed at greater levels than in the 
WT mice. Whereas TNFα expression was significantly increased in the 155-185 
Figure  2.5: Immunohistochemistry staining of the expression and localization of pro-
inflammatory cytokines: IL-1α (A); IL-1β (C); IL-1RI (E) showing the immunopositive intensity 
quantification across the small intestinal architecture. B, D, and F showing the 
immunopositive staining in the ileum of the 55 day old and 155-185 day old IL-1rn
-/-
 mice 
compared with WT mice. Cell nuclei were stained with haematoxylin (blue). Black arrows 




day old IL-1rn-/- mice, where immunopositive cells were localized within the villi, 
crypts, and the submucosa of the jejunum and ileum, and was significantly 
greater than that seen in the WT mice (P≤0.05) (Figure  2.6 B and Figure  2.7 C 
& D). 
The number of infiltrated polymorphonuclear (PMN) cells in the lamina propria 
were significantly increased in the 55 day old and 155-185 day old IL-1rn-/- mice 
compared with WT mice (P≤0.05) (Figure  2.8 A and Figure  2.9 A & B). Crypt 
abscesses were observed in the ileum of 155-185 day old IL-1rn-/- mice. Here, 
PMN cells were seen to clump together within the lamina propria of the villi of 
55 day old IL-1rn-/- mice and in the crypts of the 155-185 day old IL-1rn-/- mice 
(Figure  2.8 A and Figure  2.9 A & B). The number of macrophages was 
significantly increased in 55 day old and 155-185 day old IL-1rn-/- mice 
compared with WT mice (P≤0.05). Similar distributions were seen throughout 
the lamina propria of the villi in the young and old IL-1rn-/- mice in the jejunum 




Figure  2.6: Immunohistochemistry staining of the expression and localization of pro-
inflammatory cytokines IL-15 (A); TNFα (B) in the jejunum of the 55-day old and 155-185 
day old IL-1rn
-/-
 mice compared with WT mice. Cell nuclei were stained with haematoxylin 







Figure  2.7: Immunohistochemistry staining of the expression and localization of pro-inflammatory 
cytokines: IL-15 (A); TNFα (C) showing the immunopositive intensity quantification across the 
small intestinal architecture. B and D showing immunopositive staining in the ileum of the 55 day 
old and 155-185 day old IL-1rn
-/-
 mice compared with WT mice. Cell nuclei were stained with 










Figure  2.8: Immunohistochemistry staining of the infiltrated cells: Polymorphonuclear cells 
(PMNs) (A) and Macrophage cells (B) into the lamina propria of the intact well oriented crypt-
villus axis in the jejunum of the 55-day old and 155-185 day old IL-1rn
-/-
 mice compared with 
WT mice. Cell nuclei were stained with haematoxylin (blue). Black arrows indicate 







Figure  2.9: Immunohistochemistry staining of the infiltrated cells: Polymorphonuclear cells 
(PMNs) (A) and Macrophage cells (B) into the lamina propria of the intact well oriented crypt-
villus axis in the ileum of the 55 day old and 155-185 day old IL-1rn
-/-
 mice compared with WT 
mice. Cell nuclei were stained with haematoxylin (blue). Black arrows indicate 




2.3.2.2 Assessment of degrading enzyme expression and localization 
Although MMP2 expression was higher in both the 55 day old and 155-185 day 
old IL-1rn-/- mice than WT mice, this failed to reach significance. In 55 day old 
and 155-185 day old IL-1rn-/- mice, MMP2 was highly expressed in the villi, 
crypts and muscularis mucosa (Figure  2.10 A and Figure  2.11 A and B). 
MMP9 expression was limited in all groups, its expression was higher in the 
submucosa of the ileum than the jejunum in the 55 day old IL-1rn+/+, IL-1rn-/- 
mice and in 155-185 day old IL-1rn+/+ mice (Figure  2.10 B, Figure  2.11 C and 
D). Although ADAMTS1 was highly expressed in the jejunum and ileum of the 
IL-1rn-/- mice, there were no significant differences between age and genotype 
groups (Figure  2.10 C, Figure  2.11 E and F).  
2.3.2.3 Assessment of enterocyte polarity and digestive enzyme 
expression and localization. 
ZO-1 and E-cadherin were expressed from the surface of the villi down to crypts 
in WT mice. The level of expression of both ZO-1 and E-cadherin was 
significantly decreased in both the 55 day old and 155-185 day old of IL-1rn-/- 
mice compared to age-matched WT controls (P≤0.05) (Figure  2.12 A & B and 
Figure  2.13 A, B, C, D). In the jejunum, ZO-1 expression was localized on villi 
surfaces only in the 155-185 day old of IL-1rn-/- mice, which was significantly 
less than that seen in younger 55 day old of IL-1rn-/- and WT mice (Figure 2.12 
A). In contrast, ZO-1 was uniformaly expressed at the cell surface of the villi in 
the ileum and was comparable to that seen in WT mice (Figure  2.12 A and B). 
E-cadherin immunopositivity was lost in the jejunum and ileum of 155-185 day 






Figure  2.10: Immunohistochemistry staining of the expression and localization of degrading 
enzymes: MMP2 (A); MMP9 (B); ADAMTS1 (C) in the jejunum of the 55-day old and 155-185 
day old IL-1rn
-/-
 mice compared with WT mice. Cell nuclei were stained with haematoxylin 







Figure  2.11: Immunohistochemistry staining of the expression and localization of degrading 
enzymes: MMP2 (A); MMP9 (C); ADAMTS1 (E) showing the immunopositive intensity 
quantification across the small intestinal architecture. B, D, and F showing the immunopositive 
staining in the ileum of the 55-day old and 155-185 day old IL-1rn
-/-
 mice compared with WT mice. 
Cell nuclei were stained with haematoxylin (blue). Black arrows indicate immunopositivity. Scale 









Figure  2.12: Immunohistochemistry staining of the expression and localization of junctional 
proteins: ZO-1 (A); E-cadherin (B) in the jejunum of the 55-day old and 155-185 day old IL-
1rn
-/-
 mice compared with WT mice. Cell nuclei were stained with haematoxylin (blue). Black 








Figure  2.13: Immunohistochemistry staining of the expression and localization of junctional 
proteins: ZO-1 (A); E-cadherin (C) showing the immunopositive intensity quantification across 
the small intestinal architecture. B and D showing the immunopositive staining in the ileum of 
the 55 day old and 155-185 day old IL-1rn
-/-
 mice compared with WT mice. Cell nuclei were 





ALP expression was weak in all mice; however, specific ALP immunopositivity 
was seen on the brush border of the enterocytes and in the lamina propria cells 
(Figure  2.14 A and Figure  2.15 A & B). Sucrase-isomaltase expression was 
localized to the apical epithelial surface and was highly expressed in all mice 
(Figure  2.14 B and Figure  2.15 C & D). DPP IV expression was increased in 55-
day old IL-1rn-/- mice compared with WT mice (P≤0.05) this expression was 
localized on the enterocyte surface and in the lamina propria cells (Figure  2.14 













Figure  2.14: Immunohistochemistry staining of the expression and localization of digestive  
enzymes: ALP (A); SI (B); and DPP IV (C) in the jejunum of the 55-day old and 155-185 day old 
IL-1rn
-/-
 mice compared with WT mice. Cell nuclei were stained with haematoxylin (blue). Black 













Figure  2.15: Immunohistochemistry staining of the expression and localization of the digestive 
enzymes: ALP (A); SI (C); and DPP IV (E) showing the immunopositive intensity quantification 
across the small intestinal architecture. B, D and F showing the immunopositive staining in the 
ileum of the 55 day old and 155-185 day old IL-1rn
-/-
 mice compared with WT mice. Cell nuclei 
were stained with haematoxylin (blue). Black arrows indicate immunopositivity. *P ≤ 0.05. Scale 





The balance between IL-1 and IL-1Ra as an endogenous inhibitor plays an 
essential role in stimulation and regulation of inflammation in IBD (Ludwiczek et 
al. 2004), however, whether IL-1 is an important causative factor in IBD or 
purely a result of inflammation is not currently understood. Thus, this study 
investigated whether changes seen during IBD could be induced spontaneously 
by the removal of IL-1Ra in mice that lack a functional IL-1rn gene. In IL-1rn-/- 
mice, the villi were shown to be shorter in the jejunum, while shorter and thinner 
in the ileum. This blunting of the villi is a common microscopic feature of IBD 
and has been observed in patients with Crohn's disease in both the jejunum and 
the ileum (Rutgeerts et al. 1984). In contrast, in WT mice the crypt-villus axes 
height and villi width were shown to be comparable to the villus-crypt 
architecture of wild-type C57BL/6J mice of a similar age and region of the small 
intestine (Gulbinowicz et al. 2004). As seen in the WT mice, there was a 
decrease in height and width along a proximal-distal gradient of the small 
intestine. Similarly to these findings, in a wild-type C57BL/6J mice model a 
comparison of old and young mice, showed an increase in villi height with age, 
whilst the villi width was unchanged (Gulbinowicz et al. 2004).    
Physiologically intestinal goblet cells secrete large amounts of mucus, which 
coat and cover the intestinal villi. This mucus plays an important role in the 
maintenance of the intestinal mucosal barrier and creates a milieu in which 
digestion and absorption take place (Atuma et al. 2001). Here, an increase in 
the number of goblet cells per crypt-villus axis in both jejunum and ileum of IL-
1rn-/- mice compared with WT mice was observed. This increase in goblet cells 
which accompanies the inflammatory process is believed to be caused by 
increased expression of the transcription factors: Hath1 (a bHLH factor) and 
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KLF4 (Klupper like factor 4), which are essential for goblet cell differentiation 
(Gersemann et al. 2009). This inflammatory process is believed to drive the 
increase in goblet cell differentiation, which is observed in Crohn's disease 
patients (Gersemann et al. 2009). However, it is important to note that this 
increase in goblet cells is not found in all Crohn's disease patients or throughout 
the whole gastrointestinal tract (Dorofeyev et al. 2013). 
Maintenance of intestinal homeostasis is regulated by epithelial barrier integrity 
(Noti et al. 2010). Diffusion of the luminal materials into lamina propria promotes 
a local inflammatory response causing release of proinflammatory cytokines, 
release of MMPs, and epithelial degradation and inflammation (O'Sullivan et al. 
2015). Expression of pro-inflammatory cytokines: IL-1α, IL-1β, TNFα, and IL-15 
were increased in IL-1rn-/- mice, and these results are in agreement with those 
obtained from patients with Crohn's disease (Geboes 2003). IL-1α and IL-1β are 
expressed in human intestinal epithelial cells (Garlanda et al. 2013). IL-1α is 
released when these cells are damaged or destroyed. IL-1α was detected in the 
epithelium of human IBD where released from necrotic intestinal epithelial cells 
and plays a crucial role in intestinal inflammation by inducing human intestinal 
fibroblast to produce IL-6 and IL-8 (Scarpa et al. 2015). The high concentrations 
of IL-1β in the intestine of patients with Crohn's disease are mainly attributed to 
local mononuclear cell infiltration (Mahida et al. 1989). Increased production of 
IL-1β and TNFα in inflamed Crohn's disease mucosa induces the synthesis of 
IL-8, which is an effective neutrophil chemoattractant (Andus et al. 1993). these 
findings agree with previous work, which showed increased numbers of TNFα 
positive cells in the lamina propria and submucosa of patients with Crohn's 
disease. Furthermore, TNFα produced by subepithelial macrophages has been 
shown to contribute to decreased epithelial integrity (Murch et al. 1993). TNFα 
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acts as an important mediator of inflammation through MAPK and NF-kB 
activation, increasing cell proliferation and altering epithelial barrier permeability 
(Guan & Zhang 2017). The production of TNFα is also high in cultured mucosal 
mononuclear cells from Crohn's disease patients (Reinecker et al. 1993). 
However, a previous study observed no differences in TNFα mRNA expression 
between control and IBD mucosal biopsies (Isaacs et al. 1992). 
IL-1RI is expressed on many cell types including T cells, fibroblasts, and 
intestinal epithelial cells. Despite the increased expression of IL-1β in the        
IL-1rn-/- mice, the expression of IL-1R1 was reduced; this could suggest a 
negative feedback loop decreasing expression of IL-1RI in the presence of 
uncontrolled IL-1 production. This agrees with a previous study, which showed 
IL-1β and TNFα treatment downregulated the expression of mRNA IL-1RI in rat 
intestinal epithelial cells (IEC-6) (McGee et al. 1996). Similarly, IL-1β treatment 
was also shown to downregulate IL-1RI protein in retinal endothelial cells (TR-
iBRB2) (Aveleira et al. 2010). This is contrary to previous studiy, in which an 
increase in IL-1β induced chronic intestinal inflammation in mice and an 
increase in IL-17A-secreting innate lymphoid cells which express high levels of 
IL-1R1 (Coccia et al. 2012). These differences may be a result of the different 
levels of inflammation seen in these models. Here, increased expression of IL-
15 was seen in IL-1rn-/- mice, this is in agreement with Liu et al (2000), who 
showed increased expression of IL-15 by macrophages in the inflamed ileum of 
patients with Crohn's disease and that IL-15 increased local T cell activation 
and induced proinflammatory cytokine production by T cells and macrophages. 
The presence of polymorphonuclear cells and mononuclear cells play an 
important role in the augmentation of inflammation and tissue damage in IBD 
(Valatas et al. 2015). Increased infiltration of these CD11b and CD68 positive 
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cells into the lamina propria were observed in IL-1rn-/- mice compared with WT 
mice. These findings are in agreement with previous findings which showed 
increased numbers of these cells in the inflamed mucosa of IBD patients 
(McKaig et al. 2003). Infiltration of immune cells such as macrophages and 
lymphocytes in the lamina propria is an important aspect of IBD, especially 
Crohn's disease, even in the lack of noticeable morphological, clinical, and 
endoscopic indication of inflammation. This is thought to be due to an increased 
demand of macrophages within the inflamed intestine (Fiocchi 1998). 
MMPs and ADAMTS1 expression were not significantly altered in IL-1rn-/- mice. 
MMPs have been demonstrated to be induced in several pathological conditions 
of IBD and play a key role in regulating the pathophysiology of IBD (Manicone & 
McGuire 2008). The main action of matrix metalloproteinases is to degrade 
extracellular matrix proteins. Active MMP2 and MMP9 play an important role in 
cell migration and cytokine stimulation. Indeed neutrophil infiltration has been 
shown to be induced by upregulation of MMP9 in murine inflamed intestine (Liu 
et al. 2013). Furthermore, stromal cells play an important role in intestinal 
inflammation and the pathogenesis of IBD. These cells secrete MMP2 and 
MMP9 (Drygiannakis et al. 2013); and MMP9 is produced by human colonic 
epithelium during IBD (Pedersen et al. 2009). In addition, infiltrating 
macrophages and neutrophils are the main source of MMP9 in human IBD 
(Koelink et al. 2014). Overexpression of MMP9 has been shown to cause a 
reduction in the differentiation of progenitor cells to goblet cells and 
consequently decreased MUC2 expression, which leads to decreases in the 
protective mucin barrier in colonic epithelium (Liu et al. 2013). 
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The maintenance of epithelial barrier function and control of paracellular 
permeability are regulated by tight junction proteins (Landy et al. 2016). 
Epithelial disruption and decrease in tight junctions that lead to increased 
intestinal permeability are the common features of Crohn's disease (Munkholm 
et al. 1994). Decreased expression of ZO-1 and loss of E-cadherin expression 
were observed in IL-1rn-/- mice, suggesting a dysfunctional and leaky epithelial 
barrier. Inflammatory cytokines are known to affect epithelial junctional 
complexes, causing barrier dysfunction and increased epithelial permeability 
(Landy et al. 2016). A previous study showed that a tight junction disorder has 
been found in the epithelial cells of the terminal ileum from patients with Crohn's 
disease (Marin et al. 1983). In addition, it has been shown that IL-1β and TNFα 
induced defects in intestinal epithelial tight junctions resulting in increased 
intestinal permeability (Gibson 2004). 
Surprisingly, the expression of digestive enzymes were not altered in IL-1rn-/- 
mice compared with WT mice. This demonstrated the resilience of the intestine 
to maintain function even during severe inflammation. ALP plays an essential 
role in maintaining small intestinal homeostasis and has been shown to prevent 
the activation of NF-kB, thus inhibiting release of pro-inflammatory cytokines. 
Decreased activity of ALP could increase intestinal inflammation, (Fawley & 
Gourlay 2016) and intestinal epithelial dysfunction in IBD patients has been 
attributed to lower intestinal expression and activity of ALP (Bilski et al. 2017).    
SI expression was also unchanged, which is contrary to decreased gene 
expression of SI in villus enterocytes seen in the ileum of patients with Crohn's 
disease (Ziambaras et al. 1996). DPP IV expression, however, was significantly 
increased in the young IL-1rn-/- mice, but not the older IL-1rn-/- mice compared to 
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WT mice. A similar loss of DPPIV activity has been seen in the serum of 
patients with IBD (Moran et al. 2012). 
In conclusion, IL-1Ra deficient mice (IL-1rn-/-) induced spontaneous intestinal 
inflammation which provides an effective approach to display features 
associated with IBD. Old IL-1rn-/-mice demonstrated a higher inflammatory 
response than young IL-1rn-/- mice. This model delivers an evidence for the role 
of the imbalance between IL-1 and IL-1Ra in the pathogenesis of IBD and could 
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3.1 Introduction  
In vitro 3D intestinal models are becoming useful tools for investigating how 
human intestinal cells function and are regulated (Costello et al. 2014b). The 
studies of intestinal cellular proliferation, migration, differentiation, and drug 
absorption using in vivo models have their limitations. These include difficulties 
in controlling cell behaviour, their responses to specific environmental prompts, 
and the way in which they absorb compounds (Pusch et al. 2011; Costello et al. 
2014b). Hence, this has led to the development of a number of 3D in vitro 
intestinal models. It is suggested that these 3D models could be useful to 
investigate tissue engineering, drug discovery, and used as an alternative to in 
vivo animal models in drug toxicity studies (Pampaloni et al. 2007, 2009; Ravi et 
al. 2015). Previously, in vitro intestinal models have been limited to 2D cell 
culture (Pontier et al. 2001; Imura et al. 2009), however, a number of studies 
have attempted to develop 3D intestinal models in vitro to mimic the 
morphological characteristics and function of intestinal epithelia and represent 
the micro-environment seen in vivo (Pusch et al. 2011; Sung et al. 2011; Kim & 
Ingber 2013). The choice of cells within the models is a major challenge due to 
the restricted accessibility to obtain sufficient quantity of primary cells which are 
required for 3D in vitro intestinal models (Kauffman et al. 2013). 
To date, a number of normal and tumour cell types have been tested for their 
ability to generate intestinal epithelial models. When rat intestinal epithelial cell 
line (IEC-6) were seeded on top of rat intestinal subepithelial myofibroblasts 
(ISEMF) embedded in a collagen gel, the ISEMFs were shown to induce 
enteroendocrine differentiation of the overlying IEC-6 cells after 3 weeks 
(Yoshikawa et al. 2011). Viney et al, (2009) co-cultured IEC-6, IPI-21 (small 
boar ileum epithelial cell line), and CRL-2102 (human epithelial cell line derived 
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from colorectal adenocarcinoma) with Rat-2 (fibroblast-like cells) on collagen 
gel alone; or on a collagen-Matrigel scaffold. They demonstrated that the 
greatest epithelial growth was seen on collagen gels, supplemented with 
Matrigel after 20 days. They observed multi-layered intestinal epithelium 
containing a cluster of cells resembling native small intestinal crypts. 
To reduce the cost and ethical concerns raised by using in vivo animal models, 
Caco-2 and HT29-MTX human colon adenocarcinoma cell lines have been 
extensively employed in in vitro models of the gastrointestinal tract. These two 
cell lines have been selected due to their capacity to differentiate into 
enterocyte-like cells and mucus-producing goblet cells respectively, plus they 
are capable of demonstrated properties which are characteristic of the small 
intestine in vitro (Ferruzza et al. 2012). In 2D culture, Caco-2 cells form a 
monolayer, and spontaneously differentiate when confluent, expressing 
morphological and functional characteristics of enterocytes. These cells display 
polarized morphology, with microvilli on the apical side, tight junctions between 
the adjacent cells and express high levels of hydrolase enzymes such as 
alkaline phosphatase, sucrase-isomaltase, and peptidase (Howell et al. 1992; 
Olejnik et al. 2003; Natoli et al. 2011). In contrast, HT29-MTX cells are 
characterised by the development of confluent monolayers, junction formation 
and express high level of mucins (Gagnon et al. 2013). 
It has been shown, that the use of 3D scaffolds can drive cell proliferation and 
differentiation (Costello et al. 2014a, 2014b). However, the cell growth rate 
varies depending on the scaffold used. Hence, the selection of scaffolds and 
matrices depends on cell type and other culture conditions (Ravi et al. 2015). 
Previous studies have investigated a number of potential biomaterial scaffolds 
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for the formation of 3D models of the small intestine (Yu et al. 2012; Costello et 
al. 2014a). Collagen gel has been used widely as a scaffold to develop a 3D 
model of the small intestine, although collagen gels are limited by batch 
variation (Antoine et al. 2014). Most notably, Caco-2 cells have been 
investigated within 3D collagen scaffolds which were fabricated prior to seeding 
to match the geometry of intestinal villi. On these moulded collagen scaffolds, 
Caco-2 cells proliferated and migrated to form structures resembling intestinal 
villi (Sung et al. 2011; Kim et al. 2014; Costello et al. 2014a, 2014b). 
Sung et al, (2011) demonstrated that the fabricated micro-scale collagen 
structure mimicking the intestinal villi and could be used as a scaffold for Caco-
2 cells investigated permeability. Alternatively, several studies have exploited 
biodegradable fabricated co-polymers such as poly lactic-co-glycolic acid 
(PLGA). These scaffold moulds have been used in co-culture studies of Caco-2 
and HT29-MTX and were shown to give rise to villi-like structures (Wu & Ding 
2004; Costello et al. 2014b). However, to date, no realistic 3D models which 
form intestinal villi without prefabrication of structures prior to culture have been 
achieved.  
Hence, this study aimed to investigate alternative hydrogels which could be 
used to develop a 3D model of the small intestinal villi in vitro. A number of 
biomaterials have potential in the tissue engineering of small intestinal villi, 
interestingly all the biomaterials investigated to date have been hydrogel based. 
Calcium cross-linked alginate hydrogels are increasingly being used as a 3D 
culture system for mammalian cells in biomedical engineering studies (Gombotz 
& Wee 2012; Khavari et al. 2016). Alginate is generally softer than some of the 
more commonly used collagen gels and enables facile diffusion of nutrients and 
87 
 
cellular migration, which may be beneficial in the formation of villi structures. 
Here, this study investigated three hydrogels which have not been previously 
used in 3D culture for immortalized human intestinal epithelial cells: an alginate 
hydrogel; novel synthetic non-biodegradable hydrogel systems L-pNIPAM 
(Boyes 2012) and L-pNIPAM-co-DMAc (Thorpe et al. 2016). As these hydrogels 
are highly hydrated, it is hypothesized that they would support the growth of 
small intestinal cells, which could mimic the cellular phenotypes of the small 
intestine. The latter two have been developed by our group; these hydrogels 
can be closely controlled and due to their synthetic nature do not display batch 
variation, which is a major disadvantage of natural materials (Antoine et al. 
2014). Furthermore, as these hydrogels display an extremely low viscosity they 
can be moulded into any shape required, and enable incorporation of cells 
either pre- or post-gelation (Boyes 2012; Thorpe et al. 2016). Thus, if these 
systems are shown to support intestinal cells here they could be utilised in more 
complex culture systems in the future, including its use in the lining of tube like 
strucutres to mimic more closely the closed in vivo structures of the intestine. 
Furthermore, these hydrogels have been previously shown to be 
cytocompatible (Thorpe et al. 2016). Here, the potential of these all three 
hydrogel systems to support the 3D culture of Caco-2 and HT29-MTX cells was 
investigated and determine their use as scaffolds to support formation of the villi 
architecture of the in vitro small intestine. 
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3.2 Materials and methods 
 Hydrogel scaffolds synthesis 3.2.1
3.2.1.1 Alginate hydrogel scaffolds 
1.2% (w/v) medium viscosity of alginic acid sodium salt (Sigma-Aldrich, Poole, 
UK) was dissolved in 0.15 M NaCl (Sigma-Aldrich, Poole, UK) and filter 
sterilized. To prepare alginate: 300 µL alginate was added to each well of 48 
well plates for histological assessment and 100 µL added to each well of 96 well 
plates for metabolic activity analysis. Alginate was carefully overlaid with 300 µL 
in 48 well plates and 100 µL in 96 well plates of 200 mM CaCl2 and incubated at 
37°C for 10 min to induce gelation.  
3.2.1.2 L-pNIPAM hydrogel scaffolds  
Laponite clay nanoparticles (25–30 nm diameter, ≤1 nm thickness) (0.1 g) 
were dispersed in deionised H2O (9.0 ml) (18 mΩ) for 24 h. N-isopropyl 
acrylamide (BYK Additives Ltd, Cheshire, UK) was prepared by vigorous stirring 
of 99% NIPAM (0.9 g) (Sigma, Poole, UK) and 1% 2-2’-azobisisobutyro nitrile 
(AIBN) (0.009 g) (Sigma, Poole, UK) for 1 h. After passing the suspension 
through a 5 – 8 µm pore filter paper, the polymerization was initiated by heating 
to 80°C and the reagents were allowed to react for 24 h. It was observed that 
after heating the monomeric suspension to 80°C, the transparent liquid 
transforms to a milky suspension, which is comprised of a statistical co-polymer 
with a composition of 1% Laponite, 9% pNIPAM, and 90% water (by weight) 
(Boyes 2012). This hydrogel was synthesized by Abdulsalam Essa.  
 Following 24 h the hydrogel suspension was cooled to 38 - 39°C prior to cell 
incorporation. Further cooling of the polymeric suspension to 32°C, i.e. below 




3.2.1.3 L-pNIPAM-co-DMAc hydrogel scaffolds 
L-pNIPAM-co-DMAc hydrogel was synthesized as previously described (Thorpe 
et al. 2016). Briefly, 0.1 g Laponite clay nanoparticles (25-30 nm diameter, ≤1 
nm thickness) were dispersed in deionised H2O (9.0 ml) (18 mΩ) for 24 h. N-
isopropyl acrylamide (BYK Additives Ltd, Cheshire, UK) was prepared by 
vigorous stirring 0.783 g NIPAM (Sigma, Poole, UK), 0.117 g N,N'-dimethyl 
acrylamide (DMAc) (Sigma, Gillingham, UK) and 0.009 g 2-2’-azobisisobutyro 
nitrile (AIBN) (Sigma, Poole, UK) were added to the suspension and stirred for 1 
h. After passing the suspension through a 5-8 µm pore filter paper, the 
polymerization was initiated by heating to 80°C and the reagents were allowed 
to react for 24 h. It was observed that after heating the monomeric suspension 
to 80°C, the transparent liquid transformed to a milky suspension, which is 
comprised of a statistical co-polymer with a composition of 1% Laponite, 7.83% 
pNIPAM, 1.17% DMAc and 90% water (by weight). This hydrogel was 
synthesized by Abdulsalam Essa. 
Following 24 h the hydrogel suspension was cooled to 38-39°C prior to cell 
incorporation. Further cooling of the polymeric suspension to 37°C, i.e. below 
the LCST, resulted in rapid gelation to a solidified hydrogel.  
 Material Characterisation 3.2.2
3.2.2.1 Scanning electron microscopy (SEM) 
The morphology of all samples was investigated using a scanning electron 
microscope, the samples were taken as prepared and frozen at -80°C and 
subsequently freeze-dried using (FD-1A-50) and fractured into two or more 
pieces to obtain cross-sectional edges. Samples were then mounted onto 
aluminum stubs and gold coated using (Q150T-ES sputter coater (Quorum, 
UK), (10 µA sputter current for 190 s with a 2.7 tooling factor).  
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The fractured samples were examined using a FEI NOVA nano-SEM 200 
scanning electron microscope. Images were obtained using accelerating 
voltage 5 KV with a range of magnifications (1000 to 10,000). From images 
captured, six images were randomly selected for each sample at 2400 
magnification and pore sizes measured using the Capture Pro OEM v8.0 
software (Media Cybernetics, Buckinghamshire, UK). Pore sizes were 
determined by Abdulsalam Essa. 
3.2.2.2 Dynamic mechanical analysis (DMA) 
Samples were either cast directly into an in-house designed sample holder for 
synthetic hydrogel samples or by making 3 mm thick sheet at room temperature 
(2 h), and a circular biopsy punch (4.5 mm internal diameter) was used to 
remove cylindrical samples from the solid alginate, all sample dimensions were 
confirmed using digital callipers prior to measurement. 
Dynamic mechanical analysis was conducted in compression mode at 25°C, 
using frequency testing type (0.063 - 10 Hz) at room temperature (PerkinElmer 
DMA 8000) and storage moduli determined. Six replicates for each sample 
were measured. DMA was completed by Abdulsalam Essa.  
 Cell lines  3.2.3
The human immortal epithelial cell lines Caco-2, (passage 18-27), and HT29-
MTX cells (passage 25-30), were obtained from the American Type Culture 
Collection (ATCC). Cells were cultured in complete cell culture media consisting 
of Dulbecco's modified eagle's medium (DMEM) media (Life Technologies, 
Paisley, UK) supplemented with 20% (v/v) heat-inactivated foetal bovine serum 
(FBS) for Caco-2 cells and 10% (v/v) FBS for HT29-MTX cells (Life 
Technologies, Paisley, UK), 100U/M penicillin (Life Technologies, Paisley, UK), 
100 µg/ml streptomycin (Life Technologies, Paisley, UK), 250ng/ml amphotericin 
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(Sigma, Poole, UK), 2mM glutamine (Life Technologies, Paisley, UK) and 1% 
(v/v) non-essential amino acids (NEAA) (Sigma, Poole, UK). Cells were 
maintained in an incubator at 37°C temperature and 5% CO2 in a humid 
atmosphere. Culture medium was replaced every 2 days. At 70-80% 
confluence, cells were washed with PBS (Life Technologies, Paisley, UK) and 
then treated with 0.25% w/v trypsin-EDTA (Life Technologies, Paisley, UK) and 
sub-cultured.  
3.2.3.1 Culture conditions  
Caco-2 and HT29-MTX cells were seeded at a density of 1x106 cells/ml and 
2x106 cells/ml either suspended in or layered onto the surface of the three 
hydrogels (alginate, L-pNIPAM, and L-pNIPAM-co-DMAc) in separated 
experiments.  
To prepare suspended cells in alginate culture: 1x106 cells/ml or 2x106 cells/ml 
were suspended in alginate and 300 µL added to each well of 48 well plates for 
histological assessment and 100 µL added to each well of 96 well plates for 
metabolic activity analysis. Alginate was carefully overlaid with 300 µL in 48 well 
plates and 100 µL in 96 well plates of 200 mM CaCl2 and incubated at 37°C for 
10 min to induce gelation. CaCl2 was removed and samples were washed twice 
in 0.15 M NaCl to remove free Ca2+, and complete media, before 500 µL of 
complete culture media was added to each well of 48 well plates, and 250 µL of 
complete media was added to each well of 96 well plates. Cells were incubated 
at 37°C, 5% CO2 and maintained in culture for 2, 7, 14 and 21 days under static 
or dynamic 3D culture conditions using an orbital shaker at 30 rpm, with media 
replenished every 48 h. 
To prepare L-pNIPAM and L-pNIPAM-co-DMAc suspensions: 1x106 cells/ml or 
2x106 cells/ml were suspended within either L-pNIPAM or L-pNIPAM-co-DMAc 
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at 38-39°C. Three hundred microliters of hydrogel cell suspension was added to 
each well of 48 well plates and 100 µL of hydrogel suspension was added to 
each well of 96 well plates and allowed to cool below the LCST to induce 
gelation. Five hundred microliters of complete culture media were added to 
each well of 48 well plates and 250 µL of complete culture media was added to 
each well of 96 well plates. Cells were then incubated at 37°C, 5% CO2 and 
maintained in culture for 2, 7, 14 and 21 days under static or dynamic 3D 
culture conditions using an orbital shaker at 30 rpm with media replenished 
every 48 h.  
To prepare layered cultures, 300 µL of either alginate, L-pNIPAM or L-pNIPAM-
co-DMAc were added to each well of 48 well plates and 100 µL added to each 
well of 96 well plates. Alginate culture gelation was induced by application of 
CaCl2, whilst gelation of the L-pNIPAM and L-pNIPAM-co-DMAc was induced by 
cooling. Following gelation 300 µL or 100 µL of 1x106 cells/ml or 2x106 cells/ml 
in complete media were applied to the surface of each hydrogel construct in 48 
and 96 well plates, respectively and a further 200 µL or 150 µL complete media 
added to each well after 30 min cell attachment period. All constructs were 
incubated at 37°C, 5% CO2 and maintained in culture for 2, 7, 14 and 21 days 
under static and dynamic 3D culture conditions using an orbital shaker at 30 
rpm, with media replenished every 48 h. 
3.2.3.2 Cytospins of monolayer control cells 
Monolayer cells were fixed in 4% w/v paraformaldehyde (Sigma, Poole, UK) for 
20 min. To generate a cell pellet, cells were centrifuged at 300g for 5 min and 
resuspended in PBS to a cell density of 300 cells/µl. One hundred microliters of 
cell suspension was cytospun by centrifugation at 1000 rpm for 3 min (Shandon 
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cytospin 3, Thermo Scientific, Loughborough, UK). Slides were then air-dried 
and stored at 4°C until needed for immunohistochemical investigation. 
3.2.3.3 Metabolic activity of cells 
The metabolic activity of Caco-2 and HT29-MTX cells suspended within and 
layered on hydrogels under static and dynamic 3D culture conditions were 
assessed using Alamar blue assay (Life Technologies, Paisley, UK) in normal 
complete media after 0-21 days of culture following the manufacturer's protocol. 
The fluorescent intensity was recorded using a fluorescence microplate reader 
(CLARIOstar, BMG LABTECH) fluorescence emission of 590 nm, excitation 
wavelength of 540 nm. Relative fluorescence units (RFU) were recorded for 
cellular hydrogel scaffolds and normalized to RFU of acellular control scaffolds 
as an indication of total live cells.  
 Histological assessment 3.2.4
Caco-2 and HT29-MTX cells were cultured suspended within or layered on 
each of the three hydrogel scaffolds, under static or dynamic culture conditions, 
together with no cell controls for 2, 7, 14 and 21 days. Triplicate samples were 
fixed in 4% w/v paraformaldehyde/PBS for 24 h prior to washing in PBS and 
processed to paraffin wax in a TP1020 tissue processor (Leica Microsystem, 
Milton Keynes, UK). Four-micron sections were cut and mounted onto positively 
charged slides (Leica Microsystem Milton Keynes, UK). Sections were 
deparaffinised in Sub-X and rehydrated in industrial methylated spirits (IMS) 
prior to rehydration in distilled water. Sections were then stained with either: 
Haematoxylin and Eosin; Mayer's Haematoxylin (Leica Microsystem, Milton 
Keynes, UK) for 2 min rinsed in water for 5 min and immersed in Eosin (Leica 
Microsystem, Milton Keynes, UK) for 1 min);  or Alcian Blue/Periodic acid 
Schiff's (PAS): 1% w/v Alcian Blue (PH 2.5) (Sigma-Aldrich, Poole, UK) in 3% 
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(v/v) acetic acid (Sigma-Aldrich, Poole, UK) for 30 min and immersed in 0.5% 
(w/v) Periodic acid  for 10 min and rinsed three times in deionised water. Slides 
were then immersed in Schiff reagent (Merck KGaA, Germany) for 10 min, and 
rinsed three times with deionised water. Following staining, sections were 
dehydrated in IMS, cleared with Sub-X and mounted in Pertex (Leica 
Microsystem, Milton Keynes, UK). The slides were examined with an Olympus 
BX 51 microscope and images captured by the camera and Capture Pro OEM 
V8.0 software (Media Cybernetics, Buckinghamshire, UK). 
 Immunohistochemical assessment 3.2.5
Immunohistochemistry was performed on Caco-2 and HT29-MTX cells 
harvested from monolayer cultures (cytospins) prior to hydrogel incorporation to 
serve as time zero controls. Together with cells cultured on the optimal hydrogel 
culture conditions for 21 days in culture. Briefly, 4 µm sections were de-waxed, 
rehydrated, and endogenous peroxidase blocked using hydrogen peroxide 
(Sigma-Aldrich, Poole UK). After washing in Tris-buffered saline (TBS) tissue 
sections were subjected to an appropriate antigen retrieval method, specific to 
the antibodies investigated: brush border differentiation marker using anti CD10 
antibody, tight junction protein using anti ZO-1 antibody, enzyme expression 
using anti DPP IV antibody (enzyme antigen retrieval); enterocyte differentiation 
markers using anti alkaline phosphatase (ALP) antibody, anti sucrase-
isomaltase antibody (SI), HT29-MTX differentiation marker using anti MUC2 
antibody, and anti MUC5AC antibody (heat antigen retrieval). Following this 
sections were washed in TBS. Following TBS washing, nonspecific binding 
sites were blocked at room temperature for 90 min with 25% (w/v) serum 
(Abcam, Cambridge, UK) in 1% (w/v) bovine serum albumin in TBS. Sections 
were incubated overnight at 4°C with appropriate primary antibody: CD10 
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(1:100 rabbit polyclonal) (Abcam, Cambridge, UK), ZO-1 (1:50 rabbit polyclonal) 
(Abcam, Cambridge, UK), ALP ( 1:200 rabbit polyclonal) (Abcam, Cambridge, 
UK), DPP IV (1:50 mouse monoclonal) (Abcam, Cambridge, UK), SI (1:50, 
mouse monoclonal) (Santa Cruz, Heidelberg, Germany), MUC2 (1:100 rabbit 
polyclonal) (Abcam, Cambridge, UK), MUC5AC (1:200, mouse monoclonal) 
(Abcam, Cambridge, UK). For each immunohistochemistry method, a negative 
control was performed, replacing the primary antibody with either rabbit or 
mouse IgG (Abcam, Cambridge, UK) as appropriate, at a concentration equal to 
that of the primary antibody. Sections were washed in TBS and then incubated 
in 1:500 dilution of an appropriate biotinylated secondary antibody for 30 min at 
room temperature. Binding of the secondary antibody was visualised after 
exposure to horseradish peroxidase (HRP) streptavidin-biotin complex (Vector 
Laboratories, Peterborough, UK) for 30 min. Sections were washed in TBS, and 
treated with 0.08% (v/v) hydrogen peroxide in 0.65mg/ml 3, 3′-diaminobenzidine 
tetrahydrochloride (Sigma-Aldrich, Poole, UK) in TBS for 20 min. Sections were 
counterstained with Mayer’s haematoxylin, dehydrated, cleared and mounted in 
Pertex. Immunohistochemical staining were examined with an Olympus BX51 
microscope and images captured by digital camera and Capture Pro OEM V8.0 
software (Media Cybernetics, Buckinghamshire, UK). 
 Scanning electron microscopy following cell culture 3.2.6
After 21 days in culture, samples were processed for scanning electron 
microscopy (SEM). Briefly, the samples were removed from the culture, frozen 
at -80°C then freeze-dried overnight using a FD-1A-50 freeze dryer (Genorise 
Scientific). The samples were then fractured to expose the interior surface 
morphology. The fractured samples were mounted on aluminum stubs and 
coated with gold using a Quorum Technology 150Q TES system set at 10µA 
96 
 
sputter current for 180s with a 2.7 tooling factor. The cells were examined using 
a FEI NOVA nano-200 scanning electron microscope.  
 Statistical analysis 3.2.7
All viability tests were performed at least 6 times. Normality was assessed using 
Stats Direct. Normality of data was tested using a Skewness, Kurtosis, Royston 
Chi-sq, Shapiro Wilk W and Shapiro-Francia W tests, together with a q-q plot. 
From this analysis, it was demonstrated that the data sets were from mixed 
populations with some populations displaying potential normal distribution, but 
others were shown to be not normally distributed, as such non-parametric tests 
have been performed for all data. Therefore statistical comparisons were 
performed by Kruskal-Wallis with a pairwise comparison (Dwass-Steel-
Critchlow-Fligner) between all-time points and between culture conditions and 
hydrogel systems for 21 days for Alamar blue assay with statistical significance 




 Material properties of alginate, L-pNIPAM and L-pNIPAM-co-DMAc 3.3.1
scaffolds. 
Alginate displayed significantly larger pores (30-74 µm) and lowest storage 
moduli (0.4-8.6x105 Pa) than both the synthetic hydrogels investigated 
(Figure  3.1 A & B). L-pNIPAM displayed significantly larger pores (5.6-25 µm) 
and lower storage moduli (0.18-2.8x107 Pa) than L-pNIPAM-co-DMAc 
(Figure  3.1 A & B). L-pNIPAM-co-DMAc displayed the smallest pore sizes (1.5-
30 µm) and highest storage moduli (1-5x107 Pa) indicating this was the stiffest 






Figure  3.1: Pore size (µm) for acellular alginate, L-pNIPAM, and L-pNIPAM-co-DMAc 
hydrogels determined using SEM analysis. B: Storage Modulus (G') values for acellular 
alginate, L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels determined using DMA. This figure 
prepared by Abdulsalam Essa. 
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 Metabolic activity of Caco-2 cells in three hydrogel scaffolds 3.3.2
Cell densities of 1x106 cells/ml and 2x106 cells/ml were investigated in all three 
gel systems. The data from the 2x106 cells/ml cell density were selected as 
optimal cell density and this cell density was used for further study. At this 
density the viability of the cells and cellular morphology was much better in all 
three gel systems. This thesis will report the 2x106 cells/ml data only.  
3.3.2.1 Alginate hydrogel scaffold 
Under static layered culture conditions, there was a significant decrease in cell 
metabolic activity of Caco-2 cells between day 0 and 2, when grown on alginate 
(P≤0.05) (Figure  3.2 A). Thereafter metabolic activity was significantly increased 
between day 2 to 14 (P≤0.05) (Figure  3.2 A). Likewise, when Caco-2 cells were 
suspended in alginate and cultured under static conditions, there was a 
decreased metabolic activity from day 0 and 7, which was then followed by a 
significant increase in metabolic cell activity from day 2 and day 7 to day 14 and 
21 (P≤0.05) (Figure  3.2 B). In contrast, under dynamic culture conditions, there 
was an increase in metabolic cell activity in Caco-2 cells between day 0 and 7 
when layered on the alginate, followed by a decrease in metabolic cell activity 
from day 7 to 21 which failed to reach significance (Figure  3.2 C). No significant 
difference in metabolic cell activity was observed during the initial 7 days of 
culture when the Caco-2 cells were suspended within alginate was observed. 
This was then followed by a significant increase in metabolic cell activity from 
day 7 to 21 under dynamic culture (P≤0.05) (Figure  3.2 D). Across the culture 
conditions following 3 weeks a significant decrease in metabolic activity was 
observed in Caco-2 cells layered on the surface of alginate cultured under 
dynamic conditions compared to static conditions (P≤0.05) (Figure  3.2 A & C). 
Whilst cells cultured under dynamic culture in suspension showed an increase 
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in metabolic activity compared to layered cultures under dynamic conditions 
(P≤0.05) (Figure  3.2 C & D). 
3.3.2.2 L-pNIPAM hydrogel scaffold 
When Caco2 cells were cultured as layers on the surface of L-pNIPAM hydrogel 
scaffolds under either static or dynamic culture, there was no change in 
metabolic cell activity from day 0 to 2. This was followed by a significant 
increase in metabolic cell activity from day 7 to 21 (P≤0.05) (Figure  3.2 E & G). 
In contrast, when Caco-2 cells were suspended in L-pNIPAM and cultured 
under either static or dynamic conditions there was a significant decrease in 
metabolic cell activity (P≤0.05) (Figure  3.2 F & H). Across the culture conditions 
following 3 weeks a significant decrease in metabolic activity was seen in Caco-
2 cells suspended in L-pNIPAM compared to layered cells under both static and 
dynamic culture (P≤0.05) (Figure  3.2 E - H).  
3.3.2.3 L-pNIPAM-co-DMAc hydrogel scaffold 
Under both static and dynamic culture conditions, there was a significant 
increase in metabolic cell activity from day 0 when Caco-2 cells were layered on 
the L-pNIPAM-co-DMAc (P≤0.05) (Figure  3.2 I & K). However, when Caco-2 
cells were suspended within L-pNIPAM-co-DMAc there was a significant 
decrease in metabolic cell activity, under both static and dynamic culture 
conditions (P≤0.05) (Figure  3.2 J & L). Across the culture conditions following 3 
weeks a significant decrease in metabolic activity was seen in Caco-2 cells 
suspended in L-pNIPAM-co-DMAc compared to layered cells under both static 
and dynamic culture (P≤0.05) (Figure  3.2 I - L). 
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3.3.2.4 Comparison of metabolic activity between three hydrogel 
systems. 
Caco-2 cells cultured under static conditions in layers displayed no significant 
difference in metabolic activity following 3 weeks (Figure  3.2). Whilst Caco-2 
cells cultured in suspension either under static or dynamic culture showed 
significantly higher metabolic activity in alginate culture compared to both L-
pNIPAM and L-pNIPAM-co-DMAc following 3 weeks (P<0.05) (Figure  3.2). In 
contrast, Caco-2 cells cultured in layers in dynamic culture showed highest 
metabolic activity in L-pNIPAM which was significantly higher than both L-
pNIPAM-co-DMAc and alginate cultures following 3 weeks (P<0.05) 
(Figure  3.2). Furthermore, metabolic activity of Caco-2 cells cultured in layers 
on L-pNIPAM-co-DMAc under dynamic culture was significantly higher than 















Figure  3.2: Metabolic activity of Caco-2 cells at a cell density of 2×10
6
 cells/ml layered on or suspended within Alginate: (A, B, C, D); L-




 Morphological and phenotypic assessment of Caco-2 cells cultured 3.3.3
in hydrogel systems  
Caco-2 cells cultured in layers on alginate under either static or dynamic culture 
commonly formed multilayer spheroid structures by day 2 to 21 (Figure  3.3, 
Figure  3.4, Figure  3.5 A and Figure  3.6 A). When cells were suspended within 
alginate they formed large cell clusters which had clearly defined nuclei by day 
14 to 21 Figure  3.5 A and Figure  3.6 A). In contrast, Caco-2 cells cultured as 
layers on the surface of L-pNIPAM under static culture conditions formed small 
multicellular layers, parallel to the surface of the hydrogel between day 7 and 21 
(Figure  3.5 A and Figure  3.6 A). However, when Caco-2 cells were grown as 
layers on the surface of L-pNIPAM under dynamic culture conditions, these 
cells were found to migrate into the hydrogel by day 14 (Figure  3.5 A) and then 
give rise to villus-like structures by day 21 (Figure  3.6 A).  
However, when Caco-2 cells were suspended in L-pNIPAM and maintained 
under either static or dynamic culture conditions cells showed poor nuclear 
morphology, consistent with non-viable cells (Figure  3.4, Figure  3.5 A and 
Figure  3.6 A). Similarly, when Caco-2 cells were suspended within L-pNIPAM-
co-DMAc and maintained under both static and dynamic culture, cells only 
formed a few small clusters of cells between day 7 and 21. In contrast, Caco-2 
cells grown as layers on the surface of L-pNIPAM-co-DMAc under static and 
dynamic conditions formed multi-cellular layers (Figure  3.3, Figure  3.4, 












Figure  3.4 Histological analysis of Caco-2  cells layered on or suspended within alginate, L-
pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions at a 
cell density of 2×10
6
 cells/ml following 7 days stained with H&E. Scale bar = 100 µm.  
 
Figure  3.3: Histological analysis of Caco-2  cells layered on or suspended within alginate, 
L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions 
at a cell density of 2x10
6




To determine potential mucin production, tissue sections of day 14 and 21 were 
stained using alcian blue/PAS. Whilst all three hydrogels showed background 
staining for alcian blue, cellular structures within them could be easily 
distinguished, however, due to the high levels of background staining for acidic 
mucins within all hydrogels, no increased staining over background was 
observed for acidic mucins. Within alginate scaffolds, cells were positive for 
neutral (pink) mucins in all culture conditions (Figure  3.5 B and Figure  3.6 B). 
Immunohistochemically analysis of MUC2 and MUC5AC showed Caco-2 cells 
did not express MUC2 and MUC5AC mucins in monolayer culture (0 h 
cytospin), or in cells cultured as layers or suspended in all three hydrogels 









Figure  3.5: Histological analysis of Caco-2 cells layered on or suspended within alginate, L-
pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions at a 
cell density of 2×10
6
 cells/ml following 14 days. A: Stained with H&E, and B: Stained with 
Alcian blue/PAS, blue: acidic mucin (black arrows); magenta: neutral mucin (red arrows). 











Figure  3.6: Histological analysis of Caco-2 cells layered on or suspended within alginate, L-
pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions at a 
cell density of 2×10
6
 cells/ml following 21 day. A: Stained with H&E (circles indicate villus-
like structures) and B: Stained with Alcian blue/PAS, blue: acidic mucin (black arrows); 





Figure  3.7: Immunohistochemistry staining of MUC2 and MUC5AC. A: Caco-2 cells monolayer 
and layered on or suspended within alginate; B and C: Caco-2 cells layered on L-pNIPAM, and 
L-pNIPAM-co-DMAc hydrogels, under static or dynamic culture conditions at a cell density of 
2×10
6
 cells/ml following 21 days. Cell nuclei were stained with haematoxylin (blue). Scale bar = 
100 µm.  
 
From this analysis, L-pNIPAM was selected for further phenotypical analysis 
due to the superior morphological appearance and mucin production. To 
determine the level of Caco-2 cellular differentiation, the expression of three 
brush border enzymes, together with enterocyte brush border marker and a 
tight junction protein were investigated. Immunopositivity for CD10, ZO-1, ALP, 
DPP IV and SI were seen in monolayer cultures (0 h cytospin) and on the cell 
surface of all Caco-2 cells layered on L-pNIPAM maintained under either static 




Figure  3.8: Immunohistochemistry staining (yellow arrows) for CD10, Zonulin-1 (ZO-1), Alkaline 
phosphatase (ALP), Dipeptidyl peptidase IV (DPP IV), and Sucrase-isomaltase (SI) of Caco-2 
cells in 0 h monolayer and Caco-2 cells layered on L-pNIPAM hydrogel under static or dynamic 
culture conditions at a cell density of 2×10
6
 cells/ml following 21 day. Cell nuclei were stained 




 Scanning electron microscopy of Caco-2 cells  3.3.4
SEM analysis of Caco-2 cell cultures in layers on the surface of L-pNIPAM and 
L-pNIPAM-co-DMAc hydrogel scaffolds was performed (Figure  3.9 A & B). 
Under static and dynamic culture conditions Caco-2 cells layered on L-pNIPAM 
formed comprehensive multi-layer clusters of cells which often gave rise to villi-
like structures by day 21 (Figure  3.9  A and Figure 3.10). Close examination of 
the edges of these cell clusters showed the presence of microvilli brush 
borders. Surprisingly, layered Caco-2 cells when spread on the surface of L-
pNIPAM-co-DMAc under static and dynamic culture conditions covered the 
entire surface of the scaffold (Figure  3.9 B and Figure 3.10), this contrasted with 
the no cell controls where hydrogels were cultured in media for 3 week, it can 
be seen that there were no cellular structures or disposition of matrix within the 





Figure  3.9: Scanning electron micrographs of Caco-2 cells layered on. A: L-pNIPAM; and B: L-
pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions at a cell density of 
2×10
6
 cells/ml following 21 day. White arrows show the microvilli-like structures. Scale bar = 30 






Figure  3.10: Scanning electron micrographs of Caco-2 and HT29-MTX cells layered on or 
suspended within L-pNIPAM hydrogel under static or dynamic culture conditions at a cell 
density of 2×10
6





 Metabolic activity of HT29-MTX cells in three hydrogel scaffolds 3.3.5
3.3.5.1 Alginate hydrogel scaffold 
Under static culture conditions, a significant increase in metabolic cell activity 
was observed between 0 and 21 days when HT29-MTX cells were layered on 
alginate (P≤0.05) (Figure  3.11 A). However, when HT29-MTX cells were 
suspended within alginate, a significant decrease in metabolic cell activity 
between day 0 and 21 (P≤0.05) (Figure  3.11 B). In contrast, under dynamic 
culture conditions, there was a significant increase in metabolic cell activity 
between day 0 and 7, 14 and 21, when HT29-MTX cells were layered on 
alginate (P≤0.05) (Figure  3.11 C). Whereas HT29-MTX cells, when suspended 
within alginate, showed a significant decrease in metabolic cell activity between 
day 0 and 2, which was followed by a significant increase in metabolic cell 
activity at day 21 (P≤0.05) (Figure  3.11 D). Across the culture conditions 
following 3 weeks a significant decrease in metabolic activity was observed in 
HT29-MTX cells suspended compared to those layered on the surface and 
cultured under static conditions (P≤0.05) (Figure  3.11 A & B). However, cells 
cultured under dynamic layered culture conditions showed an increase in 
metabolic activity, when compared to static layered conditions (P≤0.05) 
(Figure  3.11 A & C). 
3.3.5.2 L-pNIPAM hydrogel scaffold 
Under static culture conditions, when HT29-MTX cells were layered on or 
suspended in L-pNIPAM there was a significant decrease in metabolic cell 
activity observed between day 0 and 2, followed by a significant increase in 
metabolic cell activity between day 2 and 21 (P≤0.05) (Figure  3.11 E & F). 
Under dynamic culture conditions, initially there was a significant decrease in 
metabolic cell activity detected from 0 to 2 days (P≤0.05); followed by a 
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significant increase in metabolic cell activity from day 2 to 21 (P≤0.05) 
(Figure  3.11 G & H). Across the culture conditions following 3 weeks a 
significant difference in metabolic activity was seen in HT29-MTX cells 
suspended in L-pNIPAM compared to layered cells under both static and 
dynamic culture (P≤0.05) (Figure  3.11 E & H). 
3.3.5.3 L-pNIPAM-co-DMAc hydrogel scaffold 
Under static culture conditions, a significant increase in metabolic cell activity 
was observed at all time points where HT29-MTX cells were layered on L-
pNIPAM-co-DMAc (P≤0.05) (Figure  3.11 I). In contrast, a significant increase in 
metabolic cell activity was observed from day 2 to 7 followed by a significant 
decrease in metabolic cell activity from day 7 to 21 when HT29-MTX cells were 
suspended in L-pNIPAM-co-DMAc (P≤0.05) (Figure  3.11 J). Under dynamic 
culture conditions, when HT29-MTX cells were layered on L-pNIPAM-co-DMAc 
there was a significant increase in metabolic cell activity from day 0 to 7 
(P≤0.05) (Figure  3.11 K). Whereas, when HT29-MTX cells were suspended 
within L-pNIPAM-co-DMAc and maintained under dynamic culture conditions, 
there was a significant increase in metabolic cell activity following 14 days in 
culture (P≤0.05) (Figure  3.11 L). Across the culture conditions following 3 weeks 
HT29-MTX cells displayed significantly higher metabolic activity when cultured 
layered in static conditions compared to suspended in L-pNIPAM-co-DMAc 
under static conditions or layered under dynamic conditions (P≤0.05) 
(Figure  3.11 I & L). 
 Comparison of cell metabolic activity in three hydrogel systems. 3.3.6
HT29-MTX cells cultured under static conditions in layers displayed no 
significant difference in metabolic activity following 3 weeks in culture 
(Figure  3.11). Whilst HT29-MTX cells cultured in suspension either under static 
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or dynamic culture showed significantly higher metabolic activity in L-pNIPAM 
compared to both alginate and L-pNIPAM-co-DMAc following 3 weeks (P<0.05) 
(Figure  3.11). In contrast, HT29-MTX cells cultured in layers in dynamic culture 
showed highest metabolic activity in alginate which was significantly higher than 
both L-pNIPAM and L-pNIPAM-co-DMAc cultures following 3 weeks (P<0.05) 












Figure  3.11: Metabolic activity of HT29-MTX cells at a cell density of 2×10
6
 cells/ml layered on or suspended within Alginate: (A, B, C and D); L-




 Morphological and phenotypic assessment of HT29-MTX cells 3.3.7
cultured in hydrogel systems 
HT29-MTX cells cultured in layers on alginate under either static or dynamic 
culture conditions formed multilayer spheroids following 2 days (Figure  3.12), 
which continuously enlarged over the 21 days of culture (Figure  3.13, 
Figure  3.14 A, and Figure  3.15 A). However, multilayers of HT29-MTX cells 
were observed when cells were layered on alginate hydrogel scaffolds under 
static and dynamic culture at day 21 (Figure  3.14 A, and Figure  3.15 A). In 
contrast, HT29-MTX cells layered on L-pNIPAM under static and dynamic 
culture conditions at day 2, 7, 14 and 21, accumulated as multilayers of cells 
and formed villus-like structures at 14 and 21 days (Figure  3.12, Figure  3.13, 
Figure  3.14 A, and Figure  3.15 A). This differed considerably to suspended 
HT29-MTX cells, which migrated to the surface of L-pNIPAM and formed a 
multilayer of cells under static conditions propagating the formation of villus-like 
structures under dynamic conditions (Figure  3.14 A, and Figure  3.15 A). As a 
result by day 21, well-developed mucosal-like layers formed when HT29-MTX 
cells were layered on and suspended in L-pNIPAM-co-DMAc under both static 
and dynamic culture conditions (Figure  3.14 A, and Figure  3.15 A). HT29-MTX 
cells grown for 21 days on and in the three hydrogel systems under dynamic 
and static culture differentiated to form mucus-producing goblet-like cells 
(Figure  3.14 B, and Figure  3.15 B). Whilst background staining for acidic mucins 
was again high in no cell controls, clear increases in intensity for acidic mucins 
were observed around cells in all cultures of HT29-MTX cells (Figure  3.15). 
Although acidic and neutral mucins were secreted by the HT29-MTX cells in all 
cultures the secretion patterns varied. In alginate, acidic and neutral mucins 
were secreted in all culture conditions at day 14 and 21 (Figure  3.14 B, and 
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Figure  3.15 B). Increased secretion of acidic mucin over neutral mucin was 
observed in L-pNIPAM hydrogel scaffolds. Furthermore, mucus covered the 
HT29-MTX cells by day 21, in all culture conditions. Although the secretion of 
acidic mucin was observed in HT29-MTX cells layered on and suspended in L-
pNIPAM-co-DMAc, neutral mucins were also detected after day 21, under both 






Figure  3.12: Histological analysis of HT29-MTX cells layered on or suspended within alginate, 
L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions at a 
cell density of 2×10
6










Figure  3.13: Histological analysis of HT29-MTX cells layered on or suspended within alginate, 
L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions at a 
cell density of 2×10
6





Figure  3.14: Histological analysis of HT29-MTX cells layered on or suspended within alginate, L-
pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions at a cell 
density of 2×10
6
 cells/ml following 14 days. A: Stained with H&E (circles indicate villus like 
structures) and B: stained with Alcian blue/PAS, blue: acidic mucin (black arrows); magenta: 










Figure  3.15: Histological analysis of HT29-MTX cells layered on or suspended within alginate,   
L-pNIPAM, and L-pNIPAM-co-DMAc hydrogels under static or dynamic culture conditions at 
a cell density of 2×10
6
 cells/ml following 21 day. A: stained with H&E (circles indicate villus 
like structures) and B: stained with Alcian blue/PAS, blue: acidic mucin (black arrows); 




Immunopositivity for MUC2 and MUC5AC was observed in control cytospun 
HT29-MTX cells grown in monolayer (Figure  3.16 A). Higher levels of MUC2 
immunopositivity was seen in HT29-MTX cells cultured in layers on alginate 
scaffolds compared to those suspended within alginate (Figure  3.16 B). 
Interestingly HT29-MTX cells cultured on or in L-pNIPAM hydrogel scaffolds 
showed some immunopositivity for MUC2 and a high level of immunopositivity 
for MUC5AC (Figure  3.16 C). Whereas HT29-MTX cells layered on and 
suspended within L-pNIPAM-co-DMAc under static and dynamic culture 
conditions displayed weak immunopositivity for MUC2 with high 





Figure  3.16: Immunohistochemistry staining (yellow arrows) of MUC2 and MUC5AC. A: 
monolayer and IgG negative control. HT29-MTX cells layered on or suspended within B: 
Alginate, C: L-pNIPAM, and D: L-pNIPAM-co-DMAc hydrogels under static or dynamic culture 
conditions at a cell density of 2×10
6
 cells/ml following 21 day. Cell nuclei were stained with 




 Scanning electron microscopy of HT29-MTX cells  3.3.8
SEM analysis of HT29-MTX cells suspended within and layered on L-pNIPAM 
and L-pNIPAM-co-DMAc hydrogel scaffolds under static and dynamic culture 
conditions at 21 days, showed the presence of cells within or on the surface of 
the hydrogel (Figure  3.17 A, B). Although HT29-MTX cells were suspended 
within L-pNIPAM and L-pNIPAM-co-DMAc hydrogel scaffolds, cells migrated to 
the surface of the hydrogels, where cells formed circular clusters of cells when 
cultured under static and dynamic culture conditions. It was found that the 
HT29-MTX cells layered on the hydrogels under both static and dynamic 
















Figure  3.17: Scanning electron micrographs for HT29-MTX cells layered on or suspended 
within A: L-pNIPAM and B: L-pNIPAM-co-DMAc hydrogels under static or dynamic culture 
conditions at a cell density of 2×10
6
 cells/ml following 21 day. Squares indicate areas of 





The human intestinal Caco-2 and HT29-MTX cells have been utilized as in vitro 
models of enterocytes and goblet cells, respectively (Chen et al. 2010). Here, 
three hydrogel systems were investigated to determine which would support 3D 
culture of Caco-2 and HT29-MTX cells, and give rise to the villus architecture of 
the small intestine in vitro. Previous studies have reported the importance of 
pore size, mechanical properties, microenvironment such as pH and oxygen 
concentration and culture conditions in the differentiation and functionality of 
cells (Engler et al. 2006; Jaasma et al. 2008; Pusch et al. 2011; Knight et al. 
2013; Li et al. 2013). Interestingly, the pH of the hydrogel used here and the 
microenvironment of the natural small intenstine both are basic (KozIolek et al. 
2014). In vitro, pore size (pore diameter) can influence cell migration into the 
scaffold from its surface and this migration depends on the cell type (Knight et 
al. 2013). Thus, this study compared cell behaviour in a softer and larger pores 
alginate versus stiffer and smaller pores synthetic non-biodegradable scaffolds 
developed in our laboratory (Boyes 2012; Thorpe et al. 2016; Boyes et al. 
2016); and compared cells cultured in suspension or as layers and maintained 
under static versus dynamic culture conditions. However, it is also worth noting 
that the crosslinking type will also affect cellular migration, namely the ionic 
crosslinking seen with alginate will form a more fixed structure preventing 
cellular migration. Whilst the physical entanglement seen in the L-pNIPAM 
hydrogels where cells can effectively push their way through the hydrogel.  
Long-term static culture has been shown to contribute to decreased cell viability 
and extracellular matrix production (Jaasma et al. 2008), thus, in this study an 
orbital shaker was utilized as a simple way to simulate dynamic culture 
conditions. This study showed that not only the static or dynamic culture 
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conditions impacted on the metabolic activity of Caco-2 and HT29-MTX cells 
but also the cellular localization within or on the three hydrogels affected 
metabolic activity and tissue architecture.  
To characterize the 3D culture models in vitro, the metabolic activity of Caco-2 
and HT29-MTX cells were assessed within the three hydrogel scaffolds. The 
natural biodegradable scaffold: calcium cross-linked alginate; maintained the 
metabolic activity of Caco-2 and HT29-MTX cells for 21 days in some of the 
culture conditions and induced formation of cell spheroids. In contrast, the 
metabolic activity was decreased when Caco-2 cells were layered on alginate 
and cultured under dynamic culture and when HT29-MTX cells were suspended 
within alginate and cultured under static culture conditions. These differences 
between Caco-2 and HT29-MTX cells may be attributed to differential 
expression or properties of cell receptors. Simon-Assmann et al, (1994; 1998) 
and Orian-Rousseau et al (1998) demonstrated that Caco-2 and HT29-MTX 
cells produced different types of integrins and that this could affect how these 
cells grow in culture. Simon-Assmann et al (1994) showed that undifferentiated 
and differentiated HT29 cell populations cultured on laminin produced different 
laminin-binding integrins and grew differently under identical culture conditions. 
These differences in integrins may in part explain the difference in the growth 
seen in the HT29-MTX and Caco-2 cells observed in this current study. In 
addition, the mechanical properties of alginate may also impact on cell 
proliferation, migration, differentiation, and morphological organisation 
(Banerjee et al. 2009). This study demonstrated that suspended Caco-2 and 
HT29-MTX cells migrated into the surface of alginate following 21 days under 
static culture conditions due to shortage of O2 and nutrients. The mechanical 
properties of alginate are time dependent, the strength of alginate decreases 
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gradually during the first few weeks of culture, due to the loss of calcium ions 
(LeRoux et al. 1999). Furthermore, the average pore size of alginate probably 
increased and shifted to larger pores due to decreased in cross linking which 
resulted from the diffusion of calcium ions out of the alginate.  
Taken together, the variable metabolic activity and spheroid morphology 
observed when Caco-2 and HT29-MTX cells were cultured in alginate could in 
part be a result of the poor stability and changing properties seen in alginate; 
when used as a 3D scaffold in long-term cell culture. Scaffold stability would be 
essential to maintain cells demanding stability and time to produce their own 
matrix (Wang et al. 2009a), alginate was shown to have low storage moduli 
indicating a soft hydrogel and thus could have impacted on stability with time 
(Shoichet et al. 1996). Due to the fact that the mechanical properties of the 
hydrogel can be controlled and strengthened by controlling the components 
concentrations and gelation time (Cao 2011). It would be interesting to 
investigate the effect of cells cultured within a range of alginate concentrations, 
CaCl2 concentrations and gelation time in order to increase the storage moduli 
could improve the alginate stability and strength its mechanical properties.  
Caco-2 and HT29-MTX cells are sensitive to calcium and express the calcium-
sensing receptor (Poquet et al. 2008; Davies et al. 2008) the main effects of 
calcium on these cells appear to be on cellular migration (Peignon et al. 2006)      
and adhesion molecules (Bernet et al. 1993). Transepithelial electrical 
resistance (TEER) values increased in Caco-2 cells treated with 1.6 mM Ca2+ 
for 1 h (Davies et al. 2008). However, within alginate cultures with the exception 
of the 10 minute polymerisation time, where cells are exposed within the 
alginate to 200 mM CaCl2, the Ca
2+ is bound within the alginate as a cross 
128 
 
linker as is not freely accessible to cells. During the preparation of alginate, 
following polymerisation the alginate is washed with NaCl and media, and 
media is changed every 48 h, thus any remaining free Ca2+ would be rapidly 
removed. Chan & Mooney et al. (2013) demonstrated that in alginate which was 
unwashed following polymerisation 50% of the Ca2+ was released into the 
media over the first 10 h. Thus, following the 3 weeks of culture in this study 
and extensive washes following polymerisation, limited free Ca2+ would be 
available for cellular uptake. In the bound form Ca2+ may be involved in 
activation of the Ca2+ sensing receptor but due to its bound form is unlikely to 
be able to be taken up into cells and thus at the later time points of 2 and 3 
weeks of culture it is unlikely to have had a major effect on the cellular 
behaviour. 
Here, this study investigated the capacity of synthetic porous, non-
biodegradable, non-fabricated, cross-linked network structures which are highly 
hydrated and similar to the native microenvironment of the small intestine to 
determine their ability to provide the mechanical support for cellular proliferation 
and differentiation. Interestingly, the phenotype of Caco-2 and HT29-MTX cells 
were similar in L-pNIPAM and L-pNIPAM-co-DMAc. The metabolic activity of 
Caco-2 and HT29-MTX cells were increased when layered on these hydrogels 
under both static and dynamic culture; with both cell lines shown to form villus-
like structures under dynamic culture. The observed increases in metabolic 
activity and formation of the villus-like structure under dynamic culture 
conditions and the migration of the suspended HT29-MTX cells into the surface 
of the synthetic hydrogel may be due to the flow of nutrients and oxygen over 
cells, the fluid flow induced in these cultures will mimic the fluid flow of nutrients 
in the small intestine. This efficient delivery of nutrients and oxygen enabled 
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Caco-2 and HT29-MTX cells to reorganize into 3D villus-like structures that 
remained viable for the 21 days investigated. Furthermore, these synthetic 
hydrogels provided a hydrated space for the diffusion of nutrients and 
metabolites to and from the Caco-2 and HT29-MTX cells. Thus, stimulating the 
production of extracellular matrix (ECM) demonstrated here by the production of 
mucins. Moreover, increased cell adhesion seen through expression of 
adhesion factors, interestingly, Caco-2 cells are known to increase cell-cell 
adhesion through the production of E-cadherin-actin complexes (Peignon et al. 
2006), and are shown to adhere to decellularied scaffolds and form villus-like 
structures when grown under dynamic culture conditions (Pusch et al. 2011). 
In the synthetic hydrogel models, when Caco-2 cells were suspended within 
either L-pNIPAM or L-pNIPAM-co-DMAc the metabolic activity of cells was 
reduced, compared to alginate. It seems possible that these decreases in 
metabolic activity were due to reduced nutrient diffusion through the synthetic 
hydrogels. This is supported by the decreased pore size and increased stiffness 
seen in these synthetic hydrogels. This finding, however, is contrary to the 
groups' previous study with mesenchymal stem cells, which had excellent 
metabolic activity and cell differentiation within L-pNIPAM-co-DMAc (Thorpe et 
al. 2016). These differences in metabolic activity within the hydrogel may reflect 
the relatively higher metabolic rate of the Caco-2 cells compared to 
mesenchymal stem cells. This leads to the suggestion that Caco-2 cells are 
more sensitive to reduced nutrient supply and/or diffusion of waste material 
when suspended within either L-pNIPAM or L-pNIPAM-co-DMAc. In addition, 
there are many parameters which can influence cell behaviour in 3D synthetic 
scaffolds such as cross-linking, density, porosity, and biodegradability (Drury & 
Mooney 2003). Mechanical properties of biomaterials have been shown 
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previously to drive differentiation of cells. For example, Baker et al (2009) found 
that the stiffness of the extracellular matrix plays an important role in increasing 
the intracellular mechanical properties of prostate cancer cells when mixed with 
different concentrations of type I collagen matrix. Thus, the differential stiffness 
seen within these systems could explain at least in part the behaviour of cells 
within this study. Unfortunately comparison to the storage moduli of intestinal 
tissue was not possible within the current study. Recently, Stewart et al (2018) 
reported that the effective total modulus of human small bowel is 3.98 kPa.  
Mucins are an intrinsic part of the small intestinal niche, and these proteins give 
rise to an adherent mucus layer that coat the intestinal mucosa (Kitamura et al. 
1996). Mucins provide protection against pathogens and autodigestion and act 
as a medium for digestion and absorption (Kitamura et al. 1996; Moncada et al. 
2003). In vivo MUC2 and MUC5AC mucins are secreted and gel-forming mucin 
types and are expressed by intestinal cells to variable amounts (Kim & Gum 
1995; Bu et al. 2010; Kim & Ho 2010). MUC2 is highly expressed in goblet cells 
of the small intestine and colon (Bu et al. 2011); whereas MUC5AC is not 
normally expressed in the small and large intestinal mucosa, and are mainly 
expressed in the stomach (Kim & Gum 1995; Bu et al. 2010). Within the 
hydrogel models, immunohistochemical analysis showed that MUC2 and 
MUC5AC were not expressed by Caco-2 cells under any culture conditions. The 
expression of MUC5AC gene has been previously observed in Caco-2 cells; 
however, this was measured by qRT-PCR and was not measured as protein 
production (Bu et al. 2011). 
In the HT29-MTX cells, the results showed production of MUC2 and MUC5AC 
when cultured in and on L-pNIPAM or L-pNIPAM-co-DMAc under static or 
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dynamic cultures. These findings indicated a modification of predominantly 
MUC2 production to mostly MUC5AC in the HT29-MTX cells. This switching in 
mucin phenotype is common with formation of tumours and can be attributed to 
changes in the cell niche (Kitamura et al. 1996), thus, the switching seen in the 
current study may be due to the fact that HT29-MTX cells are derived from 
human colon adenocarcinoma. During gastrointestinal cancers there is often an 
up-regulation of the more viscous and protective MUC5AC during disease 
progression especially were auto digestion can occur (Wan et al. 2014). 
In this study, the results have shown that the cell morphology varied 
dramatically between the three in vitro systems and indeed the native small 
intestinal epithelium. However, it was clear that the cell morphology was greatly 
influenced by the 3D microenvironment; with the presence of villus like 
structures being more common when cells were cultured on the surface of L-
pNIPAM and L-pNIPAM-co-DMAc under dynamic culture conditions.  
Immunohistochemical analysis showed the presence of CD10 and ZO-1 which 
confirmed the brush border and tight junction expression, respectively when 
Caco-2 cells were layered on L-pNIPAM under static and dynamic culture 
conditions. Despite the colonic origins of Caco-2 cells, when grown on L-
pNIPAM they expressed small intestinal digestive enzymes sucrase-isomaltase, 
dipeptidyl peptidase IV, and alkaline phosphatase. Previous studies have also 
shown differentiation of Caco-2 cells into enterocyte-like cells, which mimic the 
cells of the small intestine (Jumarie & Malo 1991; Basson et al. 1996; Olejnik et 
al. 2003). However, it is important to note that not all Caco-2 cells produced 
sucrase-isomaltase; this may be due to the early passage of Caco-2 cells used 
in this study. This patchy expression of sucrase-isomaltase has been shown to 
vary in Caco-2 cells depending on the passage number (Chantret et al. 1994).  
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Hence, the results show that L-pNIPAM not only stimulates Caco-2 
differentiation in both culture conditions but also maintained expression of 
enzymes which were expressed in monolayer. These results propose a positive 
communication between the L-pNIPAM and the Caco-2 cells. These findings 
are in agreement with the previous studies which showed an increase in 
alkaline phosphatase activity when Caco-2 cells grown as a monolayer on 
polycarbonate filters (Ferruzza et al. 2012) and when co-cultured with HT29-
MTX cells on silk scaffolds (Chen et al. 2015). Similarly, Caco-2 cells cultured 
on the extracellular matrix proteins (collagen type I and the basement 
membrane components collagen type IV and laminin) also showed that the 
activity of alkaline phosphatase, dipeptidase II, and sucrase-isomaltase were 
significantly higher in cells grown on laminin or collagen type IV than cells 
grown on collagen type I for one week after confluence as a result of the effect 
of extracellular matrix proteins on the differentiation phenotype (Basson et al. 
1996).  
SEM analysis further confirmed Caco-2 differentiation when cultured in layers 
on L-pNIPAM under static and dynamic culture conditions. The results revealed 
the typical finger-like projections at the apical surface of Caco-2 cells layered on 
L-pNIPAM suggesting differentiation and formation of microvilli. Caco-2 cells 
spread and covered the surface of L-pNIPAM-co-DMAc under static and 
dynamic culture. It seems possible that these differences in the morphological 
characteristics could be due to differences in mechanical stiffness of these 
synthetic hydrogels (Boyes 2012; Thorpe et al. 2016). 
This study reports for the first time that synthetic non-biodegradable hydrogels 
could be used as scaffolds for Caco-2 and HT29-MTX cells. The most effective 
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scaffold which supported both cell lines and induced the formation of the 
optimal villus like structures was L-pNIPAM when cells were layered on the 
surface and cultured under dynamic conditions. Despite these promising 
findings, future work is required to investigate the capacity of the L-pNIPAM as 
a scaffold to co-culture Caco-2 and HT29-MTX cells under dynamic culture 
conditions to develop a 3D model of the small intestinal epithelium. 
In conclusion, Caco-2 and HT29-MTX cells were successfully layered on L-
pNIPAM hydrogel scaffolds under dynamic culture conditions which supported 
the 3D culture of these cells and stimulated them to form villus-like structures, 
maintained differentiation into enterocyte-like cells and mucus-producing goblet 
cells, respectively which expressed phenotypic markers that mimicked the 
native small intestinal epithelium. Thus, L-pNIPAM has the potential to deliver a 
3D culture of Caco-2 and HT29-MTX cells which is promising for further 
investigation and characterisation of 3D in vitro co-culture model which could be 
used in drug discovery, and studies investigating inflammatory bowel disease 




Chapter 4  
Long-term in vitro 3D hydrogel co-culture model of 
inflammatory bowel disease. 
4 Chapter 4: Long-term in vitro 3D hydrogel co-culture model 









Inflammatory bowel disease (IBD) such as Crohn's disease is characterised by 
increased intestinal permeability due to intestinal mucosal barrier dysfunction, 
which may be a critical factor in the pathogenesis of IBD (Marano et al. 1998; 
Cui et al. 2010). Furthermore, increased infiltration of inflammatory cells into the 
lamina propria and submucosa of the small and large intestines are also 
observed (Elson et al. 1995). Several inflammatory mediators are believed to be 
associated with the development of IBD. Interleukin-1 beta (IL-1β) and tumor 
necrosis factor alpha (TNFα) are endogenous proinflammatory cytokines that 
are increased during inflammation of the mucosa and are involved in the 
pathogenesis of IBD (Stevens et al. 1992; Breese et al. 1994; Rogler & Andus 
1998). IL-1β and TNFα are secreted by activated immune cells within the 
lamina propria during inflammation (Guan & Zhang 2017). Many studies have 
shown that there is an increased expression of IL-1β and TNFα in intestinal 
biopsy specimens obtained from patients with IBD (Stevens et al. 1992; 
Reinecker et al. 1993; Marano et al. 1998; Coccia et al. 2012). 
Similarly, hypoxia has been shown to impact on the permeability of intestinal 
epithelial cells (Wang et al. 2013b), and O2 signaling plays an important role in 
the response to inflammation (Shah 2016). In healthy mucosa of the small 
intestine, epithelial cells survive in physiologic hypoxia, this results from 
counter-current exchange of blood flow which diminishes oxygen tension along 
the crypt-villus axis. A steep O2 gradient exists in the normal intestine where 
PO2 levels at lamina propria and submucosa are 4-8%, this decreases across 
the epithelial and mucus layer to less than 2% in the intestinal lumen (Colgan & 
Taylor 2010; Zheng et al. 2015; Zeitouni et al. 2016a). Intestinal epithelial 
oxygen tension has an important role in intestinal inflammation, which is 
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dysregulated in IBD (Shah 2016; Colgan et al. 2016). IBD results in increased 
hypoxia over the inflamed mucosa due to increased oxygen demands of innate 
immune cells that are recruited to the site of inflammation (Zeitouni et al. 2016a).  
The normal intestinal epithelium contains a number of different epithelial cell 
types with a range of metabolic, digestive, and barrier functions (Walter et al. 
1996; Kleiveland 2015). The two main cell types lining the intestinal epithelium 
are absorptive enterocytes and mucus-producing goblet cells (Antunes et al. 
2013). The in vitro study of the pathogenesis of IBD requires the use of a cell 
model demonstrating as closely as possible the characteristics of the in vivo 
intestinal epithelium. However, to date, most in vitro models have used a single 
cell type, the human intestinal epithelial cell line Caco-2; which is derived from 
absorptive cells of human colon adenocarcinoma (Balimane et al. 2000; Ranaldi 
et al. 2003). Caco-2 cells, have been widely used to study absorptive functions 
and permeability of the intestinal epithelium. However, compared to in vivo 
conditions, these models have many limitations (Ferruzza et al. 2012; 
Béduneau et al. 2014). One of these limitations, is that Caco-2 cells form 
closely linked tight junctions, which resemble those of the colon, rather than the 
small intestine. This results in a poor permeability of the cell membrane. 
Furthermore, Caco-2 monocultures fail to produce an adherent mucus layer 
which is essential when recreating an intestinal inflammatory niche (Nollevaux 
et al. 2006; Béduneau et al. 2014; Kim et al. 2014; Lozoya-Agullo et al. 2017). 
Subsequently, this has led to the creation of a co-culture model which combines 
Caco-2 cells with the mucus-producing HT29-MTX cells; which are derived from 




A number of 2D co-culture systems of the small intestine have been developed. 
An in vitro co-culture model combining Caco-2 cells and goblet-like HT29-H 
cells were first characterised by Wikman-Larhed & Artursson in 1995. Later, 
Walter et al. (1996) established an in vitro co-culture model using Caco-2 and 
HT29-MTX cells. In vitro monocultures and co-cultures of Caco-2 and HT29-
MTX cells have been successfully developed to study intestinal permeability (Li 
et al. 2013; Chen et al. 2015; Lozoya-Agullo et al. 2017). However, when this 
model has been used in monolayer the cells fail to develop the crypt-villus 
architecture seen in the small intestine. 3D monocultures and co-culture studies 
using various types of 3D scaffolds such as porous silk, collagen, and Poly-
lactic-co-glycolic acid (PLGA) have been investigated (Costello et al. 2014a; 
Chen et al. 2015; Yi et al. 2017). For example, Chen et al., (2015) co-cultured 
Caco-2 and HT29-MTX cells on geometrically engineered hollow porous silk 
scaffolds. The Caco-2 and HT29-MTX cells formed mucus layers and the lumen 
of this tube became filled with mucus. However, there was a reduction in cell 
function following a few weeks of culture. Similarly, the culture of Caco-2 cells 
as a monolayer on 3D fabricated villi-shaped collagen scaffolds was used to 
study drug absorption. However, the collagen scaffold was a barrier to the 
diffusion of some drugs and Caco-2 cells were unable to live for a prolonged 
period as the collagen scaffold degraded (Yu et al. 2012; Yi et al. 2017). In 
contrast, when Caco-2 and HT29-MTX cells were co-cultured on a 3D PLGA 
scaffold which was designed to replicate the architecture of the intestinal villi; 
the co-cultured cells migrated to the tips of the villi and underwent differentiation 
when stimulated by epidermal growth factor (EGF) (Costello et al. 2014b).  
A limited number of studies have investigated inflammatory mediators within 
these culture systems. In vitro monolayer culture of Caco-2 cells treated with IL-
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1β and TNFα resulted in increased permeability of tight junctions (Marano et al. 
1998; Al-Sadi & Ma 2007; Al-Sadi et al. 2010) and the production of 
inflammatory chemokines, such as IL-8 (Van De Walle et al. 2010). The effects 
of proinflammatory cytokines have also been investigated in some co-culture 
models. Leonard et al. (2010) and Susewind (2015) developed an inflamed 3D 
co-culture model of Caco-2 cells cultured with either macrophage (THP-1) and 
dendritic cells (MUTZ-3) derived from peripheral blood monocytes or with 
human immune cell lines. The macrophages and dendritic cells were embedded 
in type I collagen layers on a transwell filter insert, and then Caco-2 cells were 
cultivated on top. These co-culture models were then stimulated with IL-1β for 2 
days to model the inflamed intestinal mucosa. In these models, the inflamed co-
cultures released higher amounts of IL-8 and increased TNFα expression 
compared to non-inflamed Caco-2 monocultures. However, these studies did 
not include mucus-producing cells.  
Some in vitro studies have investigated the effects of hypoxia in simple culture 
systems, where hypoxia increased the production of IL-1β and TNFα by human 
peripheral blood mononuclear cells following treatment with endotoxin (Ghezzi 
et al. 1991). Caco-2 cells have also been used to study the intestinal epithelial 
response to hypoxia (Zeitouni et al. 2016b). Lima et al. (2013) studied the effect 
of Shigella flexneri on co-cultured Caco-2 cells and rat hepatocytes in normoxia 
and hypoxia (<1% O2) conditions, resulted in apoptosis. Similary, Caco-2 cells 
cultured on polystyrene and grown under hypoxia at 1% O2 showed a significant 
decrease in brush border membrane expression of β1 integrins, which resulted 
in decreased Y. enterocolitica entry into Caco-2 cells (Zeitouni et al. 2016b). 
However, these studies did not consider the effect of pro-inflammatory 
cytokines and hypoxia conditions on 3D co-culture systems. The previous study 
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described in Chapter 3 established 3D in vitro culture models of the intestinal 
epithelium consisting of monocultures of Caco-2 and HT29-MTX cells layered 
on L-pNIPAM hydrogel scaffolds under dynamic culture conditions. This model 
supported the 3D culture of these cells generating villus-like structures and 
promoted differentiation, mimicking the native intestinal epithelium (Dosh et al. 
2017).  
Hence, with the purpose of developing a model which represents the cell types 
seen within the intestine, and under conditions seen during pathological 
conditions. This study investigated a long-term in vitro 3D co-culture model 
utilising Caco-2 and HT29-MTX cells and a novel L-pNIPAM hydrogel scaffold 
to mimic the natural epithelial layer of the native intestine. The co-culture model 
developed was then investigated under conditions representative of 
inflammation to determine its potential to study disease processes. 
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4.2 Materials and Methods 
 L-pNIPAM hydrogel scaffolds synthesis 4.2.1
The hydrogel was synthesised as previously described in Chapter 3 
Section  3.2.1.2. 
 Monocultures and co-cultures of Caco-2 and HT29-MTX layered on 4.2.2
L-pNIPAM hydrogel scaffolds 
Six different percentages of cultured cells were investigated: 100% Caco-2 
monocultures, 100% HT29-MTX monocultures and co-cultures of these cells in 
various initial seeding percentages (90% Caco-2 / 10% HT29-MTX, 85% Caco-
2 / 15% HT29-MTX, 80% Caco-2 / 20% HT29-MTX, 75% Caco-2 / 25% HT29-
MTX). To prepare layered cultures, 300 µL of liquid L-pNIPAM at 38-39ºC was 
added to each well of the 48 well plates and 100 µL was added to each well of 
96 well plates. Gelation of the L-pNIPAM was induced by cooling to below 32ºC. 
Following gelation 300 µL or 100 µL of 2x106 total cells/ml (for each of the 6 cell 
culture suspensions) in complete media were applied to the surface of hydrogel 
construct in 48 and 96 well plates respectively, and following a 30 minute cell 
attachment period a further 200 µL or 150 µL complete media (Caco-2 culture 
media) was added to each well. All constructs were incubated at 37°C, 5% CO2 
under dynamic conditions using an orbital shaker at 30 rpm, with media 
replenished every 48 h. Metabolic activity assessments utilized 96 well plates 
and were determined using Alamar Blue assay following 0 h, 48 h, and weekly 
between 1 to 7 weeks. For histological assessment 48 well plate cultures were 
utilised. Cultures were maintained for an initial 6 weeks in standard culture 
conditions, following initial model development, cultures were divided into 3 
groups as: (1) control; (2) treated with 10 ng/ml recombinant human IL-1β 
(Peprotech, London, UK), (concentrations were selected from prior studies (Al-
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Sadi et al. 2010; Susewind  2015), and (3) cultured under hypoxic conditions in 
an oxygen controlled glove box (Coy Lab products, York, UK) at 1% O2 (under 
static culture conditions) for a further week prior to harvest.  
 Long-term co-cultures  4.2.3
Cell percentages of 90% Caco-2 / 10% HT29-MTX, and 75% Caco-2 / 25% 
HT29-MTX cultures were selected for long-term co-culture. These cultures were 
also treated with pro-inflammatory cytokines and hypoxia conditions to mimic 
inflammatory conditions. Cultures were either maintained for 12 weeks in 
standard media and dynamic culture as a control. Alternatively following 11 
weeks in standard culture, co-cultures were treated with pro-inflammatory 
cytokines: 10 ng/ml recombinant human IL-1β (Peprotech, London, UK); or 10 
ng/ml recombinant human TNFα (Peprotech, London, UK) (concentrations were 
selected from prior studies (Enss et al. 2000; Cui et al. 2010), or 1% O2 in an 
oxygen controlled glove box at 1% O2 (under static culture conditions) for a 
further week in culture prior to harvest.  
 Alamar blue assessment of metabolic activity 4.2.4
The metabolic activity of monocultures and co-cultures layered on L-pNIPAM 
hydrogel scaffolds under dynamic culture conditions were assessed using 
Alamar blue assay (Life Technologies, Paisley, UK) in complete media after 0-7 
weeks of culture following the manufacturer's protocol. The fluorescent intensity 
was recorded using a fluorescence microplate reader (CLARIOstar, BMG 
LABTECH) at a fluorescence excitation wavelength of 590 nm. Relative 
fluorescence units (RFU) were recorded for cellular hydrogel scaffolds and 




 Histological assessment 4.2.5
Monocultures and different percentages of co-cultures in 48 well plates were 
utilised for histological assessment. Triplicate samples for each culture 
condition and time point (2, 3, 4, 7, and 12 weeks) were fixed in 4% w/v 
paraformaldehyde/PBS for 24 h prior to washing in PBS and processed to 
paraffin wax in a TP1020 tissue processor (Leica Microsystem, Milton Keynes, 
UK). Four-micron sections were stained with Haematoxylin and Eosin (H&E); 
and Alcian blue/periodic acid Schiff (AB-PAS) as previously described in 
Chapter 3 Section ‎3.2.4. 
The slides were examined with an Olympus BX51 microscope and images 
captured by digital camera and Olympus Cell Sens Standard software (Media 
Cybernetics, Buckinghamshire, UK).  
 Immunohistochemical assessment 4.2.6
Due to the L-pNIPAM hydrogel scaffold being non-biodegradable (Thorpe et al. 
2016), it is not possible to extract cells RNA / protein and thus qualifying gene / 
protein expression is not possible, as a result immunohistochemistry for 
presence / absence qualitative changes are reported. Immunohistochemistry 
was performed on co-cultures containing 90% Caco-2 / 10% HT29-MTX, and 
75% Caco-2 / 25% HT29-MTX following 7 weeks and co-cultures containing 
90% Caco-2 / 10% HT29-MTX following 12 weeks under the various culture 
conditions. Immunohistochemistry for anti ZO-1 antibody, anti MUC2 antibody, 
anti MUC5AC antibody, anti alkaline phosphatase antibody (ALP), anti MMP2 
antibody, anti MMP9 antibody, anti ADAMTS1 antibody, (antibodies details 
reported in Chapter 2 Section  2.2.3 and Chapter 3 Section  3.2.5), and anti 
caspase 3 antibody (1:400 rabbit polyclonal, none antigen retrieval) (Abcam, 
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Cambridge, UK) were determined. The slides were examined with an Olympus 
BX51 microscope and images captured by digital camera and Olympus cell 
Sens Standard software (Media Cybernetics, Buckinghamshire, UK). 
 Scanning electron microscopy for monocultures and co-cultures 4.2.7
Following 7 and 12 weeks in culture, constructs cultured with 90% Caco-2 / 
10% HT29-MTX, and 75% Caco-2 / 25% HT29-MTX were processed for 
scanning electron microscopy (SEM) as described previously in Chapter 3 
Section  3.2.6. 
 Statistical analysis 4.2.8
All metabolic activity assessments were performed at least 6 times. Normality of 
data was tested using a Skewness, Kurtosis, Royston Chi-sq, Shapiro Wilk W 
and Shapiro-Francia W tests, together with a q-q plot. From this analysis, it was 
demonstrated that the data sets were from mixed populations with some 
populations displaying potential normal distribution, but others were shown to 
be not normally distributed, as such non-parametric tests have been performed 
for all data. Therefore statistical comparisons were performed by Kruskal-Wallis 
with a pairwise comparison (Conover-Inman), each time points compared to 
time 0 of monocultures and co-cultures for 7 weeks for Alamar blue assay with 
statistical significance accepted at P ≤ 0.05. All replicates have been shown 





 Metabolic activity of monocultures and co-cultures of Caco-2 and 4.3.1
HT29-MTX cells layered on L-pNIPAM hydrogel scaffolds under 
dynamic culture conditions 
When Caco-2 monocultures were layered on the surface of L-pNIPAM hydrogel 
scaffold under dynamic culture, there was a significant increase in metabolic 
cell activity by week 2 to week 7 (P≤0.05) (Figure  4.1 A). In layered co-cultures 
of 90% Caco-2 /10% HT29-MTX, there was a significant increase in metabolic 
activity from week 2 to week 7 (P≤0.05) (Figure  4.1 B). In contrast, the 
metabolic activity of layered co-cultures of 85% Caco-2 / 15% HT29-MTX 
significantly decreased from week 6 to week 7 (P≤0.05) (Figure  4.1 C). In 
layered co-cultures of 80% Caco-2 / 20% HT29-MTX, there was only a 
significant increase in metabolic activity between day 0 and 2 weeks (P≤0.05) 
(Figure  4.1 D). In layered co-cultures of 75% Caco-2 / 25% HT29-MTX; there 
was a significant increase in metabolic activity by week 6 to week 7 (P≤0.05) 
(Figure  4.1 E). When HT29-MTX monocultures were layered alone on L-
pNIPAM hydrogel under dynamic culture, there was a significant decrease in 
metabolic activity from day 0 to 1 week then the metabolic activity remained 
constant and followed by a significant decrease in metabolic cell activity by 











Figure  4.1: Metabolic activity of monocultures and co-cultures of Caco-2 and HT29-MTX 
cells at a total cell density of 2×10
6
 cells/ml with different percentages A: Caco-2 cells 
alone; B: 90% Caco-2 / 10% HT29-MTX; C: 85% Caco-2 / 15% HT29-MTX; D: 80% Caco-
2 / 20% HT29-MTX; E: 75% Caco-2 / 25% HT29-MTX; F: HT29-MTX cells alone  layered 
on L-pNIPAM hydrogel scaffolds under dynamic culture conditions following 7 weeks. All 
replicates have been shown with the median ranges to clearly show the spread of 




 Morphological and phenotypic assessment of monocultures and 4.3.2
co-cultures of Caco-2 and HT29-MTX cells layered on L-pNIPAM 
hydrogel scaffolds under dynamic culture conditions 
When Caco-2 monocultures were layered on L-pNIPAM hydrogel scaffold and 
maintained under dynamic culture conditions, cells formed spheroid structures 
by 2 weeks which had villus-like structures between 3 to 7 weeks in culture 
(Figure  4.2). Layered co-cultures of 90% Caco-2 / 10% HT29-MTX formed 
multi-cellular layers over the surface of the hydrogel following 2 weeks. These 
co-cultured cells were well preserved and following 3 to 7 weeks formed villus-
like structures (Figure  4.2). However, in layered co-cultures of 85% Caco-2 / 
15% HT29-MTX cells and 80% Caco-2 / 20% HT29-MTX cells, multi-cellular 
layer were formed between 2 and 7 weeks (Figure  4.2). In layered co-cultures 
of 75% Caco-2 / 25% HT29-MTX, multi-cellular layers of cells were observed 
following 2 weeks of culture, which went on to form villus-like structures 
following 4 to 7 weeks (Figure  4.2). When HT29-MTX monocultures were 
layered on L-pNIPAM and maintained under dynamic culture conditions for 7 
weeks, multi-cellular layeres were observed in cultures between 2 and 3 weeks, 
which went on to form villus-like structures following 4 to 7 weeks in culture 
(Figure  4.2). 
To determine potential mucin production, cell cultures following 3, 4, and 7 
weeks in culture were stained using alcian blue/PAS. Alcian blue detects acidic 
mucins (blue) whereas PAS detects neutral mucins (pink magenta). Caco-2 
monocultures were positive for neutral mucins, whereas both neutral mucins 
and acidic mucins were observed over all co-cultured cells and HT29-MTX 
monocultures following 3, 4, and 7 weeks in culture. An increase in intensity for 
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acidic mucins were observed in layered co-cultures of 75% Caco-2 / 25% HT29-






Figure  4.2: Morphology of monocultures and co-cultures of Caco-2 and HT29-MTX cells at 
a total cell density of 2×10
6
 cells/ml with different percentages layered on L-pNIPAM 
hydrogel scaffolds under dynamic culture conditions following 7 weeks stained with H&E. 
























Figure 4.3: Mucin expression by monocultures and co-cultures of Caco-2 and HT29-
MTX cells at different percentages layered on L-pNIPAM hydrogel scaffolds under 
dynamic culture conditions following A: 3 weeks; B: 4 weeks; and C: 7 weeks stained 
with AB-PAS, blue: acidic mucin (black arrows); magenta: neutral mucin (red 




 Scanning electron microscopy of monocultures and co-cultures 4.3.3
following 7 weeks 
Examination of the surface of the monocultures and co-cultures by SEM 
showed the presence of morphological structures which resembled epthieilal 
microvilli. These were identified in Caco-2 monocultures, and co-cultures 
containing: 90% Caco-2 / 10% HT29-MTX, and 75% Caco-2 / 25% HT29-MTX 
following 7 weeks in culture whilst HT29-MTX monocultures showed budding of 
the mucus producing goblet-like cells (Figure  4.4, white arrows). 
 Treatment monocultures and co-cultures with pro-inflammatory 4.3.4
cytokines or cultured under hypoxic conditions 
Following 6 weeks of dynamic culture in layers on L-pNIPAM hydrogel scaffold, 
monocultures and co-cultures were treated with pro-inflammatory cytokine IL-1β 
(10 ng/ml) for 1 week under dynamic culture or cultured under hypoxic 
conditions at 1% O2 for 1 week under static culture conditions. Among these 
cultures, layered co-cultures of 85% Caco-2 / 15% HT29-MTX, 80% Caco-2 / 
20% HT29-MTX and HT29-MTX monocultures appeared to undergo cell death 
and cell debris were observed (Figure  4.5). Whilst layered Caco-2 
monocultures, co-cultures of 90% Caco-2 / 10% HT29-MTX, and 75% Caco-2 / 










Figure  4.4: Scanning electron micrographs of monocultures and co-cultures of Caco-2 and 
HT29-MTX cells at different percentages layered on L-pNIPAM hydrogel scaffolds under 
dynamic culture conditions following 7 weeks showing microvilli-like structures (white arrows). 










Figure  4.5: Morphology of monocultures and co-cultures of Caco-2 and 
HT29-MTX cells at different percentages layered on L-pNIPAM hydrogel 
scaffolds under dynamic culture conditions for 6 weeks and then treated 
with 10ng/ml IL-1β for 1 week under dynamic culture conditions or hypoxic 
at 1% O2  for 1 week under static culture conditions stained with H&E. The 
blue arrows indicate debris cells, the yellow arrows indicate dead cells. 




To determine features classically associated with IBD a number of markers 
were assessed by immunohistochemsitry. In co-cultures containing 90% Caco-2 
and 10% HT29-MTX cells, stimulation with IL-1β and 1% O2 decreased the 
expression of ZO-1, whilst increased expression of MUC2 compared to controls, 
MUC5AC was expressed in all cultures (Figure  4.6). ALP was highly expressed 
in the control, with less expression in cells treated with IL-1β and 1% O2 
(Figure  4.6). MMP2 was expressed in the control and 1% O2 cultures more than 
IL-1β treated cells (Figure  4.6). Immunopositivity for MMP9 was not observed in 
any culture. ADAMTS1 was highly expressed in 1% O2 culture compared to the 
control and IL-1β cultures. Caspase 3 was expressed at low levels in the control 
but was not observed in IL-1β and 1% O2 treated cultures (Figure  4.6).  
In co-cultures containing 75% Caco2 and 25% HT29-MTX cells, ZO-1 and 
MUC2 were highly expressed in the control with less expression in 1% O2 and 
IL-1β treated cultures (Figure  4.7). MUC5AC was positively expressed in all 
cultures. ALP was expressed in IL-1β and 1% O2 treated cultures compared to 
control (Figure  4.7). MMP2 was expressed in the control and 1% O2 cultures 
more than IL-1β treated cultures. Immunopositivity for MMP9 was not observed 
in any culture (Figure  4.7). ADAMTS1 was highly expressed in 1% O2 culture 
compared to the control and IL-1β treated cultures. Caspase 3 was expressed 
in 1% O2 cultures but was not observed in control and IL-1β treated cultures 








Figure  4.6: Immunopositivity (brown) of co-culture Caco-2 and HT29-MTX cells at percentages 
90% Caco-2 / 10% HT29-MTX layered on L-pNIPAM hydrogel scaffolds under dynamic 
culture conditions following 7 weeks as a control or for 6 weeks and then treated with 10 ng/ml 
IL-1β for 1 week under dynamic culture conditions or hypoxic at 1% O2 for 1 week under static 
culture conditions. Cell nuclei were stained with haematoxylin (blue). The black arrows 









Figure  4.7: Immunopositivity (brown) of co-culture Caco-2 and HT29-MTX cells at 
percentages of 75% Caco-2 / 25% HT29-MTX layered on L-pNIPAM hydrogel scaffolds 
following 7 weeks  as a control or for 6 weeks and then treated with 10ng/ml IL-1β for 1 
week under dynamic culture conditions or hypoxic at 1% O2  for 1 week under static culture 
conditions. Cell nuclei were stained with haematoxylin (blue). The Black arrows indicate 




To investigate the impact of long-term co-culture on cell behaviour, cell 
percentages of 90% Caco-2 / 10% HT29-MTX and 75% Caco-2 / 25% HT29-
MTX cultures were selected for further long term culture. The non-stimulated 
co-culture of 90% Caco-2 / 10% HT29-MTX cultured as layers on the surface of 
L-pNIPAM hydrogels under dynamic culture conditions were well preserved and 
formed multicellular layers. In contrast, when co-cultured cells were treated with 
IL-1β, only small cell clusters were seen. Whilst those cultures treated with 
TNFα cells showed poor nuclear morphology which is consistent with non-viable 
cells (Figure  4.8 A). This was confirmed by an increase in caspase 3 expression 
within these cells (Figure  4.9). However, when co-cultured cells were 
maintained at 1% O2 for the final week of culture, cells formed multicellular 
spheroid like structures (Figure  4.8 A). Neutral and acidic mucins were 
observed in the control cultures and cultures maintained under 1% O2 for the 
final week of culture, whilst lower levels of mucin were seen in cultures treated 
with IL-1β and TNFα (Figure  4.8 A). In cultures containing 75% Caco-2 / 25% 
HT29-MTX, cells showed evidence of cell death following stimulation with IL-1β 
and TNFα (Figure  4.8 B & Figure  4.9). Neutral and acidic mucins were observed 
in the control and at 1% O2 (Figure  4.8 B). From this morphological assessment, 
co-cultures containing 90% Caco-2 and 10% HT29-MTX were selected for 
further investigation of the inflammatory response using immunohistochemistry 
staining.  
As an indication of inflammation in the 90% Caco-2 / 10% HT29-MTX co-culture 
model, ZO-1, MUC2, ALP, MMP2, MMP9, and caspase 3 were investigated in 
the co-cultures stimulated with IL-1β, TNFα, and 1% O2 together with un-
stimulated controls using immunohistochemistry. ZO-1 was decreased in IL-1β, 
TNFα and 1% O2 compared to control suggesting an increase in membrane 
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permeability. IL-1β, TNFα and 1% O2 increased the expression of MUC2 
compared to the control (Figure  4.9). ALP was highly expressed in the control 
and 1% O2 compared to those treated with IL-1β and TNFα. MMP2 was 
expressed in the control and 1% O2  cultures but was not observed in IL-1β and 
TNFα treated cultures (Figure  4.9). MMP9 was highly expressed in TNFα 
treated cultures with less expression in IL-1β but was not observed in control 
and 1% O2 cultures. Caspase 3 was highly expressed in TNFα treated cultures 
compared with IL-1β and 1% O2 cultures but was not observed in control 













Figure  4.8: Morphology of long term co-culture of Caco-2 and HT29-MTX cells at 
percentages A: 90% Caco-2 / 10% HT29-MTX; B: 75% Caco-2 / 25% HT29-MTX layered 
on L-pNIPAM hydrogel scaffolds under dynamic culture conditions following 12 weeks as a 
control or for 11 weeks and then treated with 10 ng/ml IL-1β or 10 ng/ml TNFα for 1 week 
under dynamic culture conditions or hypoxic at 1% O2 for 1 week under static culture 
conditions. Cells were stained with H&E and AB-PAS (blue shows acidic mucin (red 










Figure  4.9: Immunopositivity (brown) of co-culture Caco-2 and HT29-MTX cells at 
percentages 90 %Caco-2 / 10% HT29-MTX layered on L-pNIPAM hydrogel scaffolds under 
dynamic culture conditions following 12 weeks as a control or for 11 weeks and then treated 
with 10 ng/ml IL-1β or 10 ng/ml TNFα for 1 week under dynamic culture conditions or 
hypoxic at 1% O2 for 1 week under static culture conditions. Cell nuclei were stained with 







 Scanning electron microscopy of long-term co-cultures following 12 4.3.5
weeks 
The SEM observations suggested that the cell morphology and spreading were 
affected by pro-inflammatory cytokines. When co-cultures containing 90% 
Caco-2 / 10% HT29-MTX, and 75% Caco-2 / 25% HT29-MTX cells layered on 
L-pNIPAM hydrogel scaffold for 12 weeks, cells were completely spread out 
with extending projections was observed in control, whereas co-cultures treated 
with IL-1β and TNFα were still rounded (Figure  4.10 & Figure  4.11). Hypoxic co-
cultures at 1% O2 were spread out with distinct microvilli on their apical surfaces 
of 90% Caco-2 / 10% HT29-MTX (white arrows) (Figure  4.10). Whilst small 
rounded cells were observed in 75% Caco-2 / 25% HT29-MTX co-cultures at 









Figure  4.10: Scanning electron micrographs of long-term co-culture Caco-2 and HT29-
MTX cells at percentages 90% Caco-2 / 10%HT29-MTX cells layered on L-pNIPAM 
hydrogel scaffolds under dynamic culture conditions following 12 weeks as a control or 
for 11 weeks and then treated with 10 ng/ml IL-1β or 10 ng/ml TNFα for 1 week under 
dynamic culture conditions or hypoxic at 1% O2 for 1 week under static culture 










Figure  4.11: Scanning electron micrographs of long term co-culture Caco-2 and HT29-MTX 
cells at percentages 75% Caco-2 / 25% HT29-MTX cells layered on L-pNIPAM hydrogel 
scaffolds under dynamic culture conditions following 12 weeks as a control or for 11 weeks and 
then treated with 10ng/ml IL-1β or 10ng/ml TNFα for 1 week under dynamic culture conditions 




4.4 Discussion  
Co-culture of intestinal epithelial cells: Caco-2 and HT29-MTX have been 
extensively used as 2D in vitro models to study intestinal epithelial barrier 
functions (Hilgendorf et al. 2000; Chen et al. 2010; Antunes et al. 2013). Here, 
L-pNIPAM hydrogel scaffold was investigated to determine its ability to provide 
the mechanical support for long-term layered monocultures and co-cultures of 
Caco-2 and HT29-MTX cells under dynamic conditions to develop an in vitro 
intestinal epithelium model. This model was then treated with proinflammatory 
cytokines IL-1β, TNFα, or hypoxic conditions at 1% O2 to mimic the environment 
observed during inflammatory bowel disease (Muzes et al. 2012; Colgan et al. 
2016). 
 To characterise the 3D mono- and co-culture models in vitro, the metabolic 
activity, and phenotype of these cultures were assessed. The metabolic activity 
of Caco-2 monoculture or 90% Caco-2 / 10% HT29-MTX co-cultures were 
increased when layered on L-pNIPAM hydrogel scaffold under dynamic culture. 
Cells formed a multi-cellular layer which became undulated and gave rise to 
villus-like structures. Importantly, this was not observed when co-cultures 
contained more than 10% HT29-MTX cells. This contradicts previous work in 
which HT29-MTX were found to have a faster proliferation rate than Caco-2 
cells grown in monolayers (Berger et al. 2017). The mono- and co-culture of 
Caco-2 and HT29-MTX cells were differentiated after 3 weeks. This was evident 
by the expression of alkaline phosphatase and the presence of microvilli-like 
structures of Caco-2 cells, plus the expression of MUC2 by HT29-MTX cells. 
However, dynamic culture conditions using an orbital shaker as a simplified way 
with non-directional flow probably resulted in formation of non-aligned microvilli. 
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Thus, utilising a perfusion bioreactor system may be useful to enable 
development of one-directional microvilli. 
The differentiation of Caco-2 and HT29-MTX cells was accompanied by a 
decrease in metabolic activity at 3 weeks. This was seen both in Caco-2 
monoculture after 3 weeks and in co-cultures where differentiation had taken 
place. Furthermore, in monoculture and co-culture models no loss of metabolic 
activity was observed, which may be due to increased flow of nutrients and 
oxygen by the use of dynamic culture conditions, this effect has been previously 
seen in Chapter 3 when cells are grown under dynamic culture conditions (Dosh 
et al. 2017). For long-term co-culture experiments, the optimal seeding 
percentages were 90% Caco-2 / 10% HT29-MTX cells and 75% Caco-2 / 25% 
HT29-MTX cells. These percentages more closely mimic the cell percentages 
found in the small (90% / 10%) and large (75% / 25%) intestine (Mahler et al. 
2009; Umar 2010). Both HT29-MTX cells and Caco-2 cells were shown to 
produce mucus. Caco-2 cells produced neutral mucins, whilst HT29-MTX cells 
produced acidic mucins when cultured as mono- and co-cultures. This agreed 
with previous observation seen when 90% Caco-2 / 10% HT29-MTX and 75% 
Caco-2 / 25% HT29-MTX cell were cultured in monolayer (Mahler et al. 2009).  
Inflammatory bowel diseases such as Crohn's disease and ulcerative colitis are 
chronic inflammatory diseases that can affect the intestine by increasing 
intestinal paracellular permeability resulted in alterations of function and 
expression of tight junction proteins such as ZO-1 (Neuman 2007). Several 
inflammatory cytokines such as IL-1β and TNFα play a crucial role in the 
development of IBD. These cytokines have been linked to the dysfunctional 
intestinal epithelium which leads to permeability defects which are key symptom 
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of IBD (Pearson et al. 1982; Ukabam et al. 1983). Thus, in vitro cell monolayers 
have often been utilised to investigate their effects on epithelial permeability 
using trans epithelial electrical resistance (TEER), where Caco-2 or HT29 cells 
on semi-permeable filters form luminal and basolateral compartments and the 
electrical resistance is measured between compartments (Press & Di Grandi 
2008). IL-1β and TNFα expression in patients with Crohn's disease has been 
shown to lead to increased intestinal permeability (Gibson 2004; Landy et al. 
2016). However, few studies have investigated the role of IL-1β and TNFα in 
intestinal permeability within 3D culture systems. In this study as a proxy 
measure of intestinal permeability, expression of ZO-1 (tight juntion protein) was 
utilised due to its role in maintaining barrier function, as TEER is difficult to 
measure within this system (Lee 2015). This study showed IL-1β and TNFα 
reduced ZO-1, which would lead to an increase in paracellular permeability of 
co-culture following 7 and 12 weeks. This observation is consistent with a 
previous studies by Wang et al., (2006) and Al-sadi et al., (2007) where IL-1β 
and TNFα increased Caco-2 tight junction permeability by inducing increase in 
Myosin L Chain Kinase (MLCK) expression and activity. 
The Mucus layer provides protective function for intestinal mucosa against 
physical and chemical injury, assist the clearance of pathogens, and play 
important role in maintaining mucosal integrity (McGuckin et al. 2008; 
Johansson et al. 2011; Kim & Khan 2013). Alteration in mucin production was 
detected in patients with IBD (Dorofeyev et al. 2013). Moderate expression of 
MUC2 was observed in patients with Crohn's disease, whereas low expression 
of MUC2 was detected in patients with ulcerative colitis. In co-culture model, 
MUC2 mucin was produced at 7 and 12 weeks in 90% Caco-2 / 10% HT29-
MTX co-cultures. This expression of MUC2 was increased when these cultures 
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were treated with IL-1β and TNFα. This agrees with previous studies that 
displayed IL-1 and TNFα stimulates secretion of mucin via IL-1R1 on the 
basolateral surface of cultured HT29-C1.6E cells and via NF-KappaB pathway 
in HM3 colon cancer cells (Jarry et al. 1996; Ahn et al. 2005). 
Although Caco-2 cells originated from colon adenocarcinoma, they resemble 
the epithelial cells of the foetal ileum and are believed to differentiate and 
express proteins phenotypically similar to normal small intestine (Sambuy et al. 
2005). Culture duration and seeding cell densities can impact on the cellular 
differentiation and senescence. Differentiation of Caco-2 cells is time-dependent 
(Sambuy et al. 2005), and a marker of the enterocyte phenotype is the 
expression of ALP. Intestinal ALP is a brush border membrane protein which is 
expressed by enterocytes and is used as a marker for crypt-villus differentiation 
(Goldberg et al. 2008). Thus, the expression of ALP was used here to select the 
optimal co-culture percentage in these models. The results showed the 
expression of ALP was increased with the increase in the percentage of Caco-2 
cells in the co-cultures. The 90% Caco-2 / 10% HT29MTX co-cultured cells 
produced the highest level of ALP activity and hence differentiation of the Caco-
2 cells to enterocyte-like cells. As a consequence, these co-culture percentages 
were used in a further study of pro-inflammatory conditions. However, 
Nollevaux et al (2006) developed co-culture model compromising 75% Caco-2 / 
25% HT29-MTX which were grown in serum-free medium. This model produced 
monolayers which expressed alkaline phosphatase. This suggests that 
differences in culture conditions, as well as the percentage of each cell line, 
may affect cell differentiation and the expression of alkaline phosphatase. 
Subsequently, here all investigations of inflammation in co-culture model were 
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performed in 90% Caco-2 / 10% HT29MTX and 75% Caco-2 / 25% HT29MTX 
co-cultures.  
An increased expression of matrix metalloproteinases (MMPs) is associated 
with intestinal inflammation and Crohn's disease. Here, the expression of MMP2 
and MMP9 as these are biomarkers for inflammation was investigated 
(O'Sullivan et al. 2015). Following 7 weeks, MMP2 was seen in control cells, IL-
1β treated and hypoxic conditions in both 90% Caco-2 / 10% HT29MTX and 
75% Caco-2 / 25% HT29MTX co-cultures. In contrast, following 12 weeks 
MMP2 was only slightly expressed in IL-1β treated co-cultures; whereas 
increased expression of MMP9 was seen in cultures treated with TNFα. These 
results are consistent with other results which showed increases in MMP9 
activity indicating an activation in tissue degrading process resulting from TNFα 
overproduction by intestinal epithelial cells in TNF ΔARE/+ mice model, whereas 
MMP2 activity was not altered in this model (Roulis et al. 2011). MMP2 has 
been shown to be upregulated in pediatric Crohn's disease (Sim et al. 2012)     
whilst other studies have shown high levels of MMP9 compared to low levels of 
MMP2 in inflamed mucosa (Baugh et al. 1999). IL-1β and TNFα have been 
shown to induce synthesis of MMP2 and MMP9 in inflammatory cells and 
epithelial cells (Saren et al. 1996). Gan et al (2001) demonstrated that MMP9 is 
highly expressed in Caco-2 cells stimulated with IL-1β and TNFα. In this study, 
the observed increased expression of MMP2 in control could be due to the 
Caco-2 and HT29-MTX cells are tumour cells in origin and indeed the 
expression and activity of MMPs are upregulated in many cancerous cells 
(Egeblad & Werb 2002). 
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Here, this study also investigated the expression of ADAMTS 1, which plays a 
critical role in the inflammation (Tang 2001). In normal tissues, ADAMTS1 is not 
highly expressed, but increases during inflammation (Hirohata et al. 2017). In 
this model, ADAMTS1 was highly expressed in control cells compared to IL-1β 
treated cells in both co-culture percentages. This could be due to the fact that 
Caco-2 and HT29-MTX cells are cancer cell lines and the proteolytic activity of 
ADAMTS1 has been related to local tissue invasion in cancer (Filou et al. 2015).  
These results are in agreement with Demircan et al (2005) and Kalinski et al 
(2007), who reported a decrease in ADAMTS1 expression in a chondrosarcoma 
cell line (OUMS-27) and chondrosarcoma cell line (C3842) stimulated with IL-1β. 
However, Filou et al (2015) stated that RNA levels of ADAMTS1 were 
upregulated in the muscular tissue of healthy colons, while downregulated in 
colon cancer. Additionally, in this study, western blot analysis showed that 
ADAMTS1 have been detected in both Caco-2 and HT-29 cells. 
The normal intestinal epithelium has been shown to be in a physiologic state of 
hypoxia (Zheng et al. 2015). The intestinal epithelial cells response to hypoxia 
through the transcription factor called hypoxia-inducible factor (HIF-1α and HIF-
2α) and are believed to be essential in maintaining intestinal homeostasis. 
Intestinal epithelial cells are expressed high amounts of HIF-1α and HIF-2α in 
Crohn's disease (Colgan & Taylor 2010; Shah 2016; Colgan et al. 2016). 
Similarly, a decreased partial pressure of O2 has been observed in mouse 
models of ulcerative colitis (Karhausen et al. 2004). It is thought to be brought 
about increased O2 consumption of intestinal epithelial cells during inflammation. 
Inflammation raises local vasculitis thus reduced O2 availability to the inflamed 
region, furthermore, transmigration of neutrophils can consume regional O2 
(Karhausen et al. 2004). In addition, hypoxia can alter gene expression, intra- 
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and extra-cellular pH and membrane receptors (Lima et al. 2013). In the current 
study, the influence of hypoxia on the cellular behaviour in monocultures and 
co-cultures was examined. Following 7 weeks, histological assessment of 
Caco-2 monocultures and in co-culture 90% Caco-2 / 10% HT29-MTX showed 
that 1% O2 hypoxia for 1 week had no effects. Only in the 100% HT29-MTX 
monoculture and in co-cultures where the number of HT29-MTX cells were 
increased an increase in cell debris and cell death was observed.  
Under hypoxic conditions, decreased expression of ZO-1 in 90% Caco-2 / 10% 
HT29-MTX and 75% Caco-2 / 25% HT29-MTX co-cultures following 7 weeks 
and 12 weeks was observed. This findings is in agreement with previous study 
which has demonstrated that hypoxia can induce decrease expression and 
reorganization of tight junction proteins including ZO-1 due to hypoxia increased 
the expression of MLCK (Wang et al. 2009b). In contrast, increased expression 
of MUC2 in 90% Caco-2 / 10% HT29-MTX co-culture following 7 weeks and 12 
weeks. This is in agreement with a recent study which showed increased MUC2 
expression in response to hypoxia in LS174T colorectal cancer cells (Dilly et al. 
2016). Importantly, hypoxia is an important factor that induces cancer 
metastasis (Munoz-Najar et al. 2006; Jing et al. 2012), following 7 weeks, 
hypoxia increased expression of MMP2 and ADAMTS1 in both percentages. 
This agrees with a previous study which showed that in breast carcinoma cells 
hypoxia-induced invasion by increased expression of MMP2 (Munoz-Najar et al. 
2006) while hypoxia had no significant influence on ADAMTS1 transcription in 
chondrosarcomas cell line (C3842) (Kalinski et al. 2007). In addition, induced 
hypoxia-mimicking conditions using CoCl2 (100 µmol/L) for 24 h increased 
expression of MMP2 in human esophageal cancer cells (Eca109) (Jing et al. 
2012). Apoptotic cells were less frequent in 90% Caco-2 / 10% HT29-MTX than 
169 
 
seen in 75% Caco-2 / 25% HT29-MTX co-culture. Caco-2 cells consume less 
oxygen under hypoxia and thus may be better adapted to hypoxic conditions 
(Lima et al. 2013). 
In conclusion, the successful application of an in vitro model depends on how 
closely this model mimics the characteristics of the in vivo intestinal epithelium; 
In this study, an intestinal epithelial model that could mimic healthy and 
diseased conditions was developed. The L-pNIPAM hydrogel scaffold and 
dynamic culture condition makes long-term co-culture possible and allows 
investigation of pro-inflammatory cytokines effect on intestinal cell behaviour. 
However, the ability of L-pNIPAM hydrogel as a scaffold for more physiologically 
relevant intestinal cells such as intestinal organoids rather than the cancerous 
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5.1 Introduction  
The intestinal mucosa is composed of columnar epithelia which form intestinal 
villi and crypts. These crypts are the site of intestinal stem cell (ISC) production 
(Clevers 2009). The intestinal epithelium rapidly self-renews every 3-5 days 
(Barker et al. 2007). The self-renewal process is driven by ISCs or crypt base 
columnar cells (CBCs), which reside at the bottom of the intestinal crypts, and 
are scattered amongst Paneth cells which support them and contribute to stem 
cell niche (Yeung et al. 2011; Foulke-Abel et al. 2014). These stem cells 
symmetrically divide every 24 h and generate new cells, which are known as 
transit amplifying cells. The transit amplifying cells proliferate rapidly, and either 
migrate towards the villi tips and terminally differentiate into the mature 
intestinal epithelial cell types (enterocytes, goblet cells or enteroendocrine cells) 
or alternatively move toward the crypt base and differentiate into Paneth cells 
(Leedham et al. 2005; Sato et al. 2009, 2011a; Sato & Clevers 2015). These 
stem cells within the crypts are capable of responding to local environment 
changes ensuring that the correct cellular populations are produced within the 
villi. Hence, this stem cell niche regulates cellular proliferation in the villi whilst 
maintaining a stem cell population (Scoville et al. 2008; Barker et al. 2008, 
2010; Munoz et al. 2012). This stem cell population within the stem cell niche 
expresses a leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5), 
which is a target gene for WNT signalling. A single Lgr5 positive stem cell 
(Lgr5+) is capable of regenerating all cell types within the intestinal epithelium 
(Barker et al. 2007, 2012, 2013; Clevers 2013). 
It has previously been shown that when small intestinal crypt cells, isolated from 
mice, are embedded within Matrigel, and cultured in the presence of R-spondin 
1, Noggin, and epidermal growth factors to mimic the physiological conditions of 
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the intestinal stem cell niche; these cells expanded in culture without significant 
genetic or physiologic alterations (Sato et al. 2009, 2011b; Fuller et al. 2012; 
Wang et al. 2013a; Xinaris et al. 2015; Sasaki et al. 2017). Under these 
conditions, cells organised themselves into 3D tissue constructs: described as 
organoids, consisting of a central sphere-shaped domain, composed mostly of 
differentiated cells, and numerous bud-like structures similar to that of an 
intestinal crypt. Found within these crypt like structures are Lgr5+ intestinal stem 
cells. Similarly Paneth cells are found at the base of the crypt (Sato et al. 2009, 
2011a; Wong et al. 2012; Sato & Clevers 2012, 2013; Date & Sato 2015; 
Zachos et al. 2016; Scott et al. 2016). A noticeable feature of the epithelial 
organoid system is its ability to grow cells almost infinitely from a small number 
of cells, or tiny pieces of tissue (Sato et al. 2011a; Mahe et al. 2013; Liu et al. 
2016). 
Similarly, isolation of Lgr5+ stem cells grown in culture also resulted in the 
formation of organoids. These organoids contain crypt and villus domains which 
recapitulate essential processes of the native intestinal epithelium (Sato et al. 
2009, 2011a; Sato & Clevers 2013; Yin et al. 2014; Date & Sato 2015; Sato & 
Clevers 2015). Wang et al. (2017) reported that when pre-isolated stem cells or 
crypts from the human small intestine were cultured within Matrigel they formed 
cystic organoids. These organoids formed an enclosed lumen surrounded by a 
single layer of non-polarized epithelial cells made up of both proliferated cells 
randomly mixed with differentiated cells. These organoids did not reflect tissue 
of the in vivo intestine and were unsuitable for studying of intestinal functions. 
This led to the development of alternative scaffolds to support the growth of 
intestinal stem cells. Those that have been investigated, including type 1 
collagen gels, which have been shown to support long-term (28 days) 
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maintenance and expansion of organoids formed from the co-culture of human 
small intestinal crypts with intestinal sub-epithelial myofibroblast (ISEMFs) 
(Jabaji et al. 2014). Sachs et al. (2017) showed that mice intestinal organoids 
could be formed from a single Lgr5+ stem cell, when embedded in Matrigel for 3 
days. These organoids were released from Matrigel and grown in contracting 
floating type 1 collagen, where, they continued to align, fuse and self-organize 
into a hollow tube-like structure which became lined with the stem cells and 
differentiated into the various intestinal epithelial cell types.  
Although these organoid systems have a huge impact on the intestinal research, 
the size, structure, and function of the epithelial components in these organoids 
are not exactly the same as that in the in vivo intestine. For example, 
differentiated epithelial cells in small intestinal organoids fail to form finger-like 
structures that accurately mimic native intestinal villi (Nakamura & Sato 2018). 
Thus, recent studies have utilised a variety of bio-fabrication to produce 
functional intestine that attempts to mimic the villus-crypt architecture of the in 
vivo intestine. A recent study, demonstrated that micro-engineered collagen 
scaffolds with appropriate extracellular matrix and stiffness (modulus young's = 
approximately 10 KPa) generated an in vitro human small intestinal epithelium 
with a polarized monolayer which mimicked in vivo crypt-villus structure with a 
suitable cell lineage and an open luminal surface (Wang et al. 2017). Although 
current organoid culture systems are dependent on animal-derived hydrogels 
such as Matrigel and collagen gels, these scaffolds are complex and vary in 
their composition (Sachs et al., 2017) which makes them inappropriate for 
organoid expansion with clinical applications. Hence, this has led to the use of 
synthetic matrices in tissue engineering of the small intestine (Gjorevski et al. 
2016). Cromeens et al. (2016) produced tissue-engineered intestine from 
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organoids. These organoids were expanded in Matrigel then released and 
suspended in poly-glycolic acid (PGA) scaffold coated with type 1 collagen this 
was then implanted in the peritoneal cavity of immunosuppressed NOD/SCID 
mice for 4 wks. Tissue-engineered intestine showed the presence of crypts and 
short villi, which contained all intestinal epithelial cell lineages. This study 
demonstrated that a synthetic extracellular matrix could provide a suitable 
scaffold for maintenance and expansion of crypts and intestinal stem cells. Thus, 
the current study investigated the potential of the novel synthetic L-pNIPAM 
hydrogel, (which have previously demonstrated the ability to support villus like 
structures formation in Caco-2 cells and HT29-MTX cells (Dosh et al. 2017) as 
a 3D scaffold for crypt cells and to support long-term culture of Lgr5+ intestinal 
stem cells under dynamic culture conditions. In addition, the capacity of these 
cells to differentiate into intestinal epithelial cells in vitro when suspended within 




5.2 Materials and methods 
 Mice 5.2.1
BALB/c mice (n=22) (Charles River Laboratories) aged 6 to12 weeks old were 
used for the extraction of intestinal crypts and isolation of single Lgr5+ stem 
cells. 
 Culture media 5.2.2
The basal culture media (Advanced Dulbecco's Modified Eagle Medium 
(DMEM/F12) (Life Technologies, Paisley, UK) supplemented with 100 µg/ml 
penicillin/ streptomycin (Life Technologies, Paisley, UK), 250 ng/ml 
amphotericin (Sigma, Poole, UK), 2 mM glutamine (Life Technologies, Paisley, 
UK), and 1 M HEPES buffer to maintain physiological PH (Sigma, Poole, UK). 
The crypt basal media was made by supplementing with B-27 (50 x) (to 
promote growth and proliferation of stem cells without differentiation in this 
serum free media) (Life Technologies, Paisley, UK), N-2 (100 x) (Life 
Technologies, Paisley, UK), and 0.5 M N-Acetyl-L-cysteine (as an antioxidant 
that directly scavenging ROS and also acts as a mucolytic) (Sigma, Poole, UK). 
 Small intestinal crypt extraction 5.2.3
Isolation of small intestinal crypts was performed, as described previously (Sato 
& Clevers 2012; Mahe et al. 2013; Pastuła & Quante 2014). Briefly, the 
abdomen of Balb/c mice, were cleaned with 70% (v/v) ethanol in dH2O. A mid-
sagittal incision was made into the abdominal cavity. The intestine was excised 
from the stomach at the pyloric sphincter, the mesentery dissected away and 
the distal segment was cut at the ileocecal junction. The intestines were then 
separated from adipose and connective tissues. Intestines were then flushed 
with ice-cold washing solution (10% (v/v) heat-inactivated foetal bovine serum 
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(FBS) (Life Technologies, Paisley, UK) in PBS without Ca2+ and Mg2+ (Life 
Technologies, Paisley, UK) using a 10 ml syringe fixed with a 18 gauge needle. 
All luminal content was removed. In order to extract the crypts, dissected 
intestines were opened lengthwise and villi of intestines were scraped off using 
a coverslip, and discarded. The rest of the intestine (including the crypts) were 
washed with washing buffer and cut with scissors into 2-4 mm pieces. These 
pieces were then transferred into a 50 ml Falcon tube and further washed with 
ice-cold washing solution (approximately 10 times), and pipetting up and down, 
until the supernatant was clear. The tissue fragments were transferred into 50 
ml falcon tubes and incubated in 25 ml of chelating buffer (2 mM EDTA (Sigma, 
Poole, UK) in PBS) on ice and shaken gently on an orbital shaker for 15 mins. 
The tubes were inverted gently, and cell fragments were allowed to settle at 
bottom of tubes. The chelating buffer was carefully removed and the crypts 
were re-suspended in 20 ml of washing solution for 5 min. Tissues were then 
passed through a 70 µm cell strainer to remove any remaining tissue debris and 
the crypt fraction was collected. The fraction (Fraction I) was stored on ice. The 
remaining tissue fragments were re-suspended in ice-cold washing solution, 
pipetted 5-10 times and the supernatant was passed through 70 µm cell 
strainers (Fraction II). The previous step was repeated a second time and a 
third fraction was collected (Fraction III). The three fractions were combined and 
centrifuged at 200 g for 5 min at 4°C. The pellet was re-suspended in 10 ml ice-
cold basal culture medium and centrifuged at 300 g for 5 min at 4°C to remove 
single cells and tissue debris. The number of crypts was counted under the 
inverted microscope. The crypts were subsequently either directly embedded in 
either Matrigel or L-pNIPAM hydrogel, or further dissociated into a single stem 
cell population (Section  5.2.8). 
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 Suspension of small intestinal crypts within Matrigel  5.2.4
Matrigel (basement membrane matrix, growth factor reduced and phenol red-
free) (Corning, UK) was mixed with growth factors (recombinant human R-
Spondin 1 (1 µg/ml) (PeproTech, London, UK), recombinant murine Noggin 
(100 ng/ml) (PeproTech, London, UK) and recombinant murine EGF (50 ng/ml) 
(PeproTech, London, UK)) on ice. One to five hundred crypts were re-
suspended in 50 µl of Matrigel. The suspension was pipetted in the middle of 
the well of pre-warmed 24 well-plates which had been allowed to cool to room 
temperature for 2-3 min. The plates were then transferred to 37°C for 15 min to 
allow complete polymerization of the Matrigel. Five hundred microliters of crypt 
basal media supplemented with epidermal growth factor (EGF) (50 ng/ml), 
Noggin (100 ng/ml), and R-Spondin 1 (1 µg/ml) (ENR) was added to each well. 
Cultures were maintained at 37°C, 5% CO2 for up to 14 days, crypt basal media 
supplemented with ENR was replaced every 48 h. 
 Suspension of small intestinal crypts within L-pNIPAM hydrogel    5.2.5
One to five hundred crypts were re-suspended in 300 µl of liquid L-pNIPAM 
hydrogel at 38-39°C. The suspension was added in each well of 48 well plates 
and allowed to cool below the lower critical solution temperature of the L-
pNIPAM hydrogel to induce gelation. Five hundred microliters of crypt basal 
medium supplemented with ENR was added per well. Cultures were maintained 
at 37°C, 5% CO2 and for up to 14 days under dynamic conditions, which were 
created using an orbital shaker set at 30 rpm. Media was replaced with fresh 





 Layering of small intestinal crypts on L-pNIPAM hydrogel        5.2.6
Three hundred microliters of L-pNIPAM was added to each well of 48 well 
plates. Following gelation 300 µl of crypt culture media (Section  5.2.2) 
containing 100-500 crypts was applied to the surface of hydrogel construct. 
After 30 min cell attachment period, 200 µl of crypt basal media (Section  5.2.2) 
was added to each well. All plates were incubated at 37°C, 5% CO2 and 
maintained in culture for up to 14 days under dynamic culture conditions, which 
were created using an orbital shaker set at 30 rpm. Fresh crypt basal media 
supplemented with ENR was replenished every 48 h. 
 Suspension of small intestinal crypts within Matrigel followed by 5.2.7
suspension within or layered on L-pNIPAM hydrogel 
The extracted crypt pellet was suspended and cultured in Matrigel for 7 days 
(Section  5.2.4). The resultant organoid were released from the Matrigel on 7 
days and were either suspended within or layered on L-pNIPAM hydrogel. 
Briefly, to release organoid from Matrigel the media was removed from the 
organoids and 500 µl of cold PBS was added to each well. Matrigel containing 
organoids was broken up by pipetting up and down. The suspension was 
transferred into 15 ml conical tubes then the organoids were pipetted up and 
down 50-100 times to mechanically disassociate the organoids into smaller 
fragments. Seven milliliters of cold PBS was added to the tube and pipetted up 
and down a further 20 times. The suspension was centrifuged at 200 g for 5 min 
at 4°C. The pellet containing the crypt cells was either suspended within or 
layered on L-pNIPAM hydrogel (Section  5.2.5 and  5.2.6) and maintained for  up 
to 14 days at 37°C, 5% CO2 under dynamic culture condition created using an 
orbital shaker set at 30 rpm. Media was replaced with fresh crypt basal media 
supplemented with ENR every 48 h. 
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 Isolation of small intestinal stem cells 5.2.8
Crypts were extracted from BALB/c mice as described in (Section  5.2.3). The 
crypt pellet was re-suspended with 2 ml of pre-warmed single cell dissociation 
medium (basal medium supplemented with Rock inhibitor, Y-27632, (10 µM/ml) 
(Sigma, Poole, UK)) for 30-45 min at 37°C until cells dissociated. During 
incubation, the crypt suspension was mechanically pipetted with fire-polished 
pasteur pipette every 5-10 min until the crypts were dissociated into single cells 
or 2-3 cell clusters. The cell suspension was filtered through 40 µm cell 
strainers to remove any remaining cell clumps then resuspended with basal 
medium and centrifuged at 300 g at 4°C. The pellet was re-suspended with 1 ml 
single-cell dissociation medium (basal medium supplemented with Y-27632 (10 
µM/ml)), and centrifuged at 500 g for 10 min and the supernatant was 
completely removed in preparation of Magnetic Activated Cell Sorting (MACS).  
 Magnetic Activated Cell Sorting (MACS) separation 5.2.9
Following the manufacturer's protocol the cell pellet was resuspended up to 106 
nucleated cells in 45 µl of degassed MACS buffer solution (PBS plus 0.5% (w/v) 
bovine serum albumin (BSA), and 2 mM EDTA). This MACS buffer solution was 
prepared by diluting 1 ml MACS BSA stock solution (Miltenyi Biotec, UK) with 
20 ml autoMACS rinsing solution (Miltenyi Biotec, UK). Five µl of FcR blocking 
reagent (Miltenyi Biotec, UK) was added to the suspension to block unwanted 
binding of Lgr 5 antibody to mouse cells expressing Fc receptors (e.g. B cells, 
monocytes or macrophages); and   mixed well, then refrigerated for 10 min at 2-
8°C. Cells were labeled by adding 5 µl of the biotinylated Lgr5 antibody (Miltenyi 
Biotec, UK), mixed well and refrigerated for 10 min. Cells were then washed by 
adding 1-2 ml of degassed MACS buffer and centrifuged at 500 g for 10 min. 
The supernatant was completely removed and the cell pellet was re-suspended 
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in 70 µl of degassed MACS buffer. Cells were magnetically labeled by adding 
20 µl of anti-biotin microbeads (Miltenyi Biotec, UK), mixed well and refrigerated 
for 15 min. The cells were washed in 1-2 ml of degassed MACS buffer and 
centrifuged at 500 g for 10 min. The supernatant was removed and the cell 
pellet re-suspended in 500 µl of degassed MACS buffer and magnetic 
separated. 
The MACS MS column (Miltenyi Biotec, UK) was inserted into the column 
holder on the MACS separator. The column was rinsed with 500 µl of degassed 
buffer and the effluent was discarded. The magnetically labeled cell suspension 
was loaded onto a MACS MS column; unlabelled cells were flushed through the 
column with 3 x 500 µl degassed MACS buffer. Unlabelled cell fraction was 
collected and a new collection tube was placed under the column. The column 
was removed from the magnetic holder, 1 ml of degassed MACS buffer was 
pipetted onto the column and plunger applied causing the magnetically labeled 
Lgr5 positive cell to be released and collected from the column. To increase the 
purity of the magnetically labeled fraction, the Lgr5 positive fraction was applied 
onto a new freshly prepared MS column as described above, and the MACS 
sorting of these cells was repeated. The number of Lgr5+ cells/ml were counted 
following sorting and cell suspensions were centrifuged at 500 g for 5 min and 
the supernatant discarded. The cell pellet was used for subsequent culture 
experiments.  
 Cytospin of Lgr5+ sorted cells  5.2.10
A sample of the Lgr5+ sorted cells was fixed in 4% w/v paraformaldehyde 
(Sigma, Poole, UK) for 20 min. The cells were centrifuged at 300 g for 5min and 
suspended in PBS at a cell density of 300 cells/µl. One hundred microliters of 
cell suspension was cytospun by centrifugation at 1000 rpm for 3 min (Shandon 
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cytospin 3, Thermo Scientific, Loughborough, UK). Slides were then air-dried 
and stored at 4°C until needed for immunohistochemical investigation. 
  Suspension of Lgr5+ stem cells within Matrigel 5.2.11
Matrigel was mixed with growth factors: Notch ligand Jagged-1 peptide (1 
µM/ml) (Eurogentec, Southampton, UK), and ENR on ice. One to two hundred 
Lgr5+ stem cells were re-suspended in 10 µl of Matrigel and pipetted into the 
middle of the well of a pre-warmed 96 well-plate. Following 2-3 min at room 
temperature, they were transferred to 37°C for 15 min to allow complete 
polymerization of the Matrigel. One hundred microliters of fresh crypt basal 
media supplemented with 2.5 µM/ml GSK3β inhibitor (CHIR99021) (Sigma, 
Poole, UK) (to activate β-catenin and other survival pathways), Rock activity 
inhibitor (Thiazovivin) (2.5 µM/ml (Sigma, Poole, UK) to decrease anoikis by 
increasing the stability of E-cadherin), and ENR was added to each well. 
Cultures were incubated at 37°C, 5% CO2 for up to 14 days, media was 
replaced with fresh crypt basal media supplemented with ENR every 48 h. To 
reduce apoptosis and promote the survival of single stem cells during the first 2 
days of culture a Notch agonist Jagged-1 peptide (1 µM/ml) was also added to 
the cell culture media.  
 Suspension of Lgr5+ stem cells within L-pNIPAM hydrogel 5.2.12
One to two hundred Lgr5+ stem cells were re-suspended in 100 µl of liquid L-
pNIPAM hydrogel at 38-39°C and added to each well of 96 well-plate, and 
allowed to cool below the lower critical solution temperature to induce gelation 
of the hydrogel. Two hundred and fifty microliters of crypt basal media 
supplemented with CHIR99021 (2.5 µM/ml), Thiazovivin (2.5 µM/ml), Jagged-1 
peptide (1 µM/ml) and ENR was added to each well. Cultures were incubated at 
37°C, 5% CO2 and maintained for up to 14 days under dynamic conditions 
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created using an orbital shaker set at 30 rpm. Media was replaced with fresh 
crypt basal media supplemented with ENR every 48 h. Jagged-1 peptide (1 
µM/ml) was added to the cell culture media during the first 2 days of culture. 
 Layering of Lgr5+ stem cells on L-pNIPAM hydrogel 5.2.13
One hundred microliters of L-pNIPAM was added to each well of 96 well plates. 
Following gelation, 100 µl of crypt culture media containing 100-200 Lgr5+ stem 
cells were applied to the surface of hydrogel construct in each well of the 96 
well plates. After an attachment period of 30 minutes, a further 150 µl basal 
crypt media supplemented with CHIR99021 (2.5 µM/ml), Thiazovivin (2.5 
µM/ml), Jagged-1 peptide (1 µM/ml), and ENR was added to each well. All 
plates were incubated at 37°C, 5% CO2 and maintained in culture for up to 14 
days under dynamic culture conditions created using an orbital shaker set at 30 
rpm. The basal crypt media supplemented with ENR was replenished every 48 
h. Jagged-1 peptide (1 µM/ml) was added to the cell culture media during the 
first 2 days of culture. 
 Suspension of Lgr5+ stem cells within Matrigel followed by 5.2.14
suspension within or layered on L-pNIPAM hydrogel 
Isolated Lgr5+ stem cells pellet were suspended in Matrigel (Section  5.2.11), the 
organoids which formed from Lgr5+ stem cells were released from Matrigel at 
day 7. Briefly, media was removed and 100 µl of cold PBS was added to each 
well. Matrigel was broken up by pipetting up and down to mechanically 
disassociate the organoid into single cells. The suspension was transferred into 
1.5 ml Eppendorf and centrifuged at 300 g for 5 min. The pellet was either 
suspended within or layered on L-pNIPAM hydrogel (Section  5.2.12 and  5.2.13) 
and maintained for 1 to 4 weeks at 37°C, 5% CO2 under dynamic culture 
conditions using an orbital shaker set at 30 rpm. Media was replaced with fresh 
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crypt basal media supplemented with ENR every 48 h. Jagged-1 peptide (1 
µM/ml) was added to the cell culture media during the first 2 days of culture.  
  Characterisation of crypts and Lgr5+ stem cells  5.2.15
5.2.15.1  A bright field images of the crypts and Lgr5+ stem cells 
Crypts and Lgr5+ stem cells were suspended within Matrigel for up to 14 days. 
Bright field images were examined using an inverted microscope (Olympus IX8, 
UK) and images captured using Cell-F software. 
5.2.15.2 Histological assessment 
Crypts and Lgr5+ stem cells either suspended within or layered on L-pNIPAM 
hydrogel together with those suspended in Matrigel for 7 days then released 
from Matrigel and suspended within or layered on L-pNIPAM hydrogel were 
assessed. Triplicate samples were fixed in 4% w/v paraformaldehyde/PBS for 
24 h prior to washing in PBS and processed to paraffin wax in a TP1020 tissue 
processor (Leica Microsystem, Milton Keynes, UK). Four-micron sections were 
cut and mounted onto positively charged slides (Leica Microsystem Milton 
Keynes, UK). Sections were stained with Haematoxylin and Eosin or Alcian 
Blue/Periodic acid Schiff's (PAS) as described in (Chapter 2 Section  2.2.2). 
5.2.15.3 Immunohistochemical Assessment 
Immunohistochemistry was performed to investigate: Adhesion junction protein 
(using anti-E-cadherin antibody (1:200 mouse monoclonal, heat antigen 
retrieval) (Abcam, Cambridge, UK); MUC2 production using anti-MUC2 
antibody (1:100 rabbit polyclonal, heat antigen retrieval) (Santa Cruz, 
Heidelberg, Germany); Chromogranin A production as an indication of 
enteroendocrine cell presence using anti-Chromogranin A antibody (1:100 
rabbit polyclonal, heat antigen retrieval) (Abcam, Cambridge, UK); and  
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lysozyme production as an indication of Paneth cell presence (using anti-
Lysozyme antibody (1:2000 rabbit monoclonal, heat antigen retrieval) (Abcam, 
Cambridge, UK). Immunohistochemistry was performed as previously described 




5.3 Results  
 Morphological assessment of crypts isolated from the small 5.3.1
intestine suspended within Matrigel, L-pNIPAM hydrogel or layered 
on L-pNIPAM hydrogel 
When isolated crypts were suspended in Matrigel, they formed spheroid-like 
structures within 1 day (Figure  5.1). After 2 days, these structures began to 
develop crypt-like buds. Larger mature buds made up of several well-defined 
cells were seen by day 6 to 7, suggesting the presence of stem cells within the 
crypt buds (Figure  5.1). Between day 7 and 14, the organoids enlarged with 
increasing number of crypt-like buds. These organoids were passaged after 7 
days and continued to grow (Figure  5.1). 
When isolated crypts were directly suspended within or layered on L-pNIPAM 
hydrogel under dynamic culture conditions, H&E staining showed that they 
formed spheroid-like structures consisting of a central core surrounded by 
multiple cells by day 10 to 14 (Figure  5.2 A). Alcian blue/PAS staining of these 
organoids showed the presence of mucin-producing cells which resembled 
goblet cells scattered throughout the organoid structures, associated with an 
adherent mucus layer covering the organoids by day 14 (Figure  5.2 B). 
 Morphological assessment of the organoids when released from 5.3.2
Matrigel, dissociated and suspended within or layered on L-pNIPAM 
hydrogel. 
When organoids were formed in Matrigel for 7 days, and dissociated into small 
fragments and then transferred to L-pNIPAM hydrogel they formed new 
organoids with numerous crypt-like buds within 10 days when cultured under 
dynamic culture conditions when suspended within or layered on the L-pNIPAM 
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hydrogel (Figure  5.3 A & B). Mucin-producing cells were distributed throughout 
the organoid structures when dissociated organoids were suspended within or 












Figure  5.1: Bright-field morphology of the isolated small intestinal crypts suspended 
within Matrigel for 0-14 days. Representative organoids with black arrows indicating 
crypt buds; red arrows suggesting the presence of stem cells within crypt-like buds. 
Organoid growth was shown to continue after passage at day 7 with the continual 









Figure  5.2: Morphology of the isolated small intestinal crypts when suspended directly 
within or layered on L-pNIPAM hydrogel under dynamic culture conditions for 14 days. The 
cells stained with: (A) H&E and (B) AB-PAS. Black arrows indicate mucin-producing goblet 













Figure  5.3: Morphology of the isolated small intestinal crypts when suspended within 
Matrigel for 7 days then the derived organoids were released from Matrigel and dissociated 
into small fragments and then (A) re-suspended within or (B) layered on L-pNIPAM 
hydrogel under dynamic culture conditions for 10 days. Stained with H&E: the black arrows 
indicate the crypt-like buds and AB-PAS: the black arrows indicate the adherent mucus 
layer coating the organoids and mucin-producing goblet cells. Scale bar = 20 µm. 
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 Phenotypical assessment of the organoids derived from crypts 5.3.3
suspended directly in L-pNIPAM hydrogel or in  Matrigel for 7 days 
then dissociated and  re-suspended in L-pNIPAM for 10 days 
Immunohistochemistry staining was used to determine the cellular composition 
of the organoids derived from crypts when suspended within L-pNIPAM 
hydrogel following 10 days culture (Figure  5.4 A-E) or derived from dissociated 
organoids re-suspended and cultured within L-pNIPAM hydrogel (Figure  5.4 F-
J). Lgr5 expression of intestinal stem cells was shown within the crypt-like 
structure; this was expressed alongside markers for all terminally differentiated 
epithelial cell lineages which identified the presence of enterocytes, goblet cells, 
enteroendocrine cells and paneth cells by day 10. Stem cell marker Lgr5 was 
expressed at the base of the crypt-like buds of the organoids (Figure  5.4 A and 
F). Cell-cell adhesion marker: E-cadherin was expressed under all culture 
conditions, but was most highly expressed in the Matrigel to L-pNIPAM 
organoids (Figure  5.4 B and G). Goblet cell marker MUC2 showed the presence 
of goblet cells and the adherent mucus layer covering the organoids (Figure 5.4 
C and H). The enteroendocrine cell marker: chromogranin A, showed 
immunopositive cells scattered throughout the organoid structure (Figure  5.4 D 
and I). Paneth cell marker lysozyme, was seen at the base of the organoids in 
those crypts which were suspended directly into L-pNIPAM hydrogel; whilst 
organoids which were grown in Matrigel and then moved to L-pNIPAM hydrogel 
showed a scattered distribution of lysosome positive cells throughout the 












Figure  5.4: Immunohistochemistry staining (black arrows) for Lgr5, E-cadherin, MUC2, 
Chromogranin-A, and Lysozyme of the isolated small intestinal crypts: A-E suspended 
directly within L-pNIPAM hydrogel under dynamic culture conditions for 10 days; F-J 
suspended within Matrigel for 7 days then the organoids were released from Matrigel and 
dissociated into small fragments then suspended within L-pNIPAM hydrogel under dynamic 
culture conditions for 10 days. Cell nuclei were stained with haematoxylin (blue). IgG as 




 Morphological assessment of the isolated Lgr5+ small intestinal 5.3.4
stem cells suspended within Matrigel, L-pNIPAM hydrogel, or 
layered on L-pNIPAM hydrogel  
Single Lgr5+ intestinal cells suspended within Matrigel formed intestinal 
spheroids following 5 days in culture. Between day 10 and 14, the intestinal 




When single Lgr5+ intestinal cells were suspended within L-pNIPAM hydrogel 
they proliferated and formed spheroid-like structures composed of multiple cells 
and started to form buds from day 10 to  14 (Figure  5.6 A). In contrast, when 
single Lgr5+ intestinal cells layered on L-pNIPAM hydrogel the spheroid 
structure was not observed (Figure  5.6 B). 
 
Figure  5.5: Bright-field morphology of the isolated Lgr5
+ 
intestinal stem cells suspended 







To determine the ability of Lgr5+ intestinal stem cells to maintain their stemness 
and differentiation in vitro using L-pNIPAM hydrogel; single sorted Lgr5+ stem 
cells were suspended within Matrigel for 7 days. The derived organoids were 
released from Matrigel and dissociated into single cells then re-suspended 
within or layered on L-pNIPAM hydrogel under dynamic culture conditions for up 
to 28 days. When suspended within or layered on L-pNIPAM hydrogel Lgr5+ 
cells proliferated and started to form buds and differentiated. The presence of 
goblet cells was seen after 7 days, and by day 21 to 28 the organoids had 
numerous buds containing mucin-secreting goblet cells and the organoid was 
surrounded by an adherent mucus layer (Figure  5.7 A & B).  
Figure  5.6: Morphology of the isolated Lgr5
+ 
intestinal stem cells: (A) suspended within L-
pNIPAM hydrogel and (B) Layered on L-pNIPAM hydrogel under dynamic culture conditions 








Figure  5.7: Morphology of the isolated Lgr5
+ 
intestinal stem cells suspended within Matrigel 
for 7 days then the organoids were released from Matrigel and dissociated into single cells 
and (A) were suspended in L-pNIPAM hydrogel or (B) were layered on L-pNIPAM hydrogel 
under dynamic culture conditions for 7 to 28 days. Cells were stained with H&E and AB-PAS. 




Immunohistochemical staining for Lgr5 showed that Lgr5 was expressed by the 
stem cells located at the base of the small intestinal crypts isolated from mice 
(Figure  5.8 A). When Lgr5+ stem cells were isolated, Lgr5 immunopositivity 
staining was observed in single sorted Lgr5+ intestinal stem cells in day 0 
cytospins (Figure  5.8 B). To investigate the specific binding of Lgr5 antibody to 
the stem cells, two cell lines (Caco-2 and HT29-MTX) were also investigated for 
Lgr5 positivity. Both cytospins of Caco-2 and HT29-MTX cells showed no 
expression of Lgr5 (Figure  5.8 C and D).  
Immunohistochemistry staining for differentiation markers of isolated Lgr5+ 
stem cells showed immunopositivity for E cadherin only (Figure  5.9 A). There 
was no immunopositivity for MUC2, Chromogranin A, and Lysozyme (Figure  5.9 





Figure  5.8: Immunohistochemistry staining (black arrows) for Lgr5 in: (A) the intact 
mouse small intestine, (B) cytospin of Lgr5
+ 
intestinal stem cells, (C) Caco-2 cells and (D) 









Immunohistochemistry staining for the intestinal epithelial differentiation 
markers were used to investigate the differentiation capability of single Lgr5+ 
intestinal stem cells derived from dissociated organoids which were suspended 
within or layered on L-pNIPAM hydrogel. Lgr5 was expressed in the organoids 
throughout the entire 28 days study period (Figure  5.10 A and B). There were 
many Lgr5+ cells with the highest levels at the base of crypt-like structures at 
day 21 to 28 under dynamic culture conditions (Figure  5.10 A). Cell-cell 
adhesion was investigated in the differentiated cells by E-cadherin expression. 
At the later time points of 21 and 28 days, E- cadherin was highly expressed in 
the differentiated cells of the organoids derived from Lgr5+ intestinal stem cells 
when suspended in or layered on L-pNIPAM hydrogel under dynamic culture 
conditions (Figure  5.11 A and B). Lgr5+ intestinal stem cells were differentiated 
into mucin-producing goblet cells. However, MUC2 expression was time-
dependent, with the highest levels of MUC2 immunopositivity observed in the 
organoids at the later time points of 21 and 28 days (Figure  5.12 A and B). 
Chromogranin-A immunopositivity which is indicative of the presence of 
enteroendocrine cells, was not consistantly observed during the early stages of 
Figure  5.9: Immunohistochemistry staining for (A) E-cadherin; (B) MUC2; (C) Chromogranin-A 
and (D) Lysozymes in cytospin of the isolated Lgr5
+ 
intestinal stem cells. Cell nuclei were 




organoid development, but was expressed following prolonged culture at 21 to 
28 days, when Lgr5+ intestinal stem cells were suspended within L-pNIPAM 







In contrast, Chromogranin-A was expressed in the organoids following 14 days 
when Lgr5+ intestinal stem cells were layered on L-pNIPAM hydrogel 
(Figure  5.13 B). Lysozyme expression was seen at day 7-28 indicating the 
differentiation of Paneth cells when suspended within or layered on L-pNIPAM 
hydrogel (Figure  5.14 A and B). The highest expression was observed in the 
organoids when layered on L-pNIPAM hydrogel (Figure  5.14 B).  
Figure  5.10: Immunohistochemistry staining (black arrows) for Lgr5 in isolated Lgr5
+ 
intestinal 
stem cells when suspended within Matrigel for 7 days then the organoids were released from 
Matrigel and dissociated into single cells then (A) suspended within L-pNIPAM hydrogel or (B) 
layered on L-pNIPAM hydrogel under dynamic culture conditions for 7 to 28 days. Cell nuclei 










Figure  5.11: Immunohistochemistry staining (black arrows) for E-cadherin of the isolated Lgr5
+
 
intestinal stem cells suspended within Matrigel for 7 days then the organoids were released 
from Matrigel and dissociated into single cells and (A) suspended within L-pNIPAM hydrogel; 
(B) layered on L-pNIPAM hydrogel under dynamic culture conditions for 7 to 28 days. Cell 




















Figure  5.12: Immunohistochemistry staining (black arrows) for MUC2 of the isolated Lgr5
+ 
intestinal stem cells suspended within Matrigel for 7 days then the organoids were released 
from Matrigel and dissociated into single cells and (A) suspended within L-pNIPAM hydrogel; 
(B) layered on L-pNIPAM hydrogel under dynamic culture conditions for 7 to 28 days. Cell 















Figure  5.13: Immunohistochemistry staining (black arrows) Chromogranin-A of the isolated Lgr5
+ 
intestinal stem cells suspended within Matrigel for 7 days then the organoids were released from 
Matrigel and dissociated into single cells and (A) suspended within L-pNIPAM hydrogel; (B) 
layered on L-pNIPAM hydrogel under dynamic culture conditions for 7 to 28 days. Cell nuclei 










Figure  5.14: Immunohistochemistry staining (black arrows) for lysozyme production of the 
isolated Lgr5+ intestinal stem cells suspended within Matrigel for 7 days then the organoids 
were released from Matrigel and dissociated into single cells and (A) suspended within L-
pNIPAM hydrogel; (B) layered on L-pNIPAM hydrogel under dynamic culture conditions for 7 




5.4 Discussion  
In vivo, intestinal stem cells are positioned at the base of the intestinal crypts 
and have the ability to renew the epithelium by differentiation into multiple 
epithelial progenies and initiate mucosal regeneration (Bjerknes & Cheng 2006). 
Thus, these intestinal stem cells hold great potential in tissue regeneration of 
the intestine and research groups worldwide are investigating different 
biomaterial or biological approaches to their use such as Matrigel, collagen type 
1, PGA, PLA, PLGA, (Agopian et al. 2009; Sato et al 2009; Fuller et al. 2013; 
Liu et al. 2014; Mochel et al. 2018). Matrigel was the first system utilised to 
culture these intestinal stem cells and form organoid cultures (Sato et al. 2009), 
however, Matrigel has a number of disadvantages and is not appropriate for use 
clinically. Therefore, researchers have explored the use of synthetic 
biomaterials for organoid formation with mixed success (Lahar et al. 2011; 
Boomer et al. 2014; Cromeens et al. 2016). This study investigated the potential 
of synthetic porous L-pNIPAM hydrogel as a 3D scaffold for organoid 
development from crypts and Lgr5+ intestinal stem cells under dynamic culture 
conditions. The capacity of these cells to differentiate into intestinal epithelial 
cells in vitro when suspended within or layered on L-pNIPAM hydrogel was 
investigated.  
Laminin and collagen rich Matrigel 3D scaffold was originally used to develop 
intestinal epithelial culture (Sato et al. 2009); as this was rich in both laminin α1 
and α2 which are highly expressed in the base of native mice intestinal crypts 
and are required to support normal villus-crypt morphology (Sasaki et al. 2002) 
Sato et al. 2009 developed an in vitro culture system capable of developing 
intestinal organoids from crypt cells and single Lgr5+ stem cells. In these 
systems, the growth media was supplemented with epidermal growth factor 
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(EGF), the BMP antagonist Noggin, and the Wnt agonist R-spondin 1. Here, this 
culture system was replicated and successfully demonstrated the development 
of organoids in Matrigel. These organoids showed the presence of a central 
core lined with villus-like domains surrounding by crypt-like structures by day 14. 
These crypt-like domains maintained the basic crypt-villus morphology of the 
intestinal epithelium and later the central core became filled with dead cells. The 
structure of these organoids was maintained over several passages. These 
observations agree with those previously seen utilising Matrigel (Sato et al. 
2009, 2011a; Fuller et al. 2012) which revealed organoids derived from crypt 
cells consisted of crypts (with occupant Lgr5 cells, Paneth cells and transit 
amplifying cells (TA)) surrounded a central lumen lined by all terminally 
differentiated epithelial lineages. In Matrigel, cells proliferated, differentiated, 
and shed into the central lumen following 5 days which mimics in vivo behaviour 
(Clevers 2013). Despite the potential advantages of Matrigel, particularly the 
similarity to native ECM (Reed et al. 2008), there are also a number of 
disadvantages, which make Matrigel inappropriate for clinical applications 
including: high batch variability; sourced from cancerous tissues (Engelbreth-
Holm-Swarm mouse sarcoma) and low mechanical stiffness (Reed et al. 2008; 
Soofi et al. 2009).  
Hence, this has led to the used of synthetic scaffolds with well-defined 
biochemical and biophysical properties as a scaffold for intestinal tissue 
engineering (Choi & Vacanti 1997; Gjorevski et al. 2014; Shaffiey et al. 2016). 
This current study demonstrated that the synthetic highly porous L-pNIPAM 
hydrogel facilitated crypt cell seeding and adhesion, however, bud structures 
were not observed when crypt cells were directly layered on the L-pNIPAM 
hydrogel. Nevertheless, immunohistochemical staining demonstrated Lgr5 
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positive stem cells together with all cells expressing positive markers for all 
differentiated cells (enterocytes, goblet cells, enteroendocrine cells and Paneth 
cells) were seen in these organoids despite the lack of bud formation. In 
contrast, when crypts were suspended within Matrigel for 7 days then released 
from Matrigel, dissociated into small fragments and re-suspended within or 
layered on L-pNIPAM hydrogel for 10 days under dynamic culture conditions 
the organoids had multiple buds containing mucin-secreting goblet cells. This 
suggests that isolated crypts require ECM signals to form organoids with crypt-
like buds which was provided by the Matrigel.  
Synthetic scaffolds have been used previously to culture intestinal crypts, these 
crypts have been seeded directly into porous PLGA scaffold (young's modulus 
= 1-2 GPa) (Costello et al. 2014b), or into PLGA coated in either Matrigel 
(Shaffiey et al. 2016) or collagen (Cromeens et al. 2016). It has been shown 
that microfabricated PLGA scaffolds which mimic the villus structure, coated 
with Matrigel could be utilised to co-culture mice intestinal crypts alongside 
myofibroblasts and macrophages. Here, intestinal organoids proliferated and 
filled the entire synthetic villus. Furthermore the cells were shown to 
differentiate into all the intestinal cell lineages. However, these fabricated 
scaffolds did not form true-villi, but the scaffolds moulded to form villi like 
structures for cells to grow on.  In contrast co-cultured human colon carcinoma 
cell lines Caco-2 and HT29-MTX cells grown on L-pNIPAM have been shown to 
spontaneous give rise to villus-like structures (Dosh et al. 2017). In the current 
study, cultures demonstrated the early stages of organoid formation and cellular 
differentiation. It remains to be determined if longer cultures of these organoids 
were performed whether spontaneous villi formation would be seen. 
Alternatively, transplantation of the L-pNIAPM organoids in in vivo models may 
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induce villi formation as has been seen previously with transplantation of 
organoids using PLGA scaffolds (Agopian et al. 2009; Yui et al. 2012; van Rijn 
et al. 2016). 
Similarly to the crypt culture, Matrigel has been used as a basement membrane 
matrix for stem cells due to its capacity to maintain self-renewal 
(undifferentiated state) of the stem cells (Hughes et al. 2010). Here, Lgr5+ ISCs 
were cultured in Matrigel and / or L-pNIPAM hydrogel in the presence of growth 
factors and the Rho kinase inhibitor Y-27632 (which inhibits stem cell anoikis). 
The current study found that the isolated Lgr5+ stem cells formed organoids with 
multiple crypt-like buds when grown in Matrigel. These agree with previous 
studies which showed that organoids were generated in Matrigel from single 
Lgr5+ stem cells after 5 days (Sato et al. 2009, 2011a; Sato & Clevers 2012, 
2013, 2015).  
Lgr5+ stem cells also survived, proliferated and started to form buds following 
10 days when suspended directly within L-pNIPAM hydrogel. Similalry, when 
organoids were initially formed in Matrigel, then dissociated into single cells and 
suspended within or layered on L-pNIPAM hydrogel the stem cells generated 
crypt-like buds within 21 days. Furthermore, expression of markers of 
enterocytes, mucus producing goblet cells, enteroendocrine, and Paneth cells 
together with a residing population of Lgr5 stem cells were observed, 
suggesting that expanded Lgr5+ stem cells can be differentiated into the four 
main types of the intestinal epithelial cells when suspended within or layered on 
L-pNIPAM hydrogel. However, it is unknown whether the cells released from the 
organoid cultures developed in the Matrigel were stem cells or differentiated 
cells. It has been shown previously that enterocyte progenitors can become 
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proliferative stem cells and Paneth-like cells during crypt regeneration to 
replenish stem cell loss. Not only enterocyte progenitors dedifferentiated to 
stem cells but also secretory progenitors, which derived from Lgr5+ stem cells 
and generate goblet cells, enteroendocrine cells and Paneth cells de-
differentiated to stem cells in vivo to replace lost stem cells (Van Es et al. 2012). 
Thus, the cells derived from the dissociated Matrigel organoids could have been 
stem cells or differentiated cells which then de-differentiated to an earlier 
progenitor cell which then went on to form later organoids in L-pNIPAM 
hydrogels.  
Gjorevski et al (2016) reported the first synthetic matrix for the expansion of 
mouse and human ISCs. They tested the effect of matrix mechanical properties 
on the ISC survival, proliferation, expansion and differentiation. It has been 
shown that varying stiffness of polyethylene glycol (PEG) hydrogel and ECM 
components were required for ISC expansion and organoid formation. 
Fibronectin based adhesion was required for intestinal stem cells survival and 
proliferation, whilst ISC expansion required high matrix stiffness. Soft matrix and 
laminin-based adhesion was required for intestinal stem cells differentiation and 
organoid formation. To study the relation between the matrix stiffness and the 
intestinal crypt and stem cell behaviours, the low stiffness Matrigel (young's 
modulus ˂ 500 Pa) was compared to the high stiffness of L-pNIPAM hydrogel 
(storage modulus= 0.18-2.8 MPa) (Chapter 3). The results have shown that the 
stiff L-pNIPAM hydrogel and the soft Matrigel, supported intestinal crypts and 
stem cells survival, differentiation and organoid formation under dynamic culture 
conditions. These findings are in agreement with (Chapter 3) study which 
demonstrated the potential of L-pNIPAM hydrogel to maintain, differentiate, and 
stimulate of both Caco-2 and HT29-MTX cells to form villus-like structures 
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compared to low stiffness alginate where the cells formed spheroid-like 
structures under dynamic culture conditions (Dosh et al. 2017). Despite these 
promising findings, future work is required to investigate the ability of L-pNIPAM 
hydrogel as scaffold to crypts and Lgr5+ stem cells isolated from human small 
intestine and colon.  
In conclusion, L-pNIPAM hydrogel was a suitable scaffold to support the 
formation of organoids in vitro from small intestinal crypts and Lgr5+ stem cells 
isolated from mice and supported appropriate cell differentiation. Thus, further 
studies are required to investigate host-pathogen interactions, or to test drug 




Chapter 6: General discussion  
 















The small intestine is a complicated hollow organ with numerous histological 
and functional layers that enable digestive functions. This active tube is 
comprised of an inner layer of absorptive mucosa, a middle layer of connective 
tissue, and smooth muscle, and an outer layer of serosa (McCance & Huether 
1998; Tortora & Derrickson 2016). Inflammatory bowel diseases (IBD) such as 
Crohn's disease and ulcerative colitis are characterised by inflammation at the 
mucosal surface, which has defects in its barrier and secretory functions, 
resulting from a disruption of the gut immune homeostasis (Munkholm et al. 
1994; Landy et al. 2016). The exact pathophysiology of IBD is not fully 
understood and curative therapies are lacking. Several effective models for the 
intestinal epithelium exist, each model has a number of advantages and 
limitations, and thus choosing the appropriate model for a specific research 
problem is essential. The best of these models are combining all cells types that 
are implicated in the IBD disease process.   
The overall aim of the studies presented in this thesis was to develop several 
models of the small intestine that can be used to investigation of IBD. Studies 
were performed by: (1) Using  genetically engineered model of IL-1Ra knockout 
mice to develop a model of inflammatory bowel disease; (2) using human 
adenocarcinoma-derived intestinal cell lines (Caco-2 and HT29-MTX cell) 
cultured on natural and synthetic hydrogel systems to investigated potential 
hydrogel which could be used to develop an in vitro 3D model of the small 
intestinal villi, and then these cells were co-cultured on L-pNIPAM hydrogel 
scaffolds under conditions which mimic those of inflammatory bowel disease to 
develop an in vitro inflamed human intestinal epithelium; (3) mice intestinal 
crypts or stem cells were used to investigate the differentiation capacity of these 
210 
 
stem cells when suspended within or layered on L-pNIPAM hydrogel scaffolds 
to develop an in vitro 3D model of intestinal organoids.  
Development of genetically engineered murine models of intestinal inflammation 
is a useful tool to understand the intestinal inflammation seen during 
inflammatory bowel disease (Cominelli et al. 1990; McCall et al. 1994; Al-Sadi 
et al. 2008). In this thesis, a number of essential features associated with IBD 
were investigated in the small intestine of IL-1Ra knockout mice model. 
Histological staining was performed on jejunum and ileum of BALB/c IL-1rn+/+ 
and IL-1rn-/- mice from two age groups to characterize the crypt-villus height, 
villus width, and number of goblet cells per crypt-villus axis. Pro-inflammatory 
cytokines; immune cell infiltration; matrix-degrading enzymes; the production of 
intestinal enzymes and the integrity of tight and adherent junction proteins was 
determined using immunohistochemistry. Genetically engineered model of IL-
1Ra knockout mice studies within Chapter 2, demonstrated that the height of 
crypt-villus axes were significantly reduced in BALB/c IL-1rn-/- mice, whilst villi 
width was decreased in the ileum compared to wild-type mice. Goblet cells per 
crypt-villus were increased, as was the expression of mucin. Proinflammatory 
cytokines expression were increased, whilst IL-1R1 expression was decreased 
in IL-1rn-/- mice, with IL-15 and TNFα expression being increased in older IL-
1rn-/- mice. Increased polymorphonuclear and macrophage cell infiltration was 
also seen in IL-1rn-/- mice, whilst expression of matrix-degrading enzymes and 
digestive enzymes were unchanged, except for dipeptidyl peptidase IV which 
was increased in younger IL-1rn-/- mice. The expression of tight and adhesion 
junctions were dramatically decreased in IL-1rn-/- mice. These data highlighted 
the importance of IL-1 in the pathogenesis of inflammatory bowel disease.   
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While genetically-modified IL-1Ra knockout mice are able to readily induce 
symptoms of IBD, this in vivo animal model shows some limitations. In vivo 
animal testing is expensive and ethically debatable in comparison to in vitro 
studies. Furthermore, species differences between rodents and humans make 
the interpretation of data from animal testing more complicated. Thus, to reduce 
the cost and ethical issues raised by using in vivo animal models, cell culture-
based in vitro models have been suggested as an alternative to animal testing.  
Caco-2 and HT29-MTX human colon adenocarcinoma cell lines were used in 
this thesis to develop an in vitro 3D cell culture model of intestinal epithelium 
using highly hydrated natural and synthetic hydrogels. Several hydrogel 
systems have been developed for 3D cell culture applications to develop villus-
like structures (Kim et al. 2014; Costello et al. 2014b; Yi et al. 2017), however to 
date, none of these systems have demonstrated the formation of villus-like 
structures without fabrication of these systems using a 3D villi scaffolds. In 
order to assess the metabolic activity and differentiation of Caco-2 and HT29-
MTX cells into enterocytes and goblet-like cells respectively; alginate, L-
pNIPAM, and L-pNIPAM-co-DMAc hydrogels scaffolds were used, alongside 
different cell culture conditions to  investigated if it is possible to develop a 3D 
model of the small intestinal villi in vitro. Caco-2 and HT29-MTX cells were 
suspended within or layered on these hydrogel scaffolds. Both static and 
dynamic culture conditions were used to mimic the fluid flow of luminal content 
over the intestinal surface. In vitro cell culture studies performed in Chapter 3 
demonstrated that the L-pNIPAM hydrogel scaffolds supported layered Caco-2 
growth in 3D culture under dynamic culture conditions and gave rise to villus-
like structures. Caco-2 cells showed cell polarization of enterocytes like cells 
which had microvilli on their apical side. There was the expressed neutral mucin, 
212 
 
small intestinal enzymes, and the presence of functional tight junction protein. 
Similarly, L-pNIPAM hydrogel scaffolds supported growth of layered HT29-MTX 
cells in 3D culture and formed villus-like structures, where they expressed 
MUC2 mucin, a characteristic of the small intestine. 
However, one cell type alone cannot mimic the whole tissue behavior in case of 
IBD. The in vitro study of the pathogenesis of IBD requires a cell model which 
closely reflects the characteristics of the in vivo intestinal epithelium. Thus, an 
investigation was made of the potential of L-pNIPAM hydrogel scaffolds to 
develop long-term 3D co-cultures of layered Caco-2 and HT29-MTX cells under 
conditions representative of inflammation by treatment with IL-1β, TNFα, and 
hypoxia (1% O2) for 1 week. In this thesis, a number of critical features 
associated with IBD were investigated in the co-culture model, including: 
metabolic activity, morphology and the expression of tight junction protein (ZO-
1), mucins, digestive enzyme, matrix degrading enzymes, and the induction of 
apoptosis. In vitro studies performed in Chapter 4 demonstrated that L-pNIPAM 
hydrogel scaffold successfully supported long-term co-cultures under dynamic 
culture conditions. Furthermore, these co-cultured cells had the ability to mimic 
the state of inflammation with the increased expression of intestinal 
inflammation markers.   
However, these findings might not always be physiologically relevant to 
epithelial tissue in‎ vivo due to the fact that the cells utilised are derived from 
tumours. Thus, this thesis went on to determine whether the hydrogel system 
could be utilised to support growth and differentiaton of intestinal stem cells. 
Lgr5 has been identified as a robust intestinal stem cell marker (Barker et al. 
2007), and subsequently the formation of the 3D organoid model when isolated 
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single Lgr5+ stem cells or crypt fractions are embedded in Matrigel (Sato et al. 
2009), has enhanced studies of the intestinal epithelium. Therefore, the 
potential of L-pNIPAM hydrogel scaffolds to develop 3D intestinal stem cell 
organoid model was investigated. In this thesis, small intestinal crypt cells, and 
Lgr5+ stem cells were isolated from mice and cultured within matrigel or within 
or on L-pNIPAM hydrogel in variable conditions, in the presence of R-spondin, 
Noggin, and epidermal growth factors to mimic the physiological conditions of 
the intestinal stem cell niche. In order to investigate the ability of single Lgr5+ 
intestinal stem cells or crypt fractions to form crypt-like buds and the 
differentiation capacity of intestinal stem cells into four different intestinal 
epithelial cells, morphology and expression of differentiation markers were 
investigated. The in vitro study in Chapter 5 demonstrated that stem cells 
generated crypt-like buds within 21 days. Moreover, expression of markers of 
enterocytes, mucus producing goblet cells, enteroendocrine, and Paneth cells 
indicating that expanded Lgr5+ stem cells can be differentiated into the four 
main types of the intestinal epithelial cells when suspended within or layered on 
L-pNIPAM hydrogel. 
Overall the work from this thesis presents a number of models of small intestine. 
This thesis has shown that IL-1rn-/- mice developed spontaneous abnormalities 
which displayed features associated with IBD suggesting a causative role in IBD 
rather than simply and increase due to inflammation. In addition, this thesis has 
demonstrated that L-pNIPAM hydrogel supported long-term 3D co-culture 
model and stimulation with factors seen during inflammation recapitulated 
features of IBD. Together this thesis has shown the ability of L-pNIPAM 
hydrogel as scaffold to support organoid formation and cell differentiation in 
vitro from small intestinal crypts and Lgr5+ stem cells isolated from mice. 
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6.1 Future directions 
 Genetically engineered animal model  6.1.1
The genetically engineered IL-Ra knockout mice model discussed in this thesis 
has demonstrated its potential as a valuable model in understanding the role of 
IL-1 in the pathogenesis of IBD. This model could be used for preclinical 
efficacy testing of new therapeutic candidates. Although within this model the 
innate immune response to intestinal inflammation was investigated, the 
responses of adaptive immune system such as T, B lymphocytes, and T helper 
cells to intestinal inflammation need to be investigated. Furthermore, it would be 
useful to investigate the effects of IL-1Ra knockout within different mice 
backgrounds to ensure these effects are not strain dependent.   
 Epithelial cell culture model 6.1.2
Work accomplished in this thesis demonstrated the potential of L-pNIPAM 
hydrogel to develop an in vitro 3D co-culture model to mimic the state of 
inflammation under dynamic culture conditions. However, in the further studies 
of the inflammatory process it is necessary to investigate the crosstalk between 
epithelial cells and immune cells such as macrophages, lymphocytes, or 
dendritic cells, which are responsible for the production of pro-inflammatory 
cytokines. This will enable a model which can combine different cell types and 
accurately reflect the in vivo model to study the interaction between cell types 
and evaluation of their role in barrier integrity. In the intestine, fluid flow and 
peristalsis-like motion stimulate the proliferation and differentiation of epithelial 
cells (Kang & Kim 2016). Hence, in human intestinal disease model, it is very 
important to engage peristalsis-like mechanical deformation. Thus, the ability to 
develop a perfusion bioreactor lined by L-pNIPAM hydrogel to cultivate co-
culture cells need to be developed. The ease of manipulation of the L-pNIPAM 
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hydrogel should allow this to be formed inside a tube system where cells can be 
seeded on the surface and though which media could be passed. 
 Intestinal stem cell organoid model 6.1.3
The survival and differentiation of intestinal crypts and Lgr5+ stem cells isolated 
from mice cultured on L-pNIPAM hydrogel for up to 28 days is extremely 
promising for future studies to investigate host - pathogen interactions or to test 
drug delivery and toxicity. Successful trials in the transplantation of organoids, 
derived from a single Lgr5 colon stem cell, in murine models of experimental 
colitis Yui et al. (2012) and Fukuda et al. (2014) suggests that intestinal stem 
cell transplantation may establish a new treatment strategy for repairing 
mucosal barrier function in patients with IBD or indeed Crohn's disease. In this 
thesis, a mice intestinal organoid model was developed, however, mice models 
may have limitations in their ability to accurately model human intestinal 
physiology, future work is required to investigate the potential of L-pNIPAM 
hydrogel to generate organoids from human intestinal crypts isolated from 
healthy and diseased biopsies or surgically resected tissues alongside 
cultivation of isolated human intestinal stem cells to provide an opportunity to 
advance gastrointestinal research and therapy. In addition, the L-pNIPAM 
system would be interesting to investigate the ability of the organoid model to 
include other cellular components such as nerve, muscle, and immune cells. 
Advanced studies in this field could result in the development of alternative 
therapies for human intestinal disease.  
Together the data presented in this thesis has developed a number of models 
which can be utilised in the study of the pathogenesis of IBD and determine 
efficacy of new therapeutic treatments for IBD. Their further development will 
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